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Cytochrome P-450 monooxygenases catalyse the insertion of molecular oxygen into 
unactivated carbon-hydrogen bonds. This reaction is difficult tn rnrndiiee 
synthetically; therefore cytochrome P-450 enzymes are of great interest as potential 
biocatalysts. Of all the cytochrome P-450 systems investigated to-date cytochrome P-
450cam from, Pseudomonas Putida, is probably the best characterized. The use of 
cytochrome P-450cam, as a biocatalyst, is hampered by the narrow substrate range. 
This was overcome by use of the cytochrome P-450cam Y96A mutant. To identify 
the substrate range of the enzyme a model of the cytochrome P-450cam binding site 
was generated and potential substrates were modelled. However discrenancs 
between predicted and observed results necessitated a more rigorous study of the 
mutant binding site. Conditions were developed and the cytochrome P-450cam 
mutant enzyme was crystallized in the presence of a number of substrates. Six 
different substrate bound structures were then solved by X-ray crystallography. With 
a crystal structure of the binding site, it was then possible to perform more rigorous 
molecular modelling; this was achieved with the modelling program DOCK. 
Biotransformations and binding studies were performed with a range of substrates, to 
test the validity of the modelling and to characterize the substrate specificity of the 
cytochrome P-450cam Y96A mutant. 
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AS 	 Ammonium sulfate 
BM-3R 	P-450BM-3 reductase 
buffer AS 	Ammonium sulfate buffer (1 M, pH 7.4) in buffer Pi 
buffer Pi 	Phosphate buffer (40mM, pH 7.4) 
buffer Pi-cam 	Phosphate buffer (40mMi, pH 7.4) with 1 mM camphor 
buffer T 	Tris buffer (50 mM, pH 7.2) 
DEAE 	Diethylamino ethyl 
DTT 	 Dithiothi-ejtol 
e Extinction coefficient 
FLD Flavodoxjn from E.coli 
FLDR Flavodoxin reductase from E. coli 
GC Gas chromatography 
GUMS Gas chromatography with mass spectral analysis 
H-bond Hydrogen bond 
IIPLC High pressure liquid chromatography 
IPA Isopropyl alcohol 
IPTG Isopropylthiogalactosjde 
JM1 09 E. coli strain JM1 09 
kbp Thousand base pairs 
kDa Thousand daltons 
t-ir Ligand it orbital to it orbital charge transfer 
MWt Molecular weight 
ME) Molecular dynamics 
moI2 SYBYL mol2 data format 
NADH Nicotinanijde adenosine dinucleotjde (reduced form) 
NIMR Nuclear magnetic resonance spectroscopy 
x 
OYE Old yellow enzyme 
P-450 Cytochrome P-450 monooxygenase 
P-450BM-3 Cytochrome P450 fatty acid monooxygenase from Bacillus 
megaterium 
P-450cam Cytochrome P-450 camphor monooxygenase from Pseudomonas 
putida 
P-450eryF Cytochrome P-450 monooxygenase from Saccharopolyspora 
erythraea 
P-450terp Cytochrome P-450 terpme monooxygeuase from Pseudomonas spp. 
PAGE Polyacrylamide gel electrophoresis 
pAW7292 Plasmid with code pAW7292 
Pd Putidaredoxin 
pdb Protein databank 
PdR Putidaredoxm reductase 
PEG Polyethylene glycol 
PMS Phenazine methylsulfate 
OD Optical density 
Rfactor Rfactor 	I FO ,Sj _I Fcaic I I / I FobJ 
Rñ-ee &actor calculated for 5 % omitted reflections 
rmsd Root mean squared deviation 
Rsym RymII..<ZI>III. 
Sd Spinach ferredoxin 
SdR Spinach ferredoxin reductase 
SDS - 	Sodiumdodecylsulphate 
TB 'Terrific broth" 
TBamp TB with 1 mM ampicillin 
TBcm TB with 1 mM chloroamphemcol 
UV/Vis Ultraviolet and visible range 
xii 
;\tf3RFV1 6.T0N 
Y96A 	Cytochrome P-450cam Y96A mutant 
Amino acid one letter codes used: 
Alanine (A), Arginine (R), Asparagine (N), Aspartate (D), Cysteine (C), Glutamate (E), 
Glutamine (Q), Glycine (G), Histidine (H), Isoleucme (I), Leucine (L), Lycine (K), 
Methionine (M), Phenyl Alanine (F), Proline (P), Serine (S), Threonine (T), Tiyptophan 
(W), Tyrosine (Y), Valine (V). 
Amino acid three letter codes used: 
Alanine (Ala), Arginine (Arg), Asparagine (Asn), Aspartate (Asp), Cysteine (Cys), 
Glutamate (Glu), Glutamine (Gin), Glycine (Gly), Histidine (His), Isoleucine (Iso), 
Leucine (Leu), Lycine (Lys), Methionine (Met), Phenyl Alanine (Phe), Proline (Pro), 
Serine (Ser), Threonine (Thr), Tryptophan (Trp), Tyrosine (Tyr), Valine (Val). 
Mutant protein coding system used: 
Y96A, F87A etc. : The first letter for the original amino acid and the last for the amino 
acid inserted, the number corresponds to the residue number. 
1)Sambrook, J.; Fritsch, E.; Maniatis, T. Molecular Cloning; 2nd ed.; Cold Spring 
Harbour Laboratory Press:, 1989. 
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1 Introduction. 
1.1 Oxygenases. 
The direct incorporation of molecular oxygen into a molecule is a type of 
oxidation known as oxygenation and it is catalyzed by enzymes called oxygenases.' 
There are three general mechanisms for oxygenation: 
Monooxygenation is the incorporation of one oxygen atom from molecular oxygen 
into a substrate, the other oxygen being reduced at the expense of a proton donor 
(usually NADH or NADPH), to form water. Monooxygenasaes are then sub 
divided into two classes, internal and external, 2 depending on whether the source 
of hydrogen for the water molecule comes from an 'external' donor or the substrate 
itself (internal). 
Di-oxygenation, the transfer of both molecular oxygen atoms to a substrate, 
(enzymes catalyzing these reactions are known as oxygen transferases as well as di-
oxygenases). 
Oxidation catalyzed by oxidases, which involves the transfer of two or four 
electrons utilizing either water or hydrogen peroxide as the acceptor. 
1 
These reactions proceed via general mechanisms, figure 1.1. 
	
Internal monooxygenase: 	 Sub-H2 + 02 	 SubO + H20 	 1 
External monooxygenase: 	Sub + 2Donor-H +02 	 SubO + 2Donor + 1120 	2 
Di-Oxygenases: 	 SubO2 	 Sub02 	 3 
Oxidases: 	Sub-H2 + 1/202 	 Sub + H20 	 4 
Sub-H2 +02 	 Sub + H202 	 5 
Sub-H +02 	 Sub +1102 	 6 
Figure 1.1: Types of oxygenation reaction (Sub = Substrate). Examples: 1- L-lysine monooxygenase; 
2- cytochroine P450; 3- tryptophan pyrolase; 4- cytochrome oxidase; 5- D-amino acid oxidase; 6- 
xanthine oxidase. 1,3 
Of these types of oxygenases the group of interest in this study is that of the 
monooxygenases. 
1.2 Monooxygenases. 
Mono oxygenases can catalyze a range of oxidations such as the epoxidation of 
alkenes, 4 sülfoxidation, 5 Baeyer-Villiger reactions, 6 dehalogenation 7  and C-C bond 
scission. 8  Monooxygenases can contain a heme cofactor as the catalytic centre (e.g. 
cytochrome P-450 9 and catalase 10),  although they can utilize an iron centre without 
heme. Of all these enzyme systems, cytochrome P-450 is the one that has been most 
extensively studied and is of interest here. 
1.3 Cytochrome P-450. 
Cytochrome P-450 (or P-450 monooxygenase) is a class of monooxygenase 
first isolated from mammalian cells in the adrenal cortex and in liver microsomes. 11,12  
Their name arises from the b-type heme group, which has an absorbance (or pigment, 
P) at 450 nm when bound to carbon monoxide. 13 Their natural substrate range varies 
in size from ethene (MWt of 28) to cyclosporin (MWt of 1201). They react with many 
diverse substrates, including: fatty acids; steroids; prostaglandins; drugs; anesthetics; 
organic solvents; alcohols; pesticides and carcinogens. They occur in nearly all types 
of living organism, from mammals 14-16  and yeast 17  to plants and bacteria. 18"9 P-450 
monooxygenases were first correctly identified, in mammals, in the 1960's 20  and they 
have been shown to be responsible for a wide range of biological functions from 
metabolism of xenobiotics (especially drugs, steroids and lipids) to detoxification, 2 ' 
which in some cases leads to the unwanted production of carcinogens. Examples of 
the wide range of reactions catalysed by P-450 monooxygenases are shown in figure 
1.2. 
The nomenclature for cytochrome P-450 was standardized in 1991 22  and by 
1995 the cytochrome P-450 gene super-family has been classified into 36 subgroups 
and many subfamilies. The P-450 monooxygenase family is now classified by the 
letters CYP followed by the number of the gene family, the letter of the subfamily and 
lastly by a number for the individual enzyme (e.g. CYP1 1A1- family 11, subfamily A, 
enzyme number 1; formally called P-450scc). The simpler eukaryotes have numbers 
starting at 50, e.g. yeast. However for bacterial P-450 monooxygenases, all numbered 
with gene family numbers over 100, the traditional names are still commonly in use 
(e.g. P-450cam, P-450terp etc.). 
3 
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Figure 1.2: Examples of reactions catalyzed by cytochrome P450, where A is a hetero atom and R is 
a hydrocarbon: 23 1-Carbon hydroxylation; 24 2-Heteroatom hydroxylation; 3-Deallcylation; 4-




Due to this potential confusion the modern CYP numbers and traditional 
cytochrome P-450 names of the most common bacterial P-450 monooxygenases are 
tabulated below. 
Table 1.1: Common bacterial P450 monooxygenases with their traditional and modern names and 
with the host organism: 9 
CYP number P-450x, where x= original bacterial source 
101 cam Pseudomonas putida 
102 BM-3 Bacillus megaterium 
105A1/B1 
1 05C 1 













107A1 eryF Saccharopolyspora erythraea 
108 terp Pseudomonas sp. 
The gene identity between all P-450 monooxygenases is less than 20 % 
however between families it can rise to 40 % and between subfamilies greater than 55 
% identity is observed. These percentages are biased by two areas of strong sequence 
identity, one for the proposed oxygen binding pocket the other for the heme binding 




367 	G1 QHL 	P450terp 
347 QH P450cam 
390 	P QQI1 P450BM-3 




In humans the function of cytochrome P-450 is of interest because of their role 
in drug metabolism and activation of procarcinogens. 3 ' Human and eukaryotic P-450 
monooxygenases generally are present in very small quantities, are hard to purify and 
are often membrane bound; therefore the focus of cytochrome P-450 research has 
been on the soluble, bacterial P-450 monooxygenases and the more readily available 
rat liver cytochrome P-450, P-450LM2. Recently however eukaryotic P-450 
monooxygenases have been expressed in mammalian 32  and insect 33,14  cell lines, yeast 
35 and E. coil -I36 the reconstitution of these membrane bound species into active forms 
is rapidly advancing. 37 
Cytochrome P-450 has the potential to be a useful catalysts in synthetic 
chemistry because they can oxidize unactivated carbon-hydrogen bonds. Eukaiyotic 
P-450 monooxygenases involved in detoxification can have a wide substrate 
specificity and low stereo selectivity 38  however prokaryotic P-450 monooxygenases 
tend to be stereoselective as well as having greater availability of genes, making them 
of potential interest as catalysts. 
The bacterial P-450 monooxygenases studied to date are able to hydroxylate a 
wide variety of substrates: Pseudomonas putida (ATCC 17453) produces a 
cytochrome P-450 that can utilize camphor as its sole carbon source, P-450cam (see 
later). Pseudomonas putida (PpG777) has a cytochrome P-450 which hydroxylates 
linalool [jJ (P-4501in), figure 1.4. 
OH 	
• 
OH 	 0 
Figure 1.4: Schematic of Linalool [1] hydroxylation by P-4501in. 39 
ii 
NIRC  
Another Pseudomonas sp. hydroxylates a-terpine (P-450terp). Bacillus 
megaterium (ATCC 14581) has two fatty acid hydroxylases: P-450BM-1 40  which has 
27 % sequence homology to P-450cam from P.putida and, the better characterized P-
450BM-3, which has greater sequence homology to mammalian P-450 
monooxygenases than even to P-450BM-1. In addition to these fatty acid 
hydroxylases another Bacillus megaterium (ATCC 13368) has a steroid hydroxylase 
P-450meg. 41 ' 42  Other well characterized P-450 monooxygenases can hydroxylate 
substrates from cyclohexane (Xanthobacter sp. 40), hexadecane (Acinetobacter 
calcoaceticus 43)  and 2-ethoxyphenol (Moraxella sp.). A large number of the P-450 
monooxygenases characterized to date belong to the actinomycetes of which P-
450eryF (Sacchropolyspora erythraea); P-450sca- 1, P-450sca-2 (Streptomyces 
carbophilus);. P-450choP (Streptomyces sp.); P-450su- 1 P-45 Osu-2 (Streptomyces 
griseolus) and P-450soy (Streptomyces griseus) are the most well known. 
The importance of research into cytochrome P-450 can be demonstrated 
when recombinant DNA technology became available; a bacterial P-450 
monooxygenase, cytochrome P-450cam, was one of the first proteins whose DNA 
was cloned and sequenced. 44  Cytochrome P-450cam consequently became the most 
extensively studied 4l and was the first cytochrome P-450 to have its crystal structure 
solved. 46 
1.4 Cytochrome P-450cam Monooxygenase. 
Cytochrome P-450cam, 9 ' 47 is a class II monooxygenase and was isolated from 
Pseudomonas putida (P.putida- ATCC 17453)48  which metabolizes the monoterpene 
camphor to ultimately produce acetate and isobutyrate, thus allowing P.putida to 
utilize camphor as the sole carbon source, 4748 figure 1.5. 
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________ ________ 	 + 
isobutyrate 
Figure 1.5: Metabolism of Camphor by Pseudomonas Putida. 
Cytochrome P-450cain 
5-Hydroxycamphor dehydrogenase 
Cytochrome P-450cam catalyses the first step in the catalytic cycle i.e. 
conversion of camphor [2] to produce 5-exo-hydroxycamphor [3],45  figure 1.6. 
9 
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Figure 1.6: The hydroxylation of camphor by cytochrome P-450cam with the standard numbering of 
camphor is shown for clarity. 
I 	 ( \:  
1.4.1 	Why Do We Study Cytochrome P-450cam? 
The oxidation of unactivated carbon centres is difficult synthetically, requiring 
harsh conditions such as high temperatures or extreme pH. An additional problem that 
is the stereoselectivity is hard to control. There are a number of reasons for using 
cytochrome P-450cam to catalyze a monooxidation; the oxidation is highly regio- and 
stereo-selective and can be performed under mild conditions. The enzyme has been 
extensively studied because its gene has been cloned and over-expressed in the 
heterologous host E. coil allowing substantial amounts of soluble protein to be 
purified to homogeneity. 49 However these conditions can be equally applied to some 
of the other prokaryotic P-450 monooxygenases discussed previously. There is strong 
homology between both the cytochrome P-450 mechanism and structures 30,50  and 
since we are studying the complex interactions between substrates and enzyme the 
availability of structural information is also essential and, to date, only six different P-
450 monooxygenases have solved crystal structures. Of these P-450 monooxygenases 
the enzymes best studied are P-450cam and P-450BM-3. The choice of cytochrome 
P-450 therefore comes down to substrate range which is either a fatty acid, in the case 
of P-450BM-3 or a small hydrophobic molecule for P-450cam. It was determined that 
the P-450cam could yield the type of hydroxylated substrates we desired. 
{)' 
1.4.2 	P-450cam Catalytic Cycle. 
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Figure 1.7: The P-450cam oxidation cycle.45'5 53 
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This water molecule and its subsequent displacement holds the key to the 
oxidation process. 56  As a substrate enters the binding site the water ligand is displaced 
converting the hexa-coordinate low-spin iron (S1/2) into a penta-coordinate high-
spin (S=512) state, 57  ii (although evidence suggests the presence of substrate near the 
heme also plays a role in spin state change). 58 This change in the electronic 
configuration of the iron has an effect of increasing the reduction potential of the 
heme from -300 mV to -170 mY. 59 
Putidaredoxin (Pd) is an electron transfer protein required in the P-450cam 
pathway. Putidaredoxin has a reduction potential of -240 mV which changes to -196 
mV upon binding to P-450cam. Thus when putidaredoxin interacts with the 
cytochrome P-450, containing heme in a high-spin state, it can transfer its electron to 
P-450cam and consequently to the heme, thus changing the penta-coordinate iron 
from Fe(III) to Fe(II), iii. 
This change in oxidation state of the iron allows binding of molecular oxygen, 
which is known to bind to iron(II). 60 Oxygen is believed to be present in the binding 
site and possibly binds to a cleft around threonine 252.60  Upon binding, the iron 
transfers the electron to the molecular oxygen thus reducing the iron back to give a 
hexa-coordinate Fe(III) species, iv. 53 This is known because the bound 0-0 
stretching frequency is detectable by Raman spectroscopy. 6 ' This species is the last 
fully detectable intermediate in the catalytic cycle and is unstable with a half life of 
-90 ns. 
The electrode potential of this oxygen bound iron is unknown however it is 
sufficiently low to allow the transfer of a second electron from Pd. The electron 
transfer of the second electron step is faster than the first thus in high concentrations 
of Pd the first electron transfer is rate limiting. However at physiological 
concentrations the second step becomes limiting. This additional electron converts the 
hexa-coordinate iron (III) to an iron-oxy species, y, only recently detected utilizing 
Raman spectroscopy by Sligar and coworkers. 51 Although it has not been confirmed, 
current experiments have indicated that species va is more likely to be the 
intermediate species. 62 
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1.4.2.2 	Radical Rebound Mechanism. 
The next few stages in the catalytic cycle are still unknown due to the 
relatively short lifetime of the intermediate species; the second electron transfer to the 
heme occurs at the same rate as the substrate turnover (5 ms) therefore none of these 
intermediates build up. 63  Most of the pathway has been deduced from experimental 
results, energetic calculations and analogies to peroxidases which have similar excited 
heme bound oxygen molecules. Kinetic isotope studies have shown that two protons 
are involved in the next stages of the catalytic cycle and it has been deduced that their 
role is to remove one of the bound oxygen atoms as water. This theory of double 
protonation via a hypothesized peroxide unit, vi and the subsequent loss of water, 
should give a highly reactive iron-oxy species, yjj 60  indeed this oxygen species is 
known to favour proton binding. 64 
It is this highly reactive iron-oxy species, vii, analogous to the peroxidase 
reactive species, that carries out the hydroxylation. It has been proposed that this 
oxygen is a charged radical which inserts into a carbon hydrogen bond of the 
substrate. This is known as the radical (or oxygen) rebound mechanism, figure 1.8. 
R\ 	R 	 R 
C H 	 H 
0
/ \ 
Fe 	 Fe 	 Fe 
Figure 1.8: The radical rebound mechanism for insertion of oxygen into a carbon hydrogen bond. 
The reactive oxygen radical extracts the nearest hydrogen, creating an iron 
with a bound hydroxyl and a carbon radical. This carbon radical then abstracts the 
hydroxyl group from the heme returning the iron to a penta-coordinate Fe(III) state, 
viii. The hydroxylated substrate is only weakly ligated to the heme and can easily be 
displaced. The substrate then leaves and is replaced by water, returning the iron to a 
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The strongest evidence for this reaction of the carbon-hydrogen bond is found 
in experiments conducted by Sugar on deuteriated substrate,. 65 e.g. hydroxylation of 
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Figure 1.9: Hydroxylation of deuteriated norcamphor by cytochrome P-450cam. 
The product profile is dependent on the deuteriation site. 3-exo hydroxylation 
(the thermodynamically favoured product) occurs when the 6- and 5- positions are 
deuteriated, however, when all three positions are deuteriated normal product profile 
is observed, albeit at a lower rate. This would indicate that the reaction proceeds via 
the sterically unfavourable 3- position rather than react with a deuteriated carbon, 
clearly indicating an isotope effect in the reaction cycle. 
The evidence for a substrate radical intermediate is extensive, 66 again 
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Figure 1.10: Hydroxylation of 5,6-exo-deutiero-norcamphor by cytochrome P-450cam. 
This data showed that, although exo abstraction is preferred endo abstraction 
is additionally possible. However, when analyzing product, entirely exo recombination 
is observed thus indicating a non-concerted mechanism. Chemical mimics of 
cytochrome P-450 systems also indicate radical intermediates. 4 
It has been proposed that a tetrahedral carbanion intermediate is present 
during the reaction, figure 1.11. 
Figure 1.11 The proposed tetrahedral carbanion intermediate of camphor. 
However, this can be discounted by experiments on pericyclocamphanone, [5], figure 
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Figure 1.12: Hydroxylation of pericyclocamphanone by cytochrome P-450cam. 
The 5-hydroxy product should still be possible via the proposed tetrahedral 
intermediate. However when hydroxylating this substrate the 6-hydroxy product is 
formed due to the impossible ring strain forced on a planar 5-hydroxy intermediate. 
Even if the 6- position is blocked no 5-hydroxylation is observed. This would indicate 
a planar rather than a tetrahedral intermediate, thus ruling out a carbanion. 
1.4.2.3 	Alternative Theories of the Catalytic Cycle (Recent Advances). 
1.4.2.3.1 	Role of Sixth Water Ligand 
Recent quantum mechanical calculations by Loew and coworkers on the 
electronic mechanism between the transition between low and high-spin have revealed 
that the removal of the aqua ligand may not be sufficient to induce the change from 
low to high-spin. 54 '55 These energy calculations indicate that the heme must undergo a 
small change in the electronic distribution of its electrons in addition to the loss of the 
aqua ligand. This would suggest that the substrate's influence on the electrostatic field 
of the protein has a role to play in changing the electronic environment of the heme to 
give a high-spin species. 
1.4.2.3.2 	Oxidation State of the Iron and the Active Species. 
Evidence has been tending towards a ferryl iron (IV) species by analogy to 
horseradish peroxidase 'compound 1'69  However some evidence would indicate that 
the iron is in a perferryl, iron (V) state; 70 either a iron (IV) or iron (V) species would 
have a mechanism that utilises the stepwise mechanism suggested by Sligar. 7 ' Recent 
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evidence from model complexes of the cytochrome P-450 system has indicated that 
the hydroxylation could proceed via a combination of a hydroxy- bound Fe (IV) 
species and a hydroxyl radical. In addition to this, peroxidase reactions have 
suggested that bound peroxide is the catalytic intermediate. 72,71 
1.4.2.3.3 	The Alternative Catalytic Pathway: the Concerted Carbocation 
Mechanism. 
Although the radical rebound mechanism has been the more favoured over the 
years, recent advances have cast doubt on this mechanism. Newcomb and co-workers 
designed experiments to probe the mechanism of the cytochrome P-450 reaction 
through use of substrates (known as radical clocks), that could rearrange, as a radical, 
to give products indicative of the intermediate radicals. 74-76 These probes are usually 
subsitituted cyclopropane rings which undergo radical rearrangement with known 
half-lives. If the cytochrome P-450 system creates a radical and the substrate 
rearranges, then the lifetime of the unstable cytochrome P-450 intermediate must be 
greater than the radical rearrangement time scale. Thus, this way the intermediate 
lifetime can be estimated. 
A variety of substrates seemed to confirm the radical pathway 	until 
inconsistencies appeared, 76 suggesting a cationic species might be involved in the 
reaction pathway, figure 1.13. 
oJ 
Figure 1.13: Proposed cationic intermediate of camphor. 
Reappraisal of the previous experiments confirmed a cationic mechanism 
could explain many, but not all, of the observations. Recently, substrates whose 
16 
rearrangements occurred at rates faster than that possible for a radical rebound 
mechanism were found ' suggesting the theory of a cationic species is more likely. 
Further studies indicated that the life time of the 'radical' species is shorter than 
70 fs. In this short life time it is impossible for two distinct species to exist, thus the 
mechanism cannot be regarded as non-concerted. It would also appear that the 
intermediate reaction contains both radical and cationic character. More recent studies 
have confirmed both the cationic 80  and a non-cationic nature of the species. 8 ' This 
apparent paradigm might be explained by a theory by Shaik 82-84  and confirmed again 
by Newcomb, 85  which indicates two species due to a competition between a one and 
two state reactivity. It therefore must be concluded that, although the radical rebound 
mechanism does not fully describe the catalytic process, a better alternative theory is 
not currently available. 
1.4.2.4 	Peroxide Shunt. 
A side reaction known as the 'peroxide shunt' also occurs within the catalytic 
cycle, figure 1.7, in which a breakdown of the cycle removes peroxide from 
intermediates v and yj,  converting them back to species jj 
45,86 The 'peroxide shunt' is 
believed to be caused by unfavorable interactions between the iron bound oxygen and 
protic solvents, due to poor binding of substrate, figure 1. 14.86,87 
H20 
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Figure 1.14: Alternative protonation mechanisms of the peroxide species. 
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This suggests that protonated water accesses the unprotonated oxygen of the 
reactive oxygen species, thus creating peroxide rather than a double protonated 
oxygen, which can be lost as water. The peroxide shunt is of particular interest when 
discussing unnatural substrates or protein mutants, as they have a higher propensity 
towards generation of peroxide. This can be seen when comparing camphor 
hydroxylation, which produces no peroxide, compared to norcamphor which can have 
as much as 60 % peroxide production, 67 or ethyl benzene which has 95 %88,89 
1.4.2.5 	Electron Transfer Mechanism. 
The two electrons required for this catalytic cycle are provided by a cofactor 
NADH which is oxidized to NAD+. 53 '90  Two co-enzymes, putidaredoxin (molecular 
weight of 1 1.5kDa)9 ' and putidaredoxin reductase (PdR, molecular weight of 
43.5kDa)92 transfer the two electrons to the P-450cam, 93 '94 figure 1.14. The rate 
determining step in the catalytic cycle is known to be after the formation of species y 
51 but before formation of species jj (see figure 1.7). However the rate determining 
step in the whole P-450cam turnover cycle is the electron transfer between the Pd and 
P-450cam. 5 ' 
::x::  ::   ::   x:x:  
Figure 1.14: Electron transfer process from NADH to P-450cam (0 and R indicate the oxidized and 
reduced species respectively). 90 
1.4.2.5.1 	Understanding Methods of Electron Transfer. 
Microsomal P-450 monooxygenases (type I) are usually membrane bound and 
accept electrons from a reductase domain containing FAD and FMN I and they are 
reduced by both NADH and NADPH. Cytochrome P-450BM-3 is a unique example 
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of a bacterial cytochrome P.450 of this type containing both the heme and reductase 
domains in one protein. 95  The crystal structure for the heme domain of P-450BM-3, 
has been solved 96  and extensive study of the flavo domain has been performed, 97'98 
making this the standard model for all microsomal P450 monooxygenases, figure 
1.15. 
NADH 	 FAD 	FMN (_ P450 
Figure 1.15: Microsomal cytochrome P450 structure, arrows indicate direction of electrons. 
Mitochondrialt type P-450 monooxygenases (type H), e.g. P-450cam, are 
distinct from microsomal P450 monooxygenases in that they use a 2Fe2S centre 
(not the FMN unit) as an electron transfer medium to the cytochrome P450, figure 
1.16. These electron transfer units are generally expressed as separate proteins, 
although they may be bound together in membranes. Their reductases are specific to 
NADH, although some lower activity towards NADPH can be observed. There is a 
strong recognition factor between the 2Fe2S protein and the cytochrome P.450 
which has only recently been characterized. 94,99-106 
NADH P450 
Figure 1.16: Mitochondrial cytochrome P.450 structure with the associated coproteins, arrows indicate 
direction of electrons. 
A mitocondrial type cytochrome P-450 is so named due to its similarity to mitocondrial cytochrome 
P.450 but is not necessarily from a mitocondrial source. 
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P450cam has PdR as its 'Flavoprotein', i.e. containing the Flavin group, 





Figure 1 17: Structure of oxidized flavin unit, R is different for FMN or FAD proteins. 
The FAD ring is incorporated into the protein substructure and is connected to the 
surface through a series of charged residues, figure 1.18. 
Figure 1.15: Model structure of PdR based on homologous structures, the FAD group is highlighted in 
yellow. 107 
Putidaredoxin is the second transfer protein in the cytochrome P450 system, 
containing a bridged 2Fe2S as the key transfer agent; these proteins are known 
collectively as ferredoxins, figure 1.19. 
CYS\/S\/CYS Fe Fe 
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Figure 1 19: The structure of the 2Fe2S sub-unit of Putidaredoxin. 
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The 2Fe2S sub-unit is sufficiently near the surface of Pd to easily transfer electrons 
via one residue to P450cam, although the exact electron transfer pathway is not 
known, figure 1.20. 
,\ 
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Figure 1.20: NMR structure of Pd with the 2Fe2S highlighted in yellow, the bound cysteines in 
green.' 08 
These 2Fe2S species are present in the transfer proteins of bacterial systems such as 
P-450cam and P-450terp (e.g. putidaredoxin, terpredoxin), in mammalian systems 
(e.g. adrenodoxin) and in plants (spinach ferredoxin). 
1.4.3 	Structure of Cytochrome P-450cam. 
The crystal structure of P-450cam has been solved with bound R-camphor 
46,109 and substrate-free 110  and additionally with 5-exo-hydroxycamphor, 11 ' S-
camphor 112  and with many unnatural substrates. 57,113,114 P450cam is one of only six 
cytochrome P450 crystal structures to be solved to date, others being: P -
450terp; 115"6 P450BM-3;' 98 P450eryF; 117 P450nor;118 and P-450sca. 119J 20 
Whether P450nor should be classified as a cytochrome P-450 is still under debate as 
it is does not actually insert oxygen into a carbon hydrogen bond. The structure of P -
450sca is under commercial restrictions and is not available. The other four proteins 
show extensive structural homology, 30 figure 1.21, which supports the theory that P -












Figure .21: Structures of four known P-450 monooxygenases showing their strong structural 
homology. 
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Cytochrome P-450cam is a 47 kDa b-type heme protein possessing the 
common cytochrome P450 shape of a triangular prism about 30 A thick with sides 
of approximately 60 A, figure 1.22. 
Figure 1.21 Structure of P-450cam. The protein is represented by the red ribbon along the backbone, 
the heme group is shown in blue and the iron centre is highlighted in yellow. 
The protein contains a helical rich region consisting of 12 helixes (A-L) which make 
up 45 % of the structure and a smaller 3 sheet rich region, figure 1.23. 
Figure 1.23, Sub structures of P-450cam showing the a-helix region (left) in red and the 3-sheet region 
(right) in green, the heme group is shown in yellow and the iron centre is highlighted in blue. 
b-type refers to the way in which the heme is attached to the protein 
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The heme group is embedded between two parallel helices (proximal side to helix L, 
distal side to helix I) with the catalytic heme centre buried deeply in the active site, 
figure 1.24. 
1gure 1.-'4, Ueiite urieiiitioii held b the hehxes L and I, the heme group is indicated in yellow, 
camphor in blue. 
1.4.3.1 	Structural Studies of Electron Transfer. 
It is still unknown which residues are responsible for the transfer of electrons 
from putidaredoxin to the heme, however Sligar and Poulos have identified a number 
of key residues that might be involved. 121,122  They propose that four basic residues 
which lie at the proximal side of the heme: Arg 72; Arg 112; Lys 344 and Arg 364 
interact with acidic residues on the surface of putidaredoxin 123  to form the electron 
transfer chain, figure 1.25. 
Figure 1.25. Proximal surface of P-450cam, the green residues represent the proposed Pd binding 
residues, other residues are represented by charge (red negative, blue positive). 
,z1 
The surface of the protein, on the proximal side of the heme, is more 
hydrophobic than the rest of the protein, allowing the putidaredoxin to bind with 
only a number of charged residues which could transfer electrons to the heme, figure 
1.26. 
ii) 
Figure 126: Comparison of the surface of proximal side of the protein (i) and distal side (ii), with 
absolute charges of surface (red for positive, blue negative and white neutral) the proposed binding 
residues are highlighted with yellow rings. 
Evidence that binding occurs v ia these charged residues is found from 
mutagenesis of Arg 72 or Lys 344, which results in slight changes to the protein-
protein binding affinity. However, mutagenesis of Arg 112 both substantially reduces 
the electron transfer rate and the binding affinity. 103 
The interaction between putidaredoxin and P-450cam can be mimicked by 
attaching P-450cam to an electrode, 124 with the negative charges on the electrode 
mimicking putidaredoxin. 
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1.4.4 	The P-450cam Binding Site. 
The substrate binding site of cytochrome P-450cam contains a large number 
of hydrophobic residues, figure 1.27. 
Figure 1.27; Structure of the P-450carn binding site with camphor bound; the heme group is at the 
bottom of the picture, the camphor in the centre, amino acid residues in a clockwise manner from the 
heme are Val 295, Asp 297, Thr 185, Phe 87, Tyr 96, Phe 98, Val 247 and Lys 244 (for picture clarity 
residues Ile 395 and Phe 193 have not been shown). 
There are only three hydrophilic residues in the binding site of P450cam: Thr 
252, which may have a role in oxygen binding; Thr 101 (which may stabilize the 
orientation of Tyr 96) and Tyr 96 itself, which hydrogen bonds to the camphor. The 
hydrogen bond between Tyr 96 and the carbonyl on the camphor, figure 1.28a, 
orientates the camphor so that the C-5 carbon is in the closest proximity to the iron 
centre, figure 1.28b. 
Figure 1.28a: Structure of the binding site showing the hydrogen bond between camphor and tyrosine 
96. (Camphor and Y96 are indicated by atom colour code; green for carbon, red for oxygen, the other 
residues are in purple). 
Figure 1.28b: Structure of the binding site showing the orientation of the carbon at position 5 on the 
camphor to the iron. (Camphor and iron are indicated by atom colour code; green for carbon, red for 
oxygen and iron, the other residues are in purple). 
The hydrophobic residues in the binding site appear to be responsible for 
orientating the camphor molecule to prevent rotation within the binding site; this is 
especially true of the interactions between the geminal methyl groups of the camphor 
and Val 395 and the CI methyl of camphor and Vat 247. 
1.4.4.1 	Thermodynamic Factors that Control Substrate Binding. 
The hydrophobic residues in the binding site, combined with hydrophobic 
residues in the entrance channel, create a strong attraction for lipophi lic substrates. 
The substrate-free structure has essentially the same binding site as the camphor 
bound structure except that six water molecules are present in the cavity, one of 
which is ligated to the heme."° The expulsion of these six water molecules from a 
hydrophobic binding site could provide the energy required for substrate binding. 
Apart from the expulsion of these water molecules other water molecules may 
remain in the binding site and play a role in the substrate binding. 125  Osmotic studies 
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have indicated 28 water molecules are involved in the catalytic process, although 
some are certainly involved in the P&P-450 reaction interface. 126 
1.4.4.2 	Substrate Specificity of P-450cam. 
For P-450cam many substrate analogues have been studied over the years, 
figure 1.29. 
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Figure 1.29: Substrates studied with P-450cam, numbers underneath are binding constants: 
norcamphor [4], pericyclocamphor [5], fenchone [6], 5,5-difluoronorcamphor [7], camphane [8], 
norbornane [9], adamantane [10], adamantanone [11], thiocamphor [12] . 127129 
Despite high specificity for camphor, a range of substrates have been shown to 
bind to wild-type P-450cam, including camphor analogues such as thiocamphor [12], 
adamantane [10], norcamphor [4] and camphane [8], for which the substrate bound 
crystal structures have been solved. 17, 1 11 
Studies of camphor analogues indicate that removal of the carbonyl group 
(e.g. adamantane [10], camphane [8] and norbornane [9]) results in a loss of product 
selectivity, due to the loss of the hydrogen bond to the tyrosine 96 hydroxyl group; 
28 
for camphane the products are the 5-exo, 6-exo and 3-exo-hydroxylated compounds. 
Removal of side chain methyl groups from the substrate has a similar effect (e.g. 
fenchone [6] and norcamphor [4]) also showing 5-, 6- and 3-hydroxy products. 
Hydroxylation of adamantane [10] and norbornane [9] indicates that even without a 
carbonyl group or side chain methyl groups hydroxylation is still possible. By 
inhibition of H-abstraction from the camphor C-5 position, e.g. 5,5-difluorocamphor 
[7], other products are observed, e.g. the 9-hydroxy product. 130 
Hydrophobic hydrocarbons such as styrene,' 31 pentane 132  and small aromatics 
compounds 133  (e.g. phenyldia.zene, which interacts with the heme group 134,135)  can 
bind to the active site. Small halomethane and haloethane derivatives have also been 
shown to bind to P-450cam, the affinity depending on the nature of the halogen 
atoms. 136-139  Dithiotreitol (DTT) has also been shown to have a binding affinity, in this 
case with sulfur ligation to the heme."° However the binding affinity of all these 
compounds is considerably lower than that of camphor. The only compounds with a 
higher affinity for the wild-type enzyme than camphor are inhibitor molecules such as 
metyrapone and phenylimidazole 114  where binding is enhanced by nitrogen ligation to 
the iron. Thus the substrate range of P-450cam is limited to molecules smaller in 
shape and size than camphor. 
1.4.4.3 	Mutagenesis Effects on P-450cam Substrate Binding. 
Mutation of tyrosine 96 to phenylalanine (Y96F) 128"40"4 ' reduces the selective 
oxidation at the C-S position on camphor from 100 % to 92 %. Other products are 
the C-3, C-6 and C-9 hydroxylated camphor, 142,143  thus mutating the enzyme has the 
same effect as removing the hydroxyl on the substrate (see above). Mutation of the 
binding site hydrophobic residues, Val 295 and Val 247 has a similar effect as the 
removal of the substrate methyl groups (see above). 
Selectivity of the enzyme for camphor and the oxidation of the C-5 position is 
thus due to a combination of the Van der Waals contacts, facilitated by the overall 
shape of the active and the hydrogen bond with tyrosine 96. 
Single point mutations and multiple mutations indicate that the 
hydrophobicity of the binding site has a role to play in preventing peroxide 
production when using unnatural substrates, since they effect the active site 
hydration and thus water access to the reactive oxygen species. Mutagenesis of 
specific residues believed to be associated with the hydroxylation process, e.g. Thr 
252 and Asp 251 has a significant role in disrupting the cytochrome P450 catalytic 
cycle. 87"44 
Mutagenesis of the protein has been performed over the years to selectively 
hydroxylate new substrates, (e.g. ethyl benzene 52).  Although most of these mutations 
have affected the substrate hydroxylation, none had a significant effect on the range 
of substrates. 
In order to expand the binding site of P450cam, to hydroxylate a wider range 
of substrates, a mutation was made to the P-450cam binding site by Flitsch and co-
workers. 145  This mutation altered Tyr 96 to an alanine, the Y96A mutant, figure 1.30. 
i) ii) 
Figure .30: Binding site of P-450cam showing the change in creation of the Y96A mutant; wild-type 
(i) and Y96A mutant model (ii). (Note: this is not based on a X-ray crystal structure, the mutant was 
generated by deletion of the phenyl and hydroxyl groups of Y96 from the pdb file for wild-type). 
This mutation has a number of effects. Firstly it removes the hydroxyl group 
from the binding site, which has the advantage of making the binding site more 
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hydrophobic thus changing the potential substrate range. Secondly this mutation 
potentially created a phenyl pocket between Phe 87 and Phe 98, where the tyrosine 
ring was previously located. This mutation has the potential to allow hydroxylation of 
new, more hydrophobic substrates thus substantially expanding the substrate range. 
Examples of some of the compounds found to be substrates for the new P-450cam 
mutant are shown below, figure 1.31. 
c c 









Figure 1.31: Diphenylmethane [13], 145 cliphenylether [14], 1, 1-diphenylethylene [15], 
diphenylamine [16], 146 ethenylberizene [17] (styrene), 131 phenyl cyclohexane [18], 147,148 
naphthalene [19], pyrene [20], 149 hexane [21] and 3-methyl pentane [221. 132 
Substrates that fit in the 'aromatic pocket' were believed to be stabilized by 7t-
stacking between the aromatic side chains of the substrate and the aromatic rings on 
either side of the pocket, i.e. Phe 87 and Phe 98, figure 1.32. 
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Figure 1.32: Estimated interaction of phenyl substituted substrates with the Y96A mutant binding site, 
showing a proposed phenyl ring of a substrate interacting with Phe 87 Phe 193 and Phe 98. 
The first of these substrates studied was diphenylmethane which is hydroxylated 
regioselectively by the Y96A mutant, to give 4-hydroxydiphenylmethane, figure 
1.33. 
Cytochromc 
cc P45Ocam (Y96A mutant) so 2c,2H,02 
OH 
Figure 1.33: Hydroxylation of diphenylmethane [13] by P-450cam mutant Y96A. 145 
No hydroxylation of diphenylmethane was observed with the wild-type 
enzyme; thus, by a single mutation the substrate specificity of the P-450cam was 
significantly altered. After these initial studies the hydroxylation of a non-aromatic 
centre was attempted. 147,149  It was hoped that the phenyl ring of phenylcyclohexane 
would still confer regioselectivity by fitting into the aromatic pocket. This substrate 
was hydroxylated with some degree of selectivity yielding three products, figure 
1.34. 
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Figure 1.34: Hydroxylation of phenylcyclohexane [18] by P-450cam mutant Y96A. 147 
In this case no aromatic hydroxylation was observed, suggesting that the aromatic 
ring is fitting in the proposed aromatic binding site. 
To explore the substrate specificity further, other aromatic substrates were 
investigated, figure 1.31. These substrates are small molecules with an aromatic side 
chain which would have an affinity for the aromatic pocket. These all show similar 
selectivity to the diphenylmethane and the phenylcyclohexane. 
1.5 Project Aims. 
The current purification protocol allows for the production of small quantities 
of pure protein and this was deemed to be insufficient for the experiments necessary in 
our study. Therefore one objective of this project was the further refinement of the 
purification protocol for P-450cam, to improve yields and protein purity. 
With sufficient protein it was hoped that a range of compounds could be 
tested for their potential to be substrates for the cytochrome P-450cam Y96A mutant. 
With the biochemical characterization of these compounds the substrate specificity of 
the enzyme could then be explored. 
Using molecular modelling it should be possible to combine the biochemical 
data on substrates for the Y96A mutant with what is currently known about the wild- 
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type binding site; thus creating a model of substrate enzyme interactions that could 
allow the prediction of the binding capacity and products of any new substrates. 
A more thorough investigation of the cytochrome P-450cam Y96A binding 
site, by analysis using X-ray crystallography, should provide a greater understanding 
of the relationship between the substrate and binding site residues. This will facilitate 
the understanding of the elements of the binding site responsible for both substrate 
selectivity and specificity. The X-ray structures could also be used to validate and 
refine the modelling studies. 
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2.1.1 	General Chemicals. 
All chemical were purchased from Sigma, UK, at analytical grade, unless 
stated otherwise. Solvents (ethanol, methanol, iso-propanol and ethyl acetate) were 
purchased from Acros chemical company and 30 % acrylamide solutions from 
Stratagene. Water was purified on a Millipore MilliRO 5+ with MilliQ plus. 
2.1.2 	Proteins. 
The cytochrome P-450cam C334A-Y96A gene, pAW7292, in E.coli cell line 
JM109, the cytochrome P-450cam C334A gene in E.coli cell line JM109, the 
putidaredoxin gene in E.coli cell line JM109 and purified putidaredoxin reductase 
were provided by Dr. Luet-Lok Wong, Oxford University, UK. Genes for wild-type 
P-450cam, pUS250, Pd, pRM534 and PdR all in E.coli cell line TB1 were provided 
by Prof. Stephen Sugar, University of Illinois (Urban-Champagne), USA. Spinach 
ferredoxin (Sd) and spinach ferredoxin reductase (SdR) were purchased from Sigma. 
Flavodoxin (FLD) and flavodoxin reductase (FLDR) from E. co/i were provided by 
Dr. Lisa McIver, University of Edinburgh, UK. Cytochrome P-450BM-3 flavo 
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domains (BM-3R) were provided by Dr. Andy Munro, University of Edinburgh, UK. 
Old yellow enzyme (OYE) was provided by Marina Alexeeva, University of 
Edinburgh, UK. 
	
2.1.3 	Protein Expression and Purification. 
Luria-Bertani broth (LB) and 'terrific broth' (TB) media and LB agar were 
provided by in house service using standard recipes.' Centrifugation was conducted 
using a Sorvall RC-413 centrifuge and sonication was performed with the SoniprepTm  
150 (MSE). Large scale concentration was achieved with a Millipore 8200 
concentrator (300 ml) with membranes YM30 (Aniicon), small scale concentration 
with centriprep, centricon, microconTm and centriplus (Amicon) with MWt cut-
off of 10 kDa or 30 kDa. HPLC was performed on a Waters 650 protein HPLC 
system. Protein purification columns and media were purchased from Pharmacia, 
except DEAE sepharoseTM, which was purchased from Sigma. Anion exchange 
column was pumped through with a P1'TM pump (Pharmacia) and protein was loaded 
on the HPLC system with a 50 ml superloopTM  (Pharmacia). 
2.1.4 	Protein Analysis. 
Spectral studies were conducted on a Hewlett Packard 8452A UV/Vis 
spectrometer using 1 ml UV grade disposable cuvettes from Kartell. SDS PAGE was 
performed with the Mini-proteanTM II system (Biorad). 
2.1.5 	Product Analysis. 
(3C/MS analysis was performed with a crosslinked 5 % siloxane column (30 m 
x 0.25 mm, HP-5MS, Hewlett Packard), with a Hewlett Packard 6890 GC and 5973 
mass spectrum analyzer. 
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2.1.6 	Crystallography. 
Polyethyleneglycol (PEG) was obtained from Fluka, UK. Dimethyldichioro 
silane (2 %), in 1,1,1 -trichioroethane was purchased from Fisons, UK. Cryo freezing 
containers and mounting loops were purchased from Hampton Research, US; 
LimbroTm plates were purchased from, ICN and cover slips were bought from BDH. 
Crystallographic computation was performed on Silicon Graphics I ndym, 02 Tm and 
IndigollTm workstations, with processing performed on a 200 MHz R10000 
Challenge L from Silicon Graphics. Software used included InsightIP (Biosym), 
2  	 3 0 IM ' and SHELX 
97TM•5 
Macromode1', ccp4TM, 	 ,  
2.1.7 	Modelling. 
Molecular modelling was performed on Silicon Graphics IndyTM 0 2  IM and 
Indigolltm workstations, the package used was Insight II TM  (Biosym). 
DOCK and all its supplemental programs were provided by Irwin Kuntz, 
University of California (San Francisco), USA. Substrates for DOCK were built using 
Insightll (Biosym) and SybylTM (Tripos associates). 
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2.2 General Experimental Conditions. 
Long-term storage of protein solutions was generally performed by snap 
freezing in liquid nitrogen and storage at -80 °C. Solutions contained 30 % glycerol, 
to enhance protein stability during the freezing process. During experiments protein 
solutions were stored on ice prior to use. All protein buffer solutions were filtered 
with cellulose membranes, 20 p.m pore size, from Altech. Columns used for glycerol 
and substrate removal by gel filtration were PD10TM columns (Pharmacia) with 
SephadexTm G25 resin. 
2.2.1 	GC method. 
Organic metabolites from the biotransformations were extracted by addition of 
500 p1 of ethyl acetate, agitated and centrifuged at 10,000 x g. The organic phase was 
extracted and analyzed on a GUMS, with a crosslinked 5 % siloxane column (30 m x 
0.25 mm, HP-5MS). Elution was achieved using a gradient program from 100 to 290 
°C, at flow rate 1 mllmin, table 2.1. 
Table 2.1: GC temperature gradient used to elute biotransformation products. 
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2.3 Growth and Expression of Cytochrome P-450cam. 
2.3.1 General Growth Conditions. 
The growth characteristics of the JM109 E.coli strain containing the pAW7292 
plasmid was determined previously 6  and optimized to give a maximal growth in 
TBcm (TB broth with 1 mM chloroamphenicol) medium at 30 °C. All cultures were 
inoculated from a single colony on a TBcm agar plate, scaled up, first to a 5 ml 
overnight culture, then to a 150 ml overnight culture. This culture was then split into 
the appropriate volume of TB and grown until induction. Protein expression was 
induced at an optimal 0D 600  (optical density of 600 nm) of 1.0 by raising the 
temperature to 37 °C and then allowing the cells to grow for at least a further 6-16 
hours. Camphor was also added at induction, to a final concentration of 1 mM, as a 
stabilizing agent for the P-450cam. 7 Expression was confirmed by SDS PAGE (12.5 
% polyacrylamide). 
2.3.2 Large Scale Growth, in a 50 L Fermenter. 
1 L of starter culture was pooled and transferred to a fermenter containing 40 L 
TB cm. Protein expression was induced as above and the culture was grown for 16 
hours. Cells were harvested with the built-in centrifuge, at 5000 x g, for 30 minutes, 
with continuous extraction of supernatant. Typical yields were -P9 g/L of cell pellet 
containing -37 mg/L of P-450cam protein. 
2.4 Purification of P-450cam. 
2.4.1 Preparation of the Cell-Free Extract. 
Revised from previous small scale protocol, 6 about 40-50 g of cell pellet was 
thawed from -20 °C, resuspended in 320 ml of Pi-cam (40 mM potassium phosphate 
Wel 
buffer with 1 mM camphor, pH 7.4), then divided into 8 x 40 ml portions. The 
samples were then sonicated, on ice, in a Soniprep 150, at medium power, for 7 x 
1 minute. The suspension was harvested at 20000 x g, for 30 minutes, at 4 °C. The 
supernatant was decanted and stored at 4 °C. The cell debris was then resuspended in 
2 x 40 ml of Pi-cam with gentle mixing. The suspension was then subjected to a 
further 2 x 1 minute sonication, with the above conditions. The solution was then 
centrifuged at 20000 x g for 10 minutes at 0 °C. The supernatant was decanted and 
pooled with the previous supernatant at 4 °C. 
2.4.2 Anion Exchange Chromatography on a DEAE SepharoseTM Column. 
A XK50TM column, 50 mm x 150 mm filled with DEAE sepharoseTM fast-flow, 
vol. -300 ml, was equilibrated with 7 column volumes of Pi-cam (-2 L) and the cell 
free extract (-200 ml) was loaded, using a Pl Tm  pump at a flow rate of 6 MI/min. The 
column was washed through with 3 column volumes of Pi-cam (-1 L), the protein 
was eluted with a stepwise increasing salt gradient of 25 mM KC1 every 30 minutes, 
at the same flow rate as before. Elution of the P-450cam (as seen by movement in the 
red/brown coloured band), began at 100 mM KC1. The gradient was increased to 150 
mM and maintained until all the protein had eluted. Fractions were analyzed on a 
UV/Vis spectrometer at 417 nm. The fractions with 0D417 > 0.5 were pooled and 
stored at 4 °C. 
2.4.3 Concentration and Desalting by Ultrafiltration. 
The fractions from the DEAE column (-150-200 ml) were concentrated in a 
300 ml pressure concentrator cell with a YM30 membrane (30 kDa cut-off). The 
sample was desalted by initial dilution with Pi-cam to 300 ml and two successive 
dilution/concentration steps from 300-70 ml. The final protein solution (-20-50 ml) 
was stored at 4 °C (<24 hours). 
50 
2.4.4 Anion Exchange Chromatography with So urceQTM Media by BIPLC. 
A HR 16/lOTm column (16 x 100 mm), containing 14 ml of Sourcel5QTm  
media, was equilibrated with buffer Pi-cam. Protein (30-40 ml) was loaded by means 
of a 50 ml superloop onto the column with a P1 pumpTm at a flow rate of 7 ml/min. 
The optical density of the column effluent was measured at 280 nm, until waste 
protein was removed. The P-450cam protein was eluted with an increasing salt 
gradient, table 2.2. 





% Buffer A % Buffer B 
(loading) 7 100 0 
0 7 100 0 
1 10 100 0 
3 10 95 5 
15 10 75 18 
22 10 50 50 
25 10 0 100 
26 10 0 100 
26.5 10 100 0 
28 10 100 0 
29 7 100 0 
30 0 100 0 
Buffer A= Pi-cam 
Buffer B= Pi-cam, 1 M potassium chloride 
Eluent was analyzed at 417 nm and fractions containing protein were pooled based on 
their purity. Low purity fractions (i.e. 280 nm: 417 nm ratio < 1.2) were concentrated 
and desalted and the HPLC step was repeated. 
2.4.5 Preparation of Protein Pure Enough for Crystallographic Studies. 
A HR 16/1 OTm column (16 x 100 mm), containing 10 ml of phenyl sepharose, 
was equilibrated with buffer AS (1 M ammonium sulfate, 40 mM potassium 
phosphate pH 7.4). Protein solution was made up to 1 M ammonium sulfate 
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concentration,, with a saturated ammonium sulfate solution, at 4 °C. Protein solution 
(20 ml) was loaded by means of a 50 ml superloop, onto the column at a flow rate of 
5 ml/min. The P-450cam protein was then eluted with a reducing salt gradient, table 
2.3 





% Buffer A % Buffer B 
(loading) 5 100 0 
0 5 100 0 
1 8 100 0 
3 8 100 0 
5 8 50 50 
15 8 30 70 
18 8 0 100 
20 8 0 100 
22 8 100 0 
26 8 100 0 
29 5 100 0 
30 0 100 0 
Buffer A= AS 
Buffer B= Pi-cam 
Eluent was analyzed at 417 nm and was pooled and stored at 4 °C. Low purity 
fractions (i.e. 280 nm: 417 nm ratio < 1.3) were concentrated, desalted and the 
HPLC step was repeated. Protein was then snap frozen in liquid nitrogen stored in 30 
% glycerol at -80 °C. 
2.4.6 Removal of Camphor and Glycerol by Gel Filtration. 
Protein that had been stored in 30 % glycerol, at -80 °C, was allowed to thaw 
to -20 °C overnight and then allowed to warm to 4 °C. Protein solution (1 ml) was 
loaded on a prepacked 10 ml SephadexTM G25 gel filtration column (PD-10). The 
protein solution was initially allowed to pass through the column under gravity. Once 
the head solution was depleted, the protein was washed through with buffer Pi (40 
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mM potassium phosphate buffer, pH 7.4). The fractions containing P-450 were then 
collected and pooled, fractions were analyzed by UV/Vis to make sure all camphor 
was removed. This step was repeated for fractions which showed the presence of 
camphor. 
2.5 Growth and Expression of Putidaredoxin. 
2.5.1 General Growth Conditions. 
The Pd gene was provided in E.coli strain JM1O9. The growth characteristics of 
the JM109 E.coli containing the Pd gene were the same as for the P-450cam, 
pAW7292, but were optimized to give maximal growth in TBamp (TB broth with 1 
mM ampicillin) media at 37 °C. All growths were started from a single colony on a 
TBamp agar plate. Protein expression was induced at an optimal 0D 600 of 1.0 by 
addition of 0.3 mM isopropylthiogalactoside (IPTG) and the cells were grown for 4 
hours. Expression was confirmed by SDS PAGE (12.5 % polyacrylamide). 
2.5.2 Large Scale Growth, in 1 L Shake Flasks. 
From 5 ml overnight culture the E. coli was grown overnight in 4 x 150 ml 
TBamp at 37 °C. The cultures were then pooled and transferred to 15 x 1 L baffled 
shake flasks, each containing 300 ml of TBamp. After reaching an 0D 600 of 1 the 
culture was induced by addition of 0.3 mM IPTG. The culture was then grown for 4 
hours. The cell solution was centrifuged at 10000 x g for 20 minutes at 4 °C. Typical 
yields were -7 g/L of cell pellet containing - 30 mg/L of Pd. 
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2.6 Purification of Putidaredoxin. 
2.6.1 Preparation of the Cell-free Extract. 
Revised from previous small scale protocols, 8 the cell pellet (-30 g) was thawed 
from -20 °C, resuspended in 400 ml of buffer T (50 mM Tris buffer, pH 7.2), then 
divided into 10 x 40 ml aliquots. The samples were then sonicated on ice, at medium 
power, for 5 x 1 minute. The suspension was centrifuged at 20,000 x g for 30 minutes 
at 4 °C. The supernatant was decanted and stored at 4 °C. The pellets were then 
resuspended in 2 x 40 ml of buffer T with gentle mixing. These pellets were then 
subjected to a further 2 x 1 minute sonication with the above conditions. The solution 
was then centrifuged again at 20000 x g for 20 minutes, at 0 °C. The supernatant was 
decanted and pooled with the previous supernatant, at 4 °C. 
2.6.2 Anion Exchange Chromatography on a DEAE Sepharose Column. 
A XK50Tm column, 50 mm x 150 mm filled with DEAE sepharose fast flow, 
(-300 ml), was equilibrated with 7 column volumes of buffer T (-2 L) and the cell 
free extract (-150 ml) was loaded. The column was washed through with 2 column 
volumes of buffer T and the protein was then eluted with an increasing salt gradient of 
25 mM KC1 every 30 minutes, using a PITm pump at a flow rate of 6 MI/min. At 175 
mM KC1 when the protein starts to elute (as seen by movement in the dark brown 
coloured band), the gradient was increased to 200 mM and maintained until the 
protein eluted. Fractions were analyzed on a UV/Vis spectrometer at 405 nm. The 
fractions with 0D 405 > 0.1 were pooled and stored at 4 °C. 
2.6.3 Desalting by Dialysis. 
The fractions from the DEAE column (-150-200 ml) were dialyzed against 
buffer T with a 8 kDa cut-off membrane at 4 °C, overnight. 
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2.6.4 Anion Exchange Chromatography with SourceQ Media and a Waters 
Protein HPLC System. 
A FIR 16/1 OTm column (16 x 100 mm), containing 14 ml of S ource 15 QTM media 
was equilibrated with buffer T. Protein (20-40 ml) was loaded onto the column by 
means of a 50 ml superloop, at a flow rate of 7 mllmin. The OD of the column 
effluent was measured at 280 nm, until waste protein was removed. The Pd protein 
was then eluted with an increasing salt gradient, table 2.4. 





% Buffer A % Buffer B 
(loading) 7 100 0 
0 7 100 0 
1 10 100 0 
5 10 85 15 
20 10 10 90 
21 10 0 100 
22 10 0 100 
23 10 100 0 
23.50 10 100 0 
24 7 100 0 
25 0 100 0 
Buffer A= buffer T 
Buffer B= buffer T, 1M potassium chloride 
Eluent was analyzed at 405 nm and samples with Pd with purity (405 nm: 280 
nm) of greater than 0.3 were stored at 4 °C. 
2.6.5 Final Purification Step of Pd. 
A HR 16/10Th column (16 x 100 mm), containing 10 ml of Phenyl 
SepharoseTh, was equilibrated with buffer AS (1 M ammonium sulfate, 40 mm 
potassium phosphate pH 7.2). Protein solution was made up to 1 M ammonium 
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sulfate concentration with a saturated ammonium sulfate solution, at 4 °C. Protein (10 
ml) was loaded onto the column by means of a 50 ml superloop, at a flow rate of 5 
ml/min. The Pd protein was then eluted with a reducing salt gradient, table 2.5. 





% Buffer A % Buffer B 
(loading) 7 100 0 
0 7 100 0 
2 7 90 10 
10 7 50 50 
23 7 0 100 
25 7 0 100 
26 7 0 100 
28 7 100 0 
29 7 100 0 
30 0 100 0 
Buffer A= l00%ASin buffer T 
Buffer B= buffer T 
Eluent was analyzed at 405 nm and fractions with purity (405 nm: 280 nm) of 
greater than 0.4 were snap frozen in liquid nitrogen and stored in 30 % glycerol at -80 
2.7 Protein Quantification. 
P-450cam content and purity was quantified by UV/Vis spectroscopy by 
measurement of OD at the Soret band maximum (at 390 nm for wild type protein in 
the presence of camphor and 417 nm for unbound wild type protein and Y96A 
mutant). Pd content and purity was quantified by UV/Vis spectroscopy by 
measurement of OD at the maximum of 405 nm. PdR content or purity was quantified 
by UV/Vis spectroscopy by measurement of OD at the maximum of 454 nm. Protein 
concentration was measured on a diode array spectrometer with a 1 ml cuvette and 
solutions with a X-max over 1 were diluted. 
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2.8 Binding Assays. 
2.8.1 	Preparation of Protein Solution for Binding Experiments. 
Protein that had been stored in 30 % glycerol, at -80 °C, was allowed to thaw 
at -20 °C overnight and then allowed to warm to 4 °C. Glycerol and camphor were 
removed using the same procedure as for the preparation of crystallographic quality 
protein. Protein was then diluted to a concentration of -1.7 1iM and stored on ice 
until use. 
2.8.2 	Assay to Determine Maximum Binding via Shift in the Soret Band. 
A UV/Vis spectrum of 1 ml of protein solution (-1.7 1.tM, 0D 417 of 0. 2), 
equilibrated to 30 °C for 5 minutes, was measured on a diode array spectrometer, in 
the range of 270-500 nm and the absorbance at 390 nm, 404 nm and 417 nm were 
monitored. 20 p.g of substrate (from a 10 mg/ml stock solution in ethanol), was added 
and the solution was allowed to equilibrate to 30 °C for 1 minute. If binding was not 
observed then addition of substrate was repeated until maximum binding was achieved 
or precipitation of the substrate occurred. 
2.8.3 	Assay to Determine Binding Constants. 
A UVIVis spectrum of 1 ml of protein solution (10-20 j.tM), equilibrated to 30 
°C for 5 minutes, was measured on a diode array spectrometer, in the range of 270-
500 nm and the absorbencies at 390 nm, 404 nm and 417 nm were monitored. 
Substrate, 0.2 tM, was added, (from a 0.1 mg/mi stock solution in ethanol), and the 
spectrum recorded as before. If no significant shift of the Soret band towards the 
known maximum binding shift was observed the concentration was increased by 
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additions of 1 mg/ml stock solution. This data collection continued until at least 10 
different, non extreme, data points were gathered. 
2.8.4 	Assay to Determine Binding at a Maximum Soret Shift for Oxygen 
Ligation. 
DTT (dithiotreitiol) was added to the substrate free protein solution at a 
concentration of 50 mM, from a 1 M stock solution. Substrate was then added in 
incremental amounts, as above, except the absorbance at 460 nm and 417 nm were 
measured. 
2.9 Solvent Stability of Cytochrome P-450cam. 
The turnover of camphor by P-450cam was performed with 1 p.M P-450cam, 1 
p.M PdR, 5 p.M Pd, 4 mM NADH and 10 mM camphor in a 1 ml reaction volume. 
The reaction was performed in a sealed 50 ml vessel and shaken continuously for 3 
hours, at 30 °C. Product was extracted with standard procedures. 
2.10 Optimization of the Electronic Transfer Agents. 
2.10.1 	Preparation of Enzymes and Chemicals. 
P-450cam was used from a 40 mM potassium phosphate buffer, (pH 7.4), stock 
solution, PdR and Pd were in 50 mM Tris (pH 7.2). Crude P-450cam extract was a 
-1 p.M P-450cam concentration in buffer Pi. Spinach ferredoxin and spinach 
ferredoxin reductase were made up in 50 mM This buffer pH 7.2, flavodoxin and 
flavodoxin reductase were provided in 40 mM Tris buffer, pH 7.4, P-450BM-3 flavo 
domain and OYE were provided in 40 mM Tris buffer pH 7.2. 
Phenazinemethylsulphate (PMS) stock solution was made up to 10 mM in water. 
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2.10.2 	Biotransformation Conditions. 
The standard for the experiment was the turnover of camphor by P-450cam 
with 1 tM P-450cam, 1 p.M of PdR, 5 p.M Pd, 500 1.tM NADH and 1 mM of 
camphor, in a 1 ml reaction volume. The reaction was performed in a 10 ml vessel and 
shaken continuously for 3 hours, at 30 °C. 
Reactions with alternate reductases were performed in similar conditions with 1 
p.M of the reductase and 5 p.M of the ferredoxin or flavodoxin. P-450BM-3 flavo-
domain was made up to 2 p.M as it contains both reductase and flavodoxin. OYE was 
treated as a reductase and used at 1 p.M concentration. Crude P-450cam extract was 
at an estimated P-450cam level of at least 2 p.M. PMS concentrations varied between 
10-500 p.M. Products were analyzed as before. The combinations used of the various 
electron transfer agents used is presented in the results section. 
2.11 Biotransformations with P-450cam. 
Substrate turnovers were performed at 30 °C with 1 p.M P-450cam, 5 p.M Pd, 1 
p.M PdR, 50 p.g/ml catalase in buffer Pi containing 100 mM KC1. The reaction was 
initiated by the addition of 5 mg NADH and 5 p.1 of substrate (from -10 mg/mi 
ethanol stock). Reaction mixtures were shaken for 1 hour and the reaction was 
stopped by addition of ethyl acetate. 
Authentic standards of 5-exo-hydroxycamphor were synthesized by turnover of 
wild type enzyme. 6-exo and 6-endo-hydroxycamphor were isolated from 
fermentation of (1R)-(+)-camphor with Rhodococcus species NCIMB 9784 and 
provided by Dr. Gideon Grogan, University of Edinburgh, UK. 
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2.12 Crystallography of the Cytochrome P-450cam Y96A C334A 
Mutant. 
2.12.1 	Preparation of Protein. 
Purified P-450cam from a 1 ml, 20 jiM stock solution, was removed from 
cryostorage at -80 °C and allowed to thaw at 4 °C. Camphor was removed with 
standard protocols and its removal and protein concentration was confirmed by 
UV/Vis spectroscopy. This solution was then concentrated by a factor of ten by 
ultrafiltration (from -.2 ml - 200 pil) using a CentriconTm 30 concentrator, spun at 
6000 x g for 2 x 20 minutes, at 4 °C. The solution was then diluted with 1 ml of 
buffer Pi containing 1 mM of relevant substrate. The concentration step and dilution 
steps were repeated with an incremental addition of 1 mM substrate until a 
concentration of 4 mM substrate concentration was achieved. Protein solution was 
then concentrated to a final concentration of 1 mM (45 mg/ml). 
2.12.2 	Crystallization Screens. 
The P-450cam mutant was co-crystallized in the presence of substrate using 
vapor diffusion with the hanging drop technique. 9 Drops consisted of 2 4 well 
solution and 2 p.L protein solution. Screening plates contained 24 wells of -3-4 ml in 
a 6 x 4 grid. Cover slips were prepared prior to use with silicanization, by vapor 
diffusion by leaving the cover slips in a vacuum in the presence 2 % dimethyldichloro 
silane in 1,1,1-trichloroethane for 2 hours. Screens were performed with variation in 
precipitant solution, either ammonium sulfate (AS) or different sized 
polyethyleneglycol (PEG) and their relative concentrations. Additionally, variations 
were made in protein concentration, pH and in the presence or absence of substrate 
(details are presented in results section). In all wells, solutions consisted of 40 MM 
potassium phosphate and 200 mM potassium chloride. Screening was performed at 
18, 14or4°C. 
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2.12.3 	Freezing Condition Screening. 
The freezing solution consisted of the well solution from which the crystal 
came from, plus glycerol. The amount of glycerol was varied and the crystals were 
screened by X-ray diffraction. The criterium for the selected glycerol concentration 
was a value that was sufficiently high to prevent the formation of ice, as observed by 
the detection of ice rings on the image plate. However, the glycerol concentration 
must be low enough to prevent premature fracturing of the crystal, as observed under 
a microscope. 
2.12.4 	Final Conditions for Crystal Growth. 
Wells consisted of 40 mlvI potassium phosphate buffer (pH 7.4), 200 mM 
potassium chloride, 4 mM substrate. Precipitant was PEG 4000 with wells from 16-
24 % or 14-26 %. Drops consisted of 2 .tl of 45 mg/mI protein solution in 40 mM 
potassium phosphate buffer (pH 7.4) and 2 p1 of well solution. Trays were left at 4 or 
14 °C, crystals formed between 3 days and 2 weeks. 
2.12.5 	Final Conditions for Cryofreezing of Cytochrome P-450cam Crystals. 
Crystals were transferred at 18 °C, by mounting loop, to a cryo-solution 
consisting of well solution and 21 % glycerol (pH 7.4) and allowed to diffuse. The 
crystal was then removed from the cryo-solution in a 0.3-0.5 mm mounting loop, so 
that the crystal lies head-tail in the loop (figure 2.1). The crystal was then snap 
frozen at -80 °C and stored in liquid nitrogen. 
Figure 2.1: Orientation of the crystal in the mounting loop. 
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2.12.6 	Crystal Screening. 
Crystals were screened in-house on a 30 mm Mar imaging plate with a Enraf-
Nonius FR571 rotating anode generator, which generated CuK a-radiation at a 
wavelength of A=1.5412 A-'. Suitable crystals were then run for one frame of 
collection for 20 minutes, with the orientation of the beam towards the centre of the 
crystal. The crystal was then repositioned off-centre at either end of the crystal and 
data collected again for 20 minutes. Crystals with diffraction better than 2.5 A were 
then stored for later data collection. 
2.12.7 	Data Collection. 
For the camphor and N-Cbz-2,6-dimethylpiperidine bound protein crystals 
diffraction data was collected at the Daresbury Synchrotron Facility, by Prof 
Malcolm Walkinshaw and Dr. Paul Taylor, University of Edinburgh, UK, on a 30 mm 
Mar image plate, at station 7.2, with wavelength of 1.488 A 1 . For the 4-
hydroxydipheny1methane, diphenylmethane, phenylcyclohexane and bicyclohexyl 
bound protein crystals data was collected in-house, as above. 
For in-house data collection crystals were mounted in a continuous stream of 
liquid nitrogen. Collection was at a psi-angle of 1.5 ° or 1.0 ° depending on mosaicity. 
Data collection was for 30 minutes per frame, with the number of frames collected 
being dependent on time restraints, but always at least 100 frames. 
2.12.8 	Data Reduction and Refinement. 
The data was indexed and reduced with DENZOTM  and SCALEPACK. The 
structure of the P-450cam mutant with 4-hydroxydiphenylmethane bound was solved 
by molecular replacement with AM0ReTM, (by Dr. Paul Taylor, University of 
Edinburgh, UK), using the camphor bound wild type structure as a model. The 
camphor bound structure was solved with the 4-hydroxydiphenylmethane bound 
structure as a model. Subsequent structures were solved based upon the camphor 
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bound model. Refinement was carried out using SHELXTm and model building with 
0. Over refinement was monitored by following the Rfree value at a level of 5 %. 
2.12.8.1 Substrate Building. 
Substrates were built in Insightil and minimized with a Discover (Biosym) 
force field. For substrates with multiple low energy conformations, all conformations 
were built. Substrate conformations were stored as pdb format (protein databank 
format). 
Substrate parameters for SHELXIM were built by hand, 'DFIX and 'DANG 
parameters were based on the measured distances of the energy minimized structure. 
For substrates with multiple orientations the 'DANG parameters that configure 
between these conformers were omitted from the SHELXM input file. Aromatic rings 
were additionally restrained with the 'FLAT' restraint set at a level of 0.1. 
2.12.8.2 4-Hydroxydiphenylmethane Structure. 
The individual residues of the Y96A protein were modelled into the a-weighted 
2Fo-Fc difference map contoured between a level of 1.5 and 2.0. Subsequent 
adjustments of the protein were made until the Rfactor  dropped below 0.25. Water 
molecules were added by SBELXWATTm and by eye, using cs-weighted 2Fo-Fc 
maps. Once there was approximately 1 water molecule for every protein residue 
(.....800 in total) the substrate was modelled into the binding site. The 4-
hydroxydipheny1methane molecule was modelled into the 2Fo-Fc difference map by 
initially placing the oxygen of the hydroxyl group above the heme, as indicated by the 
binding data. The remainder of the substrate was modelled into the residual density. 
Structure was refined until no significant difference in the a weighted 2Fo-Fc 
difference map was observed at the a 3cy level. The 4-hydroxydiphenylmethane 
orientation with the hydroxyl group away from the heme was also modelled. 
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2.12.8.3 General Technique. 
The other refinements were essentially carried out in the same way except for 
the differences noted below. Structurally conserved waters, 1-500, were refined in the 
new structures before the SBF-LXWAT 7m refinement and the waters with high 
temperature factors were removed. 
Since there are two molecules per asymmetric unit they were refined with non-
crystallographic restraints (the NCSY parameter set at 0.1). This was only performed 
once the structure was refined to a Rfactor of less than 0.22. The NCSY restraint was 
removed once refinement was complete and any change to the Rfactor and Rfree  was 
observed. 
2.12.8.4 Camphor Structure. 
Camphor was initially placed in the same orientation as the wild-type structure 
and then allowed to refine freely. The alternate conformations of camphor were 
investigated by placing the carbon/hydrogen bond known to be hydroxyated near the 
heme and fitting the rest of the camphor molecule into the remaining density. A water 
molecule was modelled in the binding site, ligated to the iron, in addition to the 
camphor molecule with both fixed and free occupancy. Starting distances and bond 
restraints for both the iron-sulfur and the iron-aqua bonds were altered and the effect 
on the refined structure was noted. 
2.12.8.5 Phenylcyclohexane Structure. 
Phenylcyclohexane was modelled into the density map by placing the phenyl 
ring in the same orientation as the non-hydroxylated phenyl ring from the 4-
hydroxydiphenylmethane structure; alternate conformations with the aliphatic ring in 
this position and the other geometric isomers were additionally modelled. 
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2.12.8.6 Diphenylmethane Structure. 
Diphenylmethane was initially modelled into the density based upon the 4-
hydroxydiphenylmethane structure and refined. Diphenylmethane was modelled with 
variable occupancies and in cases where the occupancy was -50 % water molecules 
were additionally modelled in the binding site. 
2.12.8.7 Bicyclohexyl Structure. 
Bicyclohexyl was fitted into the 2Fo-Fc density map initially with the separate 
refinement of the two cyclohexane rings. The first ring was fitted into the density in 
both chair and the boat conformation. The other ring was modelled after optimization 
of their first ring, again in both chair and boat conformations. 
2.12.8.8 N-Cbz-2,6-dimethylpiperidine. 
The low energy orientations of the N_Cbz-2,6-dimethylpiperidifle was 
additionally modelled in Macromodel. One energy minimized structure was entered 
and a Monte Carlo minimization run was performed (in collaboration with Suzanne 
Aitken, University of Edinburgh); the lowest energy forms were then noted. 
For this structure the averaged a-weighted difference map was used to model 
the substrate. After initial refinement the average map was generated in the ccp4 
modules; f2mtz, mapman, 6d_ave and 6d_mapman, with rotational matrix from 0. 
The map was generated in the second asymmetric unit (residues 510-914). The N-
Cbz-2,6-dimethylpiperidine was modelled in two halves. The first was to model the 
phenyl ring in the orientation occupied by the phenyl ring of all the other substrates. 
The piperidine ring was orientated in the density and refined separately. The link 
between the two molecules was then modelled into the remaining density and the 
whole molecule was refined. After completion of the model building the ligand was 
translated to the other asymmetric unit, by overlapping the two units with ccp4 
module 'match'. Refinement of the structure was then carried out as above. 
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The final orientation was, with the protein coordinates removed, subjected to 
energy minimization in Insightil with a discover force field and the minimized form 
compared to the crystal structure. 
2.12.8.9 Structural Verification. 
The validity of the structures was verified initially by following the Re during 
the refinement and not allowing it to rise from its lowest refined level. Final structures 
were verified by processing the structure in Procheck and examining the 
Ramachandran plots and the analysis of the individual residues. After any adjustments 
the final structure was again checked with Procheck. 
2.12.8.10 Comparison of Structures. 
Comparison of the various ligand bound structures and the sub-units of the 
asymmetric units was performed with the ccp4 suite of programs. For the asymmetric 
sub-units, the second molecule (510-914) was overlapped onto the first, with the 
residue numbers being altered with 'transform'. 'Match' was used to overlay the 
structures on top of each other and 'Compar' was used to compare the data between 
the different structures. In every case the structures only contained the heteroatoms of 
the heme group and no water molecules. Substrates were only included for analysis 
when analyzing the overlaid substrate positions. For the wild type structure the 4cp4 
(camphor bound) structure was used. 10  The heme group and camphor molecule were 
altered manually with a text editor to conform to the numbering convention used in 
the Y96A structures (i.e. 451 and 461 respectively). 
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2.13 Molecular Modelling. 
2.13.1 	Initial Modelling. 
Without the available P-450cam Y96A mutant structure modelling was 
initially performed on a model structure generated by manipulation of the camphor 
bound wild-type structure (2cpp4).'t This structure was generated by deletion of the 
phenyl and hydroxyl groups of the tyrosine 96 residues (atoms 761-768) to generate 
alanine. It was believed that this model was a good approximation of the actual 
mutant structure. 8 
Substrates were generated using InsightllTM. To obtain a realistic 
conformation for the substrates, the general structure was entered and then minimized 
with a Discover force field. Multiple low energy ligand conformations were explored 
by manual manipulation of the structure to an alternate conformation followed by 
energy minimization. 
Substrates were modelled into the binding site by placement of the phenyl ring 
of the substrate in the location previously occupied by the tyrosine phenyl ring. The 
rest of the substrate was then placed in the binding site above the phenyl ring. The 
substrates were initially moved in the binding site, to maintain the phenyl ring 
orientation and to minimize any Van der Waals interactions between the protein and 
the substrate. This meant maintaining a greater than 3 A distance for all carbon-
carbon interactions; if this was not possible small torsional adjustments was made to 
the molecule. Once a satisfactory orientation was achieved the nearest carbon 
hydrogen bonds to the heme iron were measured. 
2.13.2 	Remodelling of Substrates. 
Once the crystal structure of the Y96A mutant was solved this was used for 
modelling studies. The studies performed with the model were repeated with the 4-
hydroxydiphenyl methane structure. The unhydroxylated phenyl ring position from the 
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4-hydroxydiphenylmethane structure was used as a starting point for placement of 
the substrate aromatic rings and the substrate was then modelled as before. 
2.13.3 	Use of DOCK. 
The DOCK suite of programs has a series of steps involved in substrate 
modelling (figure 2.2): 12.17 
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Figure 2.2: Overview of DOCK suite of programs 
2.13.3.1 Ligand Preparation. 
Ligands were built in Insightll and energy minimized with a Discover 




with 1000 iterations of minimization. These ligand files then had charges added using 
SYBYL utilizing the Gasteiger Marsili charge assignment method. Ligand files were 
output as mol2 format files (mol2 format is a file format compatible with the SYBYL 
suite of modelling packages which contains information on the charges and atom 
types as well as atom position). 
2.13.3.2 Site Characterization. 
Of the Y96A crystal structures available the camphor and 4-
hydroxydiphenylmethane bound structures have the best resolution. The camphor 
structure was the best choice for a DOCK template since it did not have the change to 
Thr 252 orientation (see chapter 7). However, the Phe 98 orientation is slightly 
different in the camphor structure than in structures with aromatically substituted 
substrates. Since many of the substrates modelled would be larger than camphor, it 
was not thought appropriate to have this Phe 98 ring orientation. The solution was to 
use the camphor bound structure with orientation of the Phe 98 ring from the 4-
hydroxydiphenylmethane bound structure. This was accomplished by overlapping the 
4-hydroxydiphenylmethafle bound structure with the camphor bound structure, using 
ccp4 program 'match', as before. The coordinates for the Phe 98 residue were then 
manually substituted into the pdb file for camphor bound structure, using a text editor; 
thus generating the enzyme binding site with the 'normal' Thr 252 orientation and the 
Phe 98 orientation consistant with the presence of a phenyl substituted substrate. 
The substrate and water coordinates were removed manually. To minimize the 
computational time only the binding site was modelled. This was accomplished by 
using the 'get _ near _res' program to define all residues which have any atom within 8 
A of camphor carbon Cl. This included residues: Pro 86, Phe 87, Ala 96, Asp 97, Phe 
98, Thr 101, Ser 102, Thr 181, Met 184, Thr 185, Phe 193, Gly 243, Leu 244, Val 
247, Gly 248, Asp 251, Thr 252, Leu 294, Val 295, Ala 296, Asp 297, Gln 322, Gly 
394, Ile 395, Val 396 and hem 451. 
The molecular surface was created with 'autoMS' using a surface density of 1 
dot/A2  and a probe radius of 1.2 A. The sphere centres were created in 'sphgen', 
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using the surface file generated by 'autoMS'. Parameters were set with the maximum 
and minimum radii at 5.0 A and 1.2 A respectively. 
2.13.3.3 Generating Spheres. 
Generated sphere clusters were converted to pdb format using 'showsphere' 
and examined using Insightil. Due to the limitations of sphgen, additional spheres 
were added manually. In order to determine possible ligand positions, which may have 
been overlooked by sphgen, a ligand file was created containing all the previous P-
450cam co-crystallized substrate orientations (1 akd, S-camphor; 1 cp4, phenyl radical; 
moo, 5-exo-hydroxycamphor; ipha, Pfizer + inhibitor; lphb, Pfizer - inhibitor; lphd 
and iphe, 2-phelylimidazole; lphf, 4-phenylimidazole; lphg, metyrapone; 4cp4, 
camphor; 4cpp, adamantane; 5cpp, adamantanone; 6cpp, camphane; 7cpp, 
norcamphor; 8cpp, thiocamphor) 11 ' 1825  with the six Y96A structures, overlapped with 
ccp4's 'match' as before. The sphere centres generated with sphgen were then 
examined to see if any previous ligand atom locations were not characterized by a 
sphere (no sphere centre within 0.5 A). Spheres were then added manually, with a text 
editor, to the sphgen sphere file to cover these missing sites. 
2.13.3.4 Creating Scoring Grids. 
The binding site file used to create the spheres was used to generate the grid 
with a number of modifications. 'Grid' uses mol2 format input files so the binding site 
pdb file had to be converted. Hydrogens were added with Insightil and charges with 
SYBYL. Charge parameters for the amino acids were based on the SYBYL 
bipolymer database using Kollman charges. The heme group was defined by Gasteiger 
Marsili charge calculation method, except for the iron, which cannot be defined by 
SYBYL. The iron was redefined as a planar carbon atom by attaching it via two 
double bonds to NA and NC heme nitro groups. The charge on the carbon was 
manually defined as + 0.9 based on the ab initio based charge calculation for unbound 
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heme. 26  In order to check the possibility of using oxygen species bound to the iron, 
as a means of better characterizing the binding site, a oxygen was added to the heme 
group at a distance of 1.3 A from the heme. The charge on the oxygen was defined as 
-0.6, based on the ab initlo calculated value. 26  A separate binding site file was then 
created for this oxygen bound site. Files were saved as mol2 format. 
To define the grid calculation area, a box was created with 'showbox' to 
include all points within 5 A of the bound 4-hydroxydiphenylmethafle orientation. 
Grids were calculated for both energy and contact scoring, with grid spacing of 0.1 A 
and distance cut-off at 5.0 A, while other values were as default. 
2.13.3.5 Running DOCK. 
The final DOCK parameter file used is presented in appendix 2. Notable 
differences from the default values are: the maximum orientations of the ligand and 
the number of orientations to be scored, which are significantly higher here than the 
defaults of 500 and 100 respectively. The lowest energy scored ligand orientation was 
redocked in DOCK. Output files included the lowest scored ligand orientations for 
both the contact and energy scored grid, plus the redocked values after re-inputting 
the calculated energy conformation and the DOCK output file containing the details 
of the run. For an example see appendix 3. 
Docking was performed initially on camphor until suitable file parameters 
were established. The binding site grid used for calculations was the one without 
bound heme-oxygen. The ligand orientations were then viewed with Insightil. 
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3 Protein Expression and Purification. 
3.1 Cytochrome P-450cam. 
3.1.1 	Expression of Cytochrome P-450cam in E.coli. 
The Pseudomonas bacterium has a well documented nutritional diversity.' In 
1959, the isolation from soil of a Pseudomonad (P. putida), known to be able to 
metabolize camphor as its sole carbon source, was achieved. 2 This led to an 
investigation of the enzymes involved in camphor metabolism. In 1965 the pathway 
for the camphor metabolism was established (figure 1.5) thus leading to the 
identification and isolation of the first enzyme of the camphor metabolic pathway, 
cytochrome P-450cam. 3 
Large scale expression and purification of cytochrome P-450cam was 
attempted in the early 1970s but a typical 130 L fermentation yielded only 1 mg of 
protein  .4  The genes encoding the cytochrome P-450cam and many of the other 
enzymes involved in the camphor metabolic pathway were found to reside on a 230 
kbp plasmid 5 known as the CAM' plasmid (PpG1). This plasmid encodes four 
proteins camA, B, C and D under one regulator, camR. The operon was arranged in 
order DCAB where camD is putidaredoxin, camC is putidaredoxin reductase, camA is 
cytochrome P-450cam and caniB is 5-exohydroxycamphor dehydrogenase. In 1982, 
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with the advent of modern cloning techniques, the P-450cam gene was cloned and 
overexpressed in Li coli (using the broad range pKT240 vector, 6 creating plasniid 
pKG201). For the first time, expression of the P-450cam above the normal levels 
expressed with the CAM plasmid was achieved. This expression was still poor due to 
the accidental removal of the cytochrome P-450cam promoter in the cloning 7  and in 
1986, with the elucidation of the sequence for P-450cam 8  the gene was subcloned 
into a high copy number pUC vector. 9  This allowed over-expression of the P-450cam 
under a Lac promoter, to a level of 10 % of the total soluble protein content. 8 
Although expression of cytochrome P-450cam has been optimized in P. 
putida, this expression system has a number of drawbacks compared to expression in 
E. coil: 10  i) the growth of E. coil is about 5-fold faster than P. putida, ii) the yields of 
cytochrome P-450cam are higher in E. coil; iii) E. coil only express P-450cam 
without the related co-proteins whereas the P.putida also produce the two co-
proteins putidaredoxin (Pd) and putidaredoxin reductase (PdR), which results in 
turnover of camphor and prevents the accurate study of the reaction kinetics. 
Importantly mutagenesis of a P. putida plasmid is not possible as no P. putida host 
vector currently exists. Due to the advantages of the E. coil system, the cytochrome 
P-450cam gene was incorporated into a heterologous expression system, constructed 
using plasmid pAW7292 in E. coil cell line JM109." 
The induction was controlled by a temperature rise from 30 °C to 37 °C. This 
plasmid also included antibiotic resistance genes for chloramphenicol. 1 ' It is important 
to note that the Y96A mutant and the 'wild-type' protein studied here contain the 
C334A mutation (to remove the surface cysteine), though it has been shown that this 
mutation has no effect on catalytic activity. 12,13 
3.1.2 	Purification of P-450cam. 
Many purification methodologies for P-450cam from bacterial systems have 
been established, 14  consisting of post-lysis purification with a series of anion exchange 
columns. For over-expressed proteins the most common purification technique used is 
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the method of Sugar," but this had to be adapted due to unsatisfactory preliminary 
results. 10  The general protocol used for the production of P-450cam was then adapted 
from one produced by Flitsch and Wong. 16 The following purification protocols were 
initially applied to the Y96A mutant purification but wild type protocols only differ in 
the OD at which the protein is assayed. 
3.1.2.1 	Protein Quantification and Purity Measurements. 
The heme groups of P-450 monooxygenases have a characteristic absorbance, 
known as the Soret band, at about 400 nm caused by a ic-it (ligand to ligand) charge 
transfer. As discussed previously, (chapter 1), the spin state of the iron centre alters 
upon substrate binding, increasing the it-ic transition energy, thus changing the energy 
(i.e. wavelength) of the Soret band. 15 In the case of the P-450cam, the Soret band 
shifts from a maximum absorbance (?max) absorbance of 417 nm (water bound) to an 
absorbance of 390 tim (no water bound), figure 3.1. This provides a method of 
determining both protein concentration and purity and additionally a means of 
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Figure 3.1: Soret band shift upon binding of 1 mM camphor to wild type (i) and Y96A mutant (ii) P-
450cam. 
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For protein concentration determination, the value of the Soret band maximum 
is used. For almost all stages of the purification the protein is stabilized with camphor, 
therefore the protein is in its substrate bound state. For wild type the maximum of the 
Soret band is therefore at 390 nm. For the Y96A mutant the maximum absorbance is 
at 417 nm, but at lower energy than the unbound maximum (i.e. lower extinction 
coefficient) because the camphor bound Y96A mutant has only 55 % of the heme in 
the low-spin form, figure 3.lii. 
Table 3.1: Extinction Coefficients of wild type P-450cam. 
wavelength camphor free camphor bound 
280nm 68.3 mTVf1cm' 17 63.3 mIV1T'cm 	17 
390nm 44 mlvf'cm' 18 102 mM'cm ' 
417nm 115 mMcm' 17 56 mM'cm 18 
Table 3.2: Extinction Coefficients of mutant Y96A, P-450cam. 18 
wavelength camphor free camphor bound 
280nm 68.3 mIvf 1 cm4 63 mM'cm4 
390nm 44 mM4cm' 70 mM4cm' 
417nm 115 mvf 1cm' 88 mM'cm' 
From the extinction coefficients tables 3.1 and 3.2, the ratio of 417:280 tim for 
pure camphor bound protein should be 1.2-1.3 for the mutant protein and 1.5-1.6 for 
wild type protein. 
3.1.2.2 	Extraction of Cytochrome P-450cam from E. co/i. 
Cells were harvested by centrifugation at 4 °C and stored at -20 °C. The P-
450cam was released by cell lysis, through sonication at 4 °C. After sonication and 
two centrifugation cycles the cell pellet was an 'off-white' colour, indicating complete 
cell lysis. 
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3.1.2.3 	Purification by Anion Exchange Chromatography. 
The DEAE sepharose column is a crude first protein purification step that 
equilibrates the cytochrome P-450cam into phosphate buffer containing camphor and 
potassium (40 mM), both of which stabilize the protein. 15 The movement of the 
protein, due to elution with a salt gradient, on the DEAE column was easily 
monitored by the movement of the coloured band on the column. The coloured 
DEAE column fractions were analyzed by UV/Vis spectroscopy at 417 nm, figure 
3.2. 
Fractions collected (-P200 ml) were all above an OD at 417 nm of 0.1. Other 
fractions below OD 0. 1, were not selected as their purity is not sufficiently high. The 








Figure 3.2: Selected DEAE column fractions, from an initial cell free extract load of 150 ml (only the 
coloured fractions were selected and spectroscopically analyzed). 
'1;] 
3.1.2.4 	Desalting and Concentration of DEAE Fractions. 
The DEAE fractions were desalted before the HPLC purification otherwise 
the protein would not bind to the SourceQTM anion exchange resin. The fractions also 
needed to be concentrated as the large fraction volume would prevent efficient 
binding to the I-IPLC column. 
Two successive concentration and dilution steps in a 300 ml concentrator (30 
kDa cut-off membrane) desalted the solution and concentrated it by a factor of ten, 
additionally protein contaminants below 25 kDa were removed, as confirmed by 
SDS PAGE, figure 3.5. 
3.1.2.5 	Anion Exchange Chromatography Using HPLC with SourceQTM Media. 
The final step in the protein purification consists of high resolution 
Sourcel5QTM anion exchange chromatography using a HPLC system. A significant 
amount of impurities do not bind to the SourceQ media and are washed off in the 
loading stage, figure 3.3. The protein elutes from the column at -9.5 minutes, at a 
salt concentration of 7-12 % I M KC1. 
/7 \ 
Figure 3.3: HPLC trace of Y96A protein sample, run at I Omi/min with a KCI gradient, monitored by 
absorbance at 280 nm and 417 nm. Left trace (red 280 am, black 417 am) is the sample loading stage 
(i.e. flow-through) and the right trace (red 417 am, black 280 run) is trace from the gradient elution. 
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The purity of the fraction can be directly ascertained by spectroscopic assay; 
the ratio of 280 nm : 417 nm was 1:1.2 for Y96A mutant for fractions of almost pure 
P450cam. Protein purity was confirmed by SDS PAGE, figure 3.5. 
	
3.1.2.6 	Removal of Camphor and Glycerol by Gel Filtration. 
The protein is stored in camphor and glycerol which was removed before any 
spectroscopic assays could be performed. A Sephadex G25 gel filtration column 
removed these components without excessive dilution (-2x dilution factor). As in the 
case of the DEAE column, the elution of the protein could be observed by the 
movement of the coloured band on the column. Fraction purity and concentration 
was measured by IJV/Vis spectroscopy. 
3.1.2.7 	Production of Protein of Sufficient Quality for Crystallography. 
For crystallography studies, the level of purity of the protein is vital. An extra 
HPLC step was performed using the hydrophobic interaction media phenyl 
sepharose. This removed any remaining protein contaminants (at high salt 
concentration), figure 3.4 and any denatured P450cam. 
Figure 3.4: HPLC trace of Y96A protein sample run on the phenyl sepharose hydrophobic interaction 
column with a decreasing ammonium sulfate gradient, monitoring at absorbance at 280 nm (red) and 
417 nm (black). 
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3.1.2.8 	Summary. 
Purification of cytochrome P-450cam was achieved in five steps with an 
overall yield of about 45 %, table 3.3. 





Pellet weight 46.3 g - 
Cell free extract 
(c) 
DEAE fractions 130 0.35 
Concentration and desalting 125 0.6 
HPLC fraction (d) 100 1.2 
Crystallography grade protein 90 1.3 
G-25 fractions M 80 1.7 (g) 
 
Protein concentration determined by spectroscopic assay at 417 nm. 
The ratio of 417 mn:280 urn is a used as a measure of purity. 
It is impossible to measure the cell free extract concentration accurately due to contamination from 
DNA and other E. coli impurities. 
Anion exchange HPLC was performed on 115 of the total sample, per run. 
Protein after the phenyl sepharose column performed on 115 of the total sample, per run. 
Samples loaded on the Sephadex G-25 column were about 1/8 of the total sample. 
Ratio is substrate free enzyme. 
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Figure 3.5: SDS PAGE gel of protein fractions; lanes- 1: Molecular weight markers. 2: Pre-induced 
cell suspension, 3: Induced cell suspension. 4: DEAE column fraction, 5: Concentration and 
desalting step, 6: HPLC fraction. 
After the HPLC step, the protein was pure enough for binding studies, as 
judged by SDS PAGE, figure 3.5. The only protein to be further purified was protein 
for the crystallography experiments. 
3.2 Putidaredoxin. 
3.2.1 	Expression of Putidaredoxin in E. coli. 
The gene for putidaredoxin was discovered to be associated with the genes 
encoding P-450cam and putidaredoxin reductase on the CAM plasmid. 19 Part of the 
putidaredoxin sequence was identified in 1986 20  with the sequencing of P-450cam, 
since the Pd gene lies downstream of P-450cam. In 1989 the Pd gene was sequenced 
by Koga 21  and Peterson, 22  working independently. The Pd gene was then 
engineered into the E. coil plasmid pIBI24 (derived from pEMBL) and expression 
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was placed under the control of the lacZ promoter. This gave yields of protein of 4.8 
mg/g of wet cells in E. coil strain TB 1. 
3.2.2 	Purification of Pd. 
Putidaredoxin was first purified in 1977 by Mock, in the laboratory of 
Peterson, and since then many purification methodologies have been established. 13,14 
For over-expressed proteins the purification is essentially the same as that developed 
by Sugar ' which consists of an ammonium sulfate cut followed by gel filtration and 
anion exchange chromatography. 
Attempts to reproduce this technique proved unsuccessful due to high protein 
loss during the ammonium sulfate cut (-50 % loss). It was therefore decided to 
develop new protein purification methods. 
3.2.2.1 	Protein Quantification and Purity Measurements. 
The 2Fe2S core of the putidaredoxin gives rise to a number of electronic 
transitions that are detectable by UV/Vis spectroscopy. For protein concentration 
determination, the peak at 405 nm is used because for impure protein solution, protein 
absorbance at 280 nm interferes with the 325 nm peak. 
Table 3.4: Extinction Coefficients of Pd. 
wavelength extinction coefficients 
280 nm 22.8 niM'cm 1 
325 nm 15.6 mIvf'cm' 
405 	n 11.lmM'cm' 
455 mit 10.4 niM'cm 1 
a) Extinction coefficients from published data. " 
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From the extinction coefficients, table 3.4, the ratio of 405:280 nm for pure 
protein should be 0.49. 
	
3.2.2.2 	Extraction of Pd from E. co/i. 
The protein is unstable at 37 °C, the cells were harvested by centrifugation at 
4 °C and stored at -20 °C. The Pd was released by cell lysis, through sonication at 4 
°C. After sonication and two centrifugation cycles the cell pellet was an 'off-white' 
colour, indicating complete cell lysis. 
3.2.2.3 	Purification by Anion Exchange Chromatography. 
The DEAE sepharose column is a crude first protein purification step that 
equilibrates the Pd into Tris buffer, which stabilizes the protein. 15 The movement of 
the protein, due to elution with a salt gradient, on the DEAE column was easily 
monitored by the shift of the coloured band on the column. The coloured DEAE 
column fractions eluted were analyzed by UV/Vis spectroscopy at 405 nm (figure 
3.2). 
Fractions collected (-200ml) were all above an OD at 405 nm of 0.1. Other 
fractions below OD 0. 1, were not selected as their purity is not sufficiently high. The 
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Figure 3.6: Selected DEAE column fractions, from an initial cell free extract load of 150 ml (only the 
coloured fractions were selected and spectroscopically analyzed). Fractions were collected in 10 ml 
volumes. 
	
3.2.2.4 	Desalting and Concentration of DEAE Fractions. 
The DEAE fractions were desalted before the HPLC purification otherwise 
the protein would not bind to the SourceQTM anion exchange resin. Desalting and 
concentration through use of a concentrator cell was not possible for Pd as it was for 
P-450 because with the use of a smaller molecular weight cut-off membrane the 
concentration took too long (>2 days), therefore it was decided to use dialysis to 
remove the salt from the DEAE column. Concentration was not necessary as the Pd 
eluted from the DEAE column more efficiently that the P-450cam. The resulting 
solution was sufficiently concentrated to pump directly on the SourceQ column. 
Dialysis also removed any small molecular weight proteins (<8 kDa). 
3.2.2.5 	Anion Exchange Chromatography Using HPLC with SourceQTM Media. 
The final step in the protein purification consists of high resolution 
Source 1 5QTM  anion exchange chromatography using an J-IPLC system. A significant 
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amount of impurities did not bind to the SourceQ media and were washed off in the 
loading stage (figure 3.3) The protein elutes from the column at -19 minutes, at a 
salt concentration of 50 % I M KCI (figure 3.7). 
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Figure IT 1-IPLC trace of Y96A protein sample, run at 1 OmI/min with a KCI gradient, monitoring at 
absorbance at 280 nm and 417 am. Left trace (black 280 rim) is the loading of the sample and the right 
trace (black 405 tim) is the gradient elution. The absorbance for 405 nm (i.e. black) is normalized on 
the graph by a factor of 2. 
From the dual wavelength output spectra the purity of the fraction can be 
directly ascertained without the need for a separate spectroscopic assay. The ratio of 
280 rim: 405 nm was 1:0.4. Protein purity was confirmed by SDS PAGE. 
3.2.2.6 	Final Purification Step of Pd. 
An extra HPLC step was performed using the hydrophobic interaction media 
phenyl sepharose. This removed any residual protein contaminants at high salt 
concentration along with any denatured Pd. 
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3.2.2.7 	Summary. 
Purification of cytochrome Pd was achieved in five steps with an overall yield 
of about 45% (table 3.5). 





Pellet weight 25 g - 
Cell free extract 84 0.17 
DEAE fractions 60 0.19 
Dialysis 55 0.27 
Anion exchange HPLC 50 0.45 
Hydrophobic interaction HPLC 45 0.50 
Protein concentration determined by spectroscopic assay at 405 nm. 
The ratio of 405 nm:280 rum is a used as a measure of purity. 
Anion exchange HPLC was performed on 1/10 of the total sample, per run. 
Protein after the phenyl sepharose column performed on 1/8 of the total sample, per run. 
3.3 Putidaredoxin Reductase. 
3.3.1 	PdR Quantification: 
The flavin group in the PdR give the protein a characteristic absorbance 
spectrum which can be used to quantitate the protein. From the previously published 
extinction coefficients, the protein absorbance at 454 nm is used to measure protein 
concentration, table 3 . 6 . 17 
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Table 3.6: Extinction coefficients of PdR_ 
wavelength extinction coefficients 
280 nm 72 mM'cm 1 
378 nm 9.7 mIvf'cm 
454 	n 10mIMT'cm' 
480 nm 8.5 niN'f'cm' 
3.4 Summary. 
The purification of both the wild-type cytochrome P-450cam, the Y96A 
mutant and the putidaredoxin was thus improved to give large quantities of pure 
protein. The purity of the protein used for crystallographic studies was of sufficient 
quality to give crystals that diffracted well (< 2 A), (chapter 5). Enough pure 
putidaredoxin reductase was provided by Dr. Luet Lok Wong that no expression and 
purification was necessary. 
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4 Biochemical Analysis of Cytochrome P-450cam. 
4.1 The Solvent Stability of P-450cam Y96A Mutant. 
4.1.1 	Introduction. 
The P-450cam Y96A binding site is extremely lipophilic, therefore 
successfully binding substrates that are hydrophobic. This leads to a solubility problem 
when using the reconstituted enzyme system which is in aqueous media. Higher 
substrate solubility would allow a higher substrate concentration and therefore could 
give higher product yields. Camphor is probably one of the most soluble of the P -
450cam substrates with a saturation concentration of 7 mg/ml. I  Other substrates have 
significantly lower solubility than this, normally below 1 mg/ml. For this reason, it was 
decided to investigate the tolerance of the P-450cam reconstituted system with 
increasing amounts of organic solvent. A number of limitations were placed on the 
type of solvent used. As the products were to be analyzed by GUMS the solvent must 
not have a high boiling point (e.g. DMSO), as they could interfere with substrate 
traces. Equally, solvents must be aqueously soluble to avoid generating a biphasic 
system. Substrates have, in the past, been added to P-450cam systems from ethanol 
stock solutions, therefore it was known that the reconstituted P-450cam system could 
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tolerate —I % ethanol. For these reasons it was decided to explore the use of alcohols 
to increase the substrate solubility. 
4.1.2 	Results of Solvent Stability Analysis. 
By addition of small amounts of alcohol to a reaction of camphor with 
cytochrome P-450cam any detrimental effects can be observed by measurement of 
the product formation. Thus, by plotting a graph of the loss of turn over vs the 
alcohol concentration, the effect of the alcohol can be assesed. The results of the 
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Analysis would indicate that the P-450 reconstituted system does not have a 
high tolerance for organic solvent. Ethanol would appear to be tolerated more than 
IPA however, even at a 12 % ethanol concentration the product yield is reduced by 
half. Although substrate solubility is marginally increased, the loss of product turn 
over is too great to justify the use of alcohols. The range of other possible 
solubilizing agents is extensive but due to time restraints, it was decided not to 
pursue this area of research any further, although this is a valid area for future study. 
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4.2 Alternative Electron Transfer Agents. 
4.2.1 	Introduction. 
Previous standard conditions for a biotransformation with the P-450cam 
system uses 1 l.IM P-450cam, 1 t.M PdR, 10 tM Pd, 10 mg NADH and 1 mg of 
substrate, in a 1 ml reaction volume. 2 Thus, in order to produce enough material for 
spectroscopic analysis of products (- 5 mg for NIMIR Spectroscopy), assuming 100 % 
turn over, at least a 5 ml reaction must be performed. This would mean that a large 
amount of the co-proteins, especially Pd, will be utilized in every biotransformation, 
which has financial implications. For this reason it was decided to explore the 
possibility of utilizing alternate electron transfer agents. 
Several electron transfer systems were available to us, either from commercial 
sources, or through project collaborations with other research groups. Spinach has 
reductases of the mitochondrial type and both a ferredoxin and a ferredoxin reductase 
are commercially available, (these are the cheapest commercially available ferredoxin 
and ferredoxin reductase). The possibility of using E. coil (containing a P-450cam 
gene) as a whole cell biotransformant had to be considered and for this reason it was 
decided to see if the natural flavodoxin and reductase from E. co/i were capable of 
performing the electron transfer .3,4  P-450BM-3 is potentially a more efficient electron 
transfer system than P-450cam, as only one protein needs to be produced instead of 
three. The P-450BM-3 flavo domain (BM-3R) is not commercially available but was 
made available to us. Old yellow enzyme (OYE) is a universal electron transfer agent 
present in bakers yeast and was provided by a collaborator. For the electron source, 
NADH was used in the chemical experiments and when using PdR; for all other 
protein systems NADPH was used (the other reductases have a higher affinity to 
NADPH than to NADH). Since one of the principlal costs in the biotransformation is 
the purification of the proteins, crude extract of P-450cam was used to see if the 
electron transfer was still possible in a complex mixture of proteins. Chemical electron 
transfer agents such as PMS 5  have been used previously to perform 
biotransformations6 and to turn over P-450cam in absence of co-proteins, 7 therefore 
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its use was also explored. Since the primary goal was high product yield, at a cheaper 
cost, the experimental measurements were performed based on product yield and not 
the rate of turn over. 
4.2.2 	Results of Electron Transfer Optimization. 
The various combinations of reaction mixes are presented based on their 
success relative to the standard conditions. The product analysis was based on the 
production of 5 -exo-hydroxycamphor. 
4.2.2.1 	Enzymatic Systems. 
No system was able to improve on the electron transfer rate of the 
reconstituted P-450cam system, indicating the high efficiency of the system. The only 
systems that were in any way effective were when the reductases were combined with 
Pd. This is supported by previous studies with adrenodoxin which, despite 37 % 
homology to Pd, does not react well with P-450cam. 8 For any enzymatic system not 
containing Pd there was no observable product. This evidence supports previous 
experimental data that suggests that the putidaredoxinlP-450cam binding has specific 
interactions, which prevent the P-450cam being reduced by any other system (chapter 
1). This is an essential part of the P-450cam gated system, in that it .prevents the 
reduction of the heme when not in the presence of substrate. 
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Table 4.1: Results of the optimization of electron transfer agents. 
Enzymatic controls Systems without camphor or NADWNADPH or P- 
450cam showed no products. 




Sd + PdR no detectable product 
FLD + PdR no detectable product 
Sd + SdR no detectable product 
Sd + OYE no detectable product 
FLD + FLDR no detectable product 
Pd + FLD a no detectable product 
BM-3R a no detectable product 
Chemical controls PMS does not react with camphor or P-450cam 
Successful PMS/enzymatic Pd + PMS 50% 
systems (50 p.M PMS) PMS 30% 
Unsuccessful PMS/enzymatic PdR + PMS 30 % b 
systems FLD + PMS 30% b  
Sd+PMS 20%b 
Crude extract controls unlysed pellet, or pellets containing no camphor or 
NADH gave no product 
Crude extract systems lysed pellet from a wild- 10% 
type cytochrome P-450cam 
expression 
a  product peaks were detected but could not be identified. 
b  percentage not above level with PMS alone. 
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It would appear therefore from the data, table 4. 1, that the reductases are less 
specific in their binding interaction with thier respective ferredoxins or flavodoxins, as 
both flavodoxin reductase and ferredoxin reductase are capable of interacting with Pd. 
The spinach reductase is understandably better than the E. co/i reductse since its role 
is to interact with ferredoxins. 
4.2.2.2 	PMS/ Enzymatic System. 
Results from previous experiments have indicated that PMS can transfer 
electrons to the P-450cam molecule from NADH alone and with an increased rate in 
the presence of Pd. 6  This is supported by our data which places a more efficient 
transfer to the P-450cam when PMS is present with Pd than using PMS alone. The 
PMS/Pd system is, however, still inferior to the fully reconstituted system. PMS 
combined with any reductase, including PdR, was not capable of enhancing the 
product yield above that of PMS alone. 
Since PMS is clearly capable of transferring the electron from NADH to P-
450cam, the improved efficiency upon addition of the Pd must be due to the high 
affinity between the Pd and the P-450cam, indicating that this affinity is not only 
higher than other enzyme systems, but better than an interaction from the PMS. 
The concentration of PMS used at 50 .tM is based on the value used 
previously ' and was not fully optimized. Some crude optimization of the protocol 
was carried out by varying the concentration. It was known that increasing the PMS 
concentration has the unwanted effect of interfering with the GC assay, as the PMS 
concentration becomes significantly higher than any other molecule. This aside, 
increasing the concentration to 100 jiM improved the product yield by 10 % without 
significant interference with the 5-exo-hydroxycamphor detection. PMS 
concentrations above 100 p.M did not appear to improve the overall yield. Reducing 
the PMS concentration to 10 p.M reduced the efficiency of the system five-fold, 
implying that 100 p.M is close to the optimal concentration when using these 
conditions. 
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PMS can successfully transfer electrons to the P-450cam without any co-
proteins, albeit at a lower yield, as discussed above. Only one other chemical system, 
titanium (III) citrate, has been previously employed in the reduction of P-450cam in 
anaerobic conditions and upon examination it was found that titanium (Ill) citrate is 
capable of converting oxygen to peroxide in aqueous media. 5 
4.2.2.3 	Use of Crude Enzyme Samples. 
The use of crude enzyme samples is attractive as it would significantly reduce 
the time taken purify the enzymes. Here the P-450cam protein levels for the crude 
extract, plus the Pd and PdR concentrations were in fact two times higher than the 
purified recombinant system, however, the yield of hydroxylated product was 10 %. 
The only other system with the crude extract to yield any product was the 
combination of Pd with PMS. In all cases however, there were unassigned peaks in 
the GC trace which can be attributed to the milieu of competing reaction that take 
place in a crude cell extract. 
4.2.3 	Conclusions. 
It has thus been demonstrated that it is possible to activate catalysis with the 
P-450cam system using alternative electron transfer agents. It is clear from the data 
that, unless using PMS, it is not viable to perform the reaction without the presence of 
Pd. The P-450cam/Pd affinity would appear to be too specific to allow the use of 
other ferredoxins. For the PMS system alone, the yield is sufficient to consider it as an 
alternative, however, this data was for camphor, which has 100 % conversion to 
product. For most unnatural substrates, the yield is significantly reduced thus making 
the additional use of a low yielding electron transfer system unviable. Crude extracts, 
whilst saving the time involved in purification, have the drawback of producing many 
side products. With the drop in yield and these competing reactions it is not thought 
viable to perform these biotransformations with our crude enzyme mixture. 
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Both the PMSIPd and the PdRIPd system give acceptable yields (50 % and 
100 % respectively). For their use, the lower yield of the PMSIPd system and 
potential problems in extraction will have to be assesed vs the need to purify PdR, 
which is potentially problematic as it is known to express with low yields, 
(unpublished data). 
4.3 Binding Assays and Substrate Turn over. 
4.3.1 	Introduction. 
In the study of enzymes knowing whether a new substrate binds to the active 
site is crucial. In many cases this must rely on biochemical assays, the detection of 
products or structural elucidation via NIvIR or X-ray crystallography. In the case of 
cytocbrome P-450cam, the binding of substrate can be measured directly via UV/Vis 
spectroscopy. The heme group has a characteristic absorbance, known as the Soret 
band, 9 at about 400 nm caused by a ic-.t' (ligand to ligand) charge transfer. A 
discussed previously (chapter 1) a substrate that enters the binding site displaces the 
heme bound water changing the electronic configuration of the heme. This change of 
electronic configuration shifts the Soret band from 417 nm (water bound) to 390 nm 
(substrate bound) known as a type 1 shift. Thus, the binding of substrate to P-450cam 
can be measured by observing this shift in the Soret band, providing a quick assay for 
determining if a substrate will bind. 
Extensive studies have been made of the Soret band at various stages of 
substrate binding. 10,11  Carbon or hydrogen substituents which are in the vicinity of the 
heme do not interact with the iron, which gives a Soret band at 390 nm. Nitrogen, 
sulfur and oxygen, however, bind as ligands to the iron centre (e.g. in the cases of 
imidazole, metyrapone, dithiothreitol, cyclohexanol or indeed water). 10  Where one of 
these heteroatoms is present, ligand binding can clearly be observed (for nitrogen 
ligand interaction a Soret band at -423 nm is observed, for oxygen -417 nm, and for 
sulfur two bands are observed at -374 nm and 461 nm)' ° This binding of heteroatoms 
also means that the change from hexa-coordinate low spin to penta-coordinate high- 
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spin does not occur and the enzyme is not capable of catalyzing the hydroxylation of 
the substrate. 
It is important to note that although the binding assay is a good guide to 
potential substrates it is not a guarantee that substrates causing this shift will be 
oxidized, they may act as an inhibitor or the competing peroxide shunt pathway 
(chapter 1) could prevent product formation. More accurate information is obtained 
from NADH consumption assays and product isolation (see later). The binding assay 
does however indicate whether a compound enters the binding site. 
	
4.3.1.1 	Calculation of Binding Constants. 
The binding constants can be calculated by the method of Dawson 12  using the 
following equation, figure 4.1. 
AA 
log 	 = log [S] - log Kd 
L z\Amax - AA 
Figure 4.1 Where AA is the change in absorbance of the Soret band, AAmax is the maximum 
possible change in absorbance for this substrate, [S] is the substrate concentration and KD is the 
dissociation constant. 
Thus by plotting log (AA/AAmax-AA) vs. log[S], a graph with intercept of -log KD is 
produced; an example dataset is shown in appendix 1 
4.3.1.2 	Binding with Herne Ligation. 
When substrates bind with ligation to the heme it is not possible to measure 
the change in the Soret band (nitrogen ligation occurs too close to the 417 nm to get 
.4 . F3)CIi\W• 	.'';\ \ 	ç 
accurate measurements and oxygen ligation occurs at 417 nm so no change in 
absorbance is observed). The binding properties of one of these substrates can be 
determined by observing the displacement of a ligand, rather than a heme bound 
water. Strong binding substrates would interfere with the assay therefore DTT is 
used. DTT is a weak substrate for P-450cam (KID> 100 jtM) with sulfur ligation that 
gives characteristic peaks at 370 nm and 460 nm. Its displacement can thus be 
monitored spectroscopically and, due to its low binaing affinity, binding constants (or 
more correctly DTT displacement constants) can be calculated. 
	
4.3.1.3 	Percentage High-Spin. 
The maximum percentage high-spin can be measured by addition of a 
saturating concentration of substrate and measuring the relative absorbance at 390 nm 
and 417 nm, for an example graph appendix 1. This is a measure of the water 
accessibility to the binding site in the presence of substrate, therefore should reflect 
how tightly the substrate will bind. This could thus be used as a guide to 
stereoselectivity and peroxide production, since substrates that have a low percentage 
high-spin will be more mobile therefore have lower product stereoselectivity and 
higher peroxide production. It should be noted that the percentage high-spin may not 
be related to water occupancy (see chapter 7). 
4.3.1.4 	Substrate Turn-over. 
Substrate turn over conditions were designed with excess NADH to provide 
maximum product formation, even with the high levels of peroxide production 
previously exhibited with the P-450cam Y96A mutant. 13-15  The products of the turn 
over can be easily extracted into organic solvent and analyzed by GC/MS. Peaks not 
present in the substrate GC/MS spectrum were analyzed as potential products. Peaks 
exhibiting mass ions increased by 16 (i.e. oxygen addition) were assumed to be 
hydroxylated products if the breakdown peaks were consistent with a hydroxylated 
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product. Similarly products with mass ions increased by 14, (monooxygenation 
followed by double hydrogen loss), and fitting the correct mass spectrum profile, were 
assumed to be keto-products. If possible, the oxidized product were. further 
characterized by analysis of the mass spectrum breakdown profile. 
4.3.2 	Substrates Analysis. 
The substrates studied can be divided into a number of classes based upon 
analogies to known substrates, these are: camphor and adamantane analogues; 
diphenylmethane analogues; naphthalene analogues; chlorinated aromatic molecules; 
aromatic molecules with carbocycles; aromatic molecules with nitro-heterocycles; 
aromatic molecules with oxygen heterocycles. 
4.3.2.1 	Camphor. 
R-(+)-Camphor [2], the natural substrate for P-450cam, has a strong binding 
affinity to wild-type P-450cam (KD=2.0 .tM) and near complete water dissociation 
(98 % high-spin). 16 The P-450cam Y96A mutant has a very similar binding affinity to 
the wild-type (table 4.2), however, the percentage high-spin is considerably lower. 
101 
:TE.R 4'  
Table 4.2: Camphor hydroxylation by P450cam mutants Y96F and Y96A. 





48 2.5 5 hydroxylated 
Y96A 1 keto product 
5917,18 - 5 hydroxylated 
Y96F 0, 1 unidentified 
This would imply that the factors controlling the P-450cam/camphor 
recognition are maintained, but the substrate has greater mobility in the binding site. It 
is possible that this is solely due to the loss of the hydrogen bond to camphor This can 
be confirmed by comparison to the Y96F hydroxylation (table 4.2). While it is clear 
that the Y96F and Y96A mutants have similar substrate properties, i.e. lower % high-
spin and the same number of products, the P-450cam Y96A mutation has obviously 
had a greater effect on the product distribution than could be attributed to the loss of 
the hydrogen bond alone. 
4.3.2.1.1 	Product Analysis of Camphor. 
The products of the P-450cam Y96A mutant reaction with camphor were 
analyzed by GC and these results are presented in figure 4.2. 
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Figure 4.2: GC trace of the hydroxylation of camphor by the P-450cam Y96A mutant. 
Hydroxylation of R-camphor by wild-type enzyme gives one product, the 5-
exo-hydroxy camphor. The GC trace of the P-450cam Y96A mutant hydroxylation 
clearly shows the presence of other metabolites in addition to the 5-exo-
hydroxycamphor (8.21 mm). This is consistent with previous studies which indicated 
that the removal of the hydrogen bond, by making the Y96F mutant, results in some 
loss of selectivity. 17,18  The percentage products of the Y96A and Y96F mutant turn 
overs are presented in table 4.3. 
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5-exo-hydroxycamphor 99 92 74 
5-endo-hydroxycamphor 1 4 
6-exo-hydroxycamphor 2 15 
6-endo-hydroxycamphor Oa 
9-hydroxycamphor <1 4 
3-exo-hydroxycamphor 4 1 
2,5-di-ketocamphor 1 
% High-spin 99 59 45 
a  6-exo and 6-endo-hydroxycamphor can undergo inter-conversion via a keto intermediate therefore 
6-endo levels might be due to conversion from 6-exo and not by direct hydroxylation by the enzyme. 
19 
b Although 2,5-diketocamphor was not positively identified a peak can be seen in the GC trace at the 
correct retention time. 
The six hydroxylated camphor molecules can all be distinguished by their 
retention times and mass spectral profiles, table 4.4. 
Table 4.4: MS profiles of hydroxycamphors (for numbering see chapter 1). 
Hydroxy Camphor Retention time Highest mass ions 
3-exo 7.33 83, 84, 55, 125, 69, 168 
6-exo 7.95 153, 108, 107, 93, 70, 55 
6-endo 8.01 153, 70, 55, 97, 108, 69 
5-exo 8.21 111, 168, 125, 69, 55, 83 
5-endo 8.42 153, 111, 107, 108, 93, 55 
9- 8.59 95, 108, 109, 93, 67, 137 
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In order to determine the products of the hydroxylation detailed mass spectral 
analysis was necessary. The camphor molecule has a number of 'high mass' ions in the 
mass spectrum (137, 109, 95). Careful analysis of the possible breakdown peaks for 
camphor indicate how these products are formed, figure 4.3. 
From this, the identity of peaks in the GC-MS spectrum was determined, since 
the breakdown pathway will be affected differently depending on the site of 
hydroxylation. 
The 3-hydroxy products of camphor can be distinguished from the others because 
they have a peak at + 95, due to the loss of the hydroxyl group from next to the 









Figure 4.3: Possible camphor breakdown products formed by El mass spectrometry. 
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Figure 4.4: Possible formation of the +95 species in 3-hydroxycamphor. 
In addition the 3-hydroxy products have significantly lower retention times on 
the column, due to an internal H-bond to the camphor carbonyl, figure 4.5. 
H- -- -    o 
\' 
0 
Figure 4.5: Intramolecular hydrogen bond present in 3-exo-hydroxycamphor. 
The 3-exo species is characterized by a significant peak at -28 (mass ion 140) 
corresponding to the loss of carbon monoxide. This is distinctly different from the 3-
endo product which has loss of water, -18 (mass ion 150), as a major peak since the 
3-exo product has no access to a readily extractable hydrogen for the alcohol moiety, 
figure 4 . 6 . 20 
o i 	) 
+ 
	
H 	 LH,0 	 H20 
Figure 4.6: Possible loss of water from 3-endo-hydroxycamphor. 
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The 9-exo-hydroxycamphor can be characterized by the loss of methanol as 
described previously. 20 
The 5- and 6-hydroxy products could not be identified by the mass spectrum 
analysis alone, therefore had to be determined from authentic standards. The 5-exo-
hydroxycamphor was made by hydroxylation of R-camphor by wild-type P-450cam. 
The 5-endo-hydroxycamphor was provided by Prof Sabine Flitsch. The 6-exo and 6-
endo-hydroxycamphor was provided by Dr. Gideon Grogan,, University of Edinburgh. 
The 2,5 di-keto product was identified by an authentic standard although it 
was not previously identified in the hydroxylation of camphor by Y96F mutant. 17"8 
When performing the biotransformation reaction with the Y96F mutant the same 2,5 
di-keto product was produced. The mechanism of formation of this di-keto species is 
not known, however, it only appears in biotransformations that have a non-saturated 
amount of camphor and may therefore could be due to a second 5-hydroxylation of 
the 5-exo-hydroxycamphor followed by loss of water, figure 4.7; alternately it could 





2e, 2H, 02 
0 H 
[2] 	 [3] 
Figure 4.7: Possible fonnation of 2,5-diketocamphor. 
When the biotransformation was repeated in the presence of alcohol 
dehydrogenase the keto product increased to 30 % of the total product distribution, 
with the corresponding decrease in the 5-exo-hydroxy product. This could imply that 
the keto product was formed due to contamination of one of the protein preparations 
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4.3.2.1.2 	Effect of the P-450cam Y96A Mutation on R-Camphor Hydroxylation. 
The additional removal of the phenyl ring (i.e. the difference between the 
Y96A and Y96F mutant) increases the movement of camphor in the binding site 
beyond that of the removal of the tyrosine-camphor hydrogen bond, resulting in an 
increase of other hydroxy-camphor products. The significant presence of 5-exo-
hydroxycamphor indicates that the movement of the camphor molecule is still 
restricted, despite the removal of the hydrogen bond to the tyrosine. This is also found 
in previous studies with the wild-type enzyme which showed that substrate with no 
geminal methyl groups, e.g. norcamphor, had increased movement in the binding site. 
This indicates both the hydrogen bond to tyrosine 96 and the hydrophobic interactions 
with the geminal methyl groups are essential to maintain 100 % product 
specificity. 17,18  The 6-ex-hydroxy camphor is the primary secondary product as seen 
for the Y96F mutant, however, the percentage of product is significantly increased 
from 2 % to 15 %. The percentage of other products essentially remains the same as 
for the Y96F mutant. These results would indicate that the general rotation of the 
camphor is still inhibited by hydrophobic interactions between the geminal methyl 
groups and the binding site but the molecule has some minimal increase in movement 
about the C5 carbon that additionally allows the C6 position to be hydroxylated. 
The binding data on P-450cam Y96A mutant indicated that the enzyme rests 
48 % in the high-spin state, at 390 nm, when saturated with camphor. This partial spin 
state is probably due to the presence of a water molecule in addition to the camphor. 
It has been shown with the wild-type enzyme that the camphor must be able to move 
off the enzyme binding site to allow the oxygen to bind to the heme and it is thought 
that the hydroxy group of the tyrosine helps to push the camphor back towards the 
iron. This hypothesis would be supported by our data for the Y96A and Y96F 
mutants, as the increased space at the 'top' of the binding site allows the camphor 
molecule to exist in a place that partially allows water to enter the binding site and 
interact with the heme. The extra space in the Y96A mutant compared to the Y96F 
mutant is reflected in the lower percentage high-spin. 
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Other P-450 monooxygenases that hydroxylate camphor include P-450LM2 
(63 % 5-endo, 14 % 5-exo and 16 % 3-endo), and P-450soy (60 % 6-endo, 9 % 5-
exo, 5 %-endo and 2 % 3- endo) but only P-450camr from rhodococcus sp. 
hydroxylates to give a stereo selective product, 100 % 6-endo-hydroxycamphor. 19 
4.3.2.2 	Hydroxylation of Camphor! Adamantane Analogues. 
Although camphor hydroxylation is less stereo selective with the use of the P-
450cam Y96A mutant, it was still of interest to examine compounds known to be 
substrates for the wild-type enzyme. 
S-camphor [23], is hydroxylated to produce mostly 5-exo product (40 %), but 
with significantly greater amounts of the other hydroxy products (6-exo=33 %, 5-
endo=12 %, 3-exo=15 %). The lower KD is indicative of the selectivity of the enzyme 
for R-camphor, however, the % high-spin is similar, thus suggesting that once the 
substrate is in the binding site the poor complementarity between the enzyme and the 
S-camphor allows partial water access to the heme, as sen with the R-camphor. 
Bicyclo[3.2. 1]octan-2-one [24], is structurally similar to camphor and it was 
of interest to see if the extra carbon in the bicyclic ring would confer greater 
stereo selectivity. As can be seen from the data, table 4.5, oxidation of substrate 24 
occurs with lower stereoselectivity than camphor. 
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Table 4.5: Biochemical data of compounds 23-28. 
Compound Structure % high- K1) Products Retention time 
spin (p. and percentage 
23 45 10 starting material 5.72 
° hydroxy product 7.33 
hydroxy product 8.01 
hydroxy product 8.21 
hydroxy product 8.42 
24 32 - starting material 4.90 
keto product 6.07 (trace) 
hydroxy product 6.15 (3%) 
hydroxy product 6.57(18%) 
hydroxy product 6.67 (25%) 
hydroxy product 7.15 (1%) 
hydroxy product 7.21 (trace) 
keto product 7.53(2%) 
keto product 7.82 (50%) 
hydroxy product 8.11(10%) 
hydroxy product 8.23(1%) 
25 N 56 a a 
110 
(IH API: FR 4.- 13 IOCF.WM i( :.AL A N. A.LY S IS 
26 ° Oxygen - starting material 7.33 
OO 
binding 
10 45 - starting material 5.49 
hydroxy product 7.10 (trace) 
hydroxy product 7.18 (trace) 
dihydroxy product 7.56 (1%) 
dihydroxy product 8.20 (96.5%) 
dihydroxy product 8.62 (2.5%) 
27 OH Oxygen - starting material 7.10 
binding dihydroxy product 7.56 (1%) 
dihydroxy product 8.20 (96.5%) 
dihydroxy product 8.62 (2.5%) 
28 OH Oxygen - starting material 7.18 
binding dihydroxy product 7.56(l.5%) 
dihydroxy product 7.95(47%) 
dihydroxy product 8.20(9%) 
dihydroxy product 8.62 (6.5%) 
dihydroxy product 8.78(4%) 
dihydroxy product 8.95(5%) 
keto-hydro product 9.11(18%) 
keto-hydro product 9.15 (l.5%) 
a  Compound could not be analyzed due to excessive evaporation 
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The low percentage high-spin indicates a high degree of mobility of the substrate in 
the binding site. This is possibly due to the absence of the geminal carbons in 24 
which, as with other camphor analogues, have been shown to decrease 
stereoselectivity when absent (chapter 7). 
Bicyclo[2.2.1]hepta-2,5-diene [25] is a norbornane [9] analogue, and it was 
thought that, due to the greater movement exhibited by camphor analogues in the P-
450cam Y96A mutant binding site that dihydroxylation might be possible to give a di-
epoxide species. Unfortunately, due to the volatility of the compound, a 
biotransformation could not be successfully performed to test this. Attempts to 
prevent this proved unsuccessful. Since the compound binds, table 4.5, it could be of 
interest to pursue methods of performing the turn over without evaporation of 
substrate. 
2-Acetyl-1,3-cyclohexanedione [26] was of similar size to the other 
compounds studied, however, it contains additional carbonyl groups and therefore it 
was of interest to examine the effect this would have on the enzyme/substrate 
recognition. Data, table 4.5, clearly shows that compound 26 is a substrate for the 
enzyme. The carbonyl group would not be expected to interact with the heme 
therefore the 0-ligation might be caused by a bound water hydrogen bonded to the 
heme and the substrate 
Adamantane [10] is a known substrate for wild-type P-450cam 20  giving the 1-
adamantanol [27] as the product. This is not indicative of high regioselectivity, as the 
adamantane molecule only has two distinct carbons, of which the tertiary carbon is the 
more favoured for hydroxylation, on thermodynamic grounds. The binding constant 
for adamantane with wild-type enzyme is 50 iM with a percentage high-spin of 99 %. 
For the P-450cam Y96A mutant, as for camphor, the percentage high-spin is lower 
than the wild-type, indicative of the increased movement of the adamantane in the 
mutant binding site. This is also confirmed by the increase in the number of products, 
table 4.5. Through commercially available standards, the two hydroxylated peaks in 
the product mixture were identified as the 1-adamantanol (1 %) and the 2-
adamantanol [28] (<1 %). Three peaks at a M of 168 (i.e. + 32) were found. It was 
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possible that these products were the due to the biohydroxylation of 1- and 2-
adamantanol. To confirm this 27 and 28 were hydroxylated with the P-450cam Y96A 
mutant. The 1-adamantanol gave three products similar to the unidentified peaks from 
the adamantane hydroxylation. The 2-adamantanol gave six di-hydroxylated products 
and three keto-products. By comparison of the products to literature values and 
analysis of the products produced by each adamantanol the di-hydroxylated species 
could be identified. The 1-adamantanol produces, in order of retention time, the 1,2-
diol (1 %) the 1,3-diol (96.5 %) and the 1,4-diol (2.5 %). The 1,2-diol is 
distinguishable from the other products by the lower retention time caused by the 
internal hydrogen bond. The 1,3-diol is distinct by its absence from the 2-adamantanol 
hydroxylation. The 2-adamantanol produces, in order of retention time, the 1,2-diol 
(1.5 %), the 1,4-diol (47 %), cis and trans 2,4-diol (9 %, 6.5 %) cis and trans 2,6-diol 
(4 %, 5 %) and three keto products (18 %, 1.5 % and 7 %), figure 4.8. 
As for the camphor, it is believed that the keto products are due to the 
presence of alcohol dehydrogenase. 
The hydroxylation of adamantane is significant because it is the first example 
of a double hydroxylation by P-450cam. In addition to this the hydroxylation of 
adamantanol is the first example of alcohol hydroxylation by P-450cam. 
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Figure 4.8: Hydroxylation of adainantane by P-450cam Y96A mutant, the major product (1,3-
adainantan-thol) is boxed. 
4.3.2.3 	Diphenylmethane Analogues. 
Both diphenylmethane [13] and phenylcyclohexane [18] are known substrates 
for P-450cam. It was therefore of interest to explore the binding of a phenyl 
substituted pentane chain, amyl benzene [29], table 4.6. 
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Table 4.6: Biochemical data of compounds 13, 18, 29, 30. 
Compound Structure % KD GC peaks Retention 
time 
high- (j.tM) and 
percentage 
spin (in mm, 
_ _________________ (% total)) 
13 starting material 8.67 
hydro 	product 10.96 (80/6) 
18 85a 1.8 starting material 7.72 
hydroxy product 9.52 (2-/.) 
29 85 starting material 5.64 
hydroxy product 8.7 (9.5 %) 
10.8 (15 %) 
30 45 3.5 starting material 6.34 
hydroxy product 8.56 (<1%) 
a, b thiS is verified by previous data 21,22 
The binding constant for amyl benzene is only slightly higher than for 
diphenylmethane and phenylcyclohexane, showing that the recognition of the P-
450cam mutant binding site is still maintained with aliphatic chains on the molecule. 
The percentage high-spin is the same for amyl benzene as for phenylcyclohexane and 
both are significantly higher than diphenylmethane. There are a number possible 
reasons for this difference. The increased size of the aliphatic molecules could cause 
greater displacement of the iron bound water. An alternative to this theory would be, 
that due to the increased degrees of mobility allowed with an aliphatic ring or chain 
they have greater movement and displace the iron bound water. It is possible that the 
percentage high-spin is purely related to the orientation of the substrate in the binding 
site, thus each of the above substrates has a different orientation that causes the 
changes in percentage high-spin. One alternative theory is more controversial, and 
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states that it is the effect of the substrate on the heme environment that causes the 
change and not a direct change in the iron bound water. 23 
The binding of diphenylmethane, phenylcyclohexane and amylbenzene implies 
that the P-450cam Y96A mutation has created a binding affinity for phenyl rings i.e. a 
'handle', possibly in the proposed phenyl binding pocket (see chapter 7). To test this 
theory the binding of a non-aromatic substrate, of similar shape to the other substrates 
studied, was explored. Bicyclohexyl [30] binds with similar efficiency to 
diphenylmethane, phenylcyclohexane and amyl benzene (table 4.6) and with only a 
slightly lower percentage binding. This would imply that the phenyl ring on the 
substrates enhances binding but is by no means essential. The slightly lower 
percentage high-spin here would suggest that, of the above theories, the substrate 
orientation might play the most significant role as the bicyclohexyl is bulkier and more 
mobile and thus should have a higher percentage high-spin if these are the controlling 
factors. 
Diphenylmethane has been previously shown to produce the 4-hydroxy 
product, 22  figure 4.9, although this probably results from formation of the epoxide, 
followed by ring opening to form the more favoured para- substituted product and by 
a hydrogen shift. 24 
The phenylcyclohexane has been shown to have similar stereoselectivity, 2 ' 
producing 3- and 4-hydroxy products. These products may all be present in the 
biotransformation but may not be separated by the GC method used here and hence 
appear as one product. The product of the amyl benzene biotransformation could be 
identified from the mass spectral breakdown peaks which showed the presence of M 
peak of 118 corresponding to the loss of ethanol (46) and no peaks for loss of 
methanol or propanol, suggesting the 1 -benzylpentan-4-ol product. 
116 
CliAPT ER 4: BJOC.U.EM iCI.. AN A.LY S S 
Cytochrome P450 








2e. 2H4, 02 18 	iii) KIII OH 
Cytochrome P450 




OH (D-0 ----------- 
2e, 2H, 02 
30 
Figure 4.9: Known products of the biotransformations of compounds 13, 18, 29, 30. 
The bicyclohexyl product could not be readily identified and as with the 
phenylcyclohexane, probably contains multiple hydroxylated products that did not 
separate on the GC. 
For these substrates a consensus about the binding properties of the P-450cam 
Y96A mutant towards molecules with a hydrophobic 'handle' can be seen. The 
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binding site orientates the substrate in a position so that the hydroxylation takes place 
opposite the hydrophobic handle. The region that binds this handle has a strong 
preference for aromatic rings although it still binds aliphatic groups. 
4.3.2.4 	Naphthalene Analogues. 
Naphthalene [19] is a known substrate of the P-450cam Y96A mutant 25  and it 
is thought that it binds similarly to diphenylmethane and the phenylcyclohexane, with 
one of the naphthalene rings in the hydrophobic pocket. 
Naphthalene analogues 1,2,3 ,4-tetrahydronaphthalene [31] (tetralin) and 1,2-
dihydronaphthalene [32] both bind to the Y96A mutant enzyme, table 4.7, with 
percentage high-spins comparable to the more mobile substrates such as adamantane. 
Tetralin has previously been shown to be a substrate 26  for the wild-type 
enzyme producing the 1,2,3,4-tetrahydronaphth-1-ol [33]. Substrate 31 produces one 
hydroxylated product. Both 1,2,3 ,4-tetrahydronaphth- 1 -ol and 1,2,3,4-
tetrahydronaphth-2-ol [34] were commercially available and upon analysis the product 
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Figure 4.10: Products of the biotransformation of compounds 31 and 32. 
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When analyzing the alcohols as substrates they were shown to bind to the 
heme via oxygen ligation and produce no product upon biotransformation. Substrate 
32 produces an epoxide, which exhibits similar fragmentation patterns to 33 and 34 
which suggests it is 1,2-epoxy-1,2,3,4-tetrahydronaphthlene. 
Table 4.7: Biochemical data of compounds 31-36. 
Compound Structure % high- KD GC peaks Retention time 
and percentage 
spin (j.tM) in mm, 
____ ______  (% total) 
31 starting material 5.73 
(III[IIIIIIII] - hydroxy product 8.18(80/o) 
32 32 - starting material 5.73 (98.5 %) 
epoxide product 7.92 (l.5 %) 
33 OH Oxygen - starting material 8.18 
binding 
34 OF Oxygen - starting material 8.66 
binding 
35 a b b - 
36 a b b - 
a-uompouna was too insoluble for accurate readings 
b-Compound could not be analyzed due to excessive evaporation 
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Acenaphthene [35] and acenaphthylene [36] were both potential substrates for 
the P-450cam mutant however due to poor aqueous solubility and high levels of 
evaporation during the biotransformation their substrate potential could not be 
confirmed. 
4.3.2.5 	Chlorinated Aromatic Compounds. 
Halogenated substrates have been shown to be substrates for wild-type P-
450cam, 2730 sometimes exhibiting dehalogenation; 6 ' 29' 31 which is of great interest in 
studies of biodegradation of polyhalohydrocarbons. 30 ' 3234 Here we were interested in 
chlorinated substrates because of their potential for crystallographic studies, as heavy 
atoms in the substrate would make interpretation of the electron density maps easier. 
Diclofenac [37] is an important anti-inflammatory agent and it has been 
suggested that hydroxylation of either of the aromatic rings could enhance biological 
activity. Selective hydroxylation of diclofenac is chemically difficult and it was hoped 
that hydroxylation of diclofenac or a synthetic intermediate might be achieved using 
the P-450cam Y96A mutant enzyme system. 
Monochiorodiphenylmethane [38] and dichlorodiphenylmethane [39] are of 
potential interest due to their similarity to a known substrate, diphenylmethane, and 
are thus of potential use as heavy atom substrates in crystallographic studies, table 
4.8. 
Of these two compounds only the monosubstituted diphenylmethane bound to 
the enzyme, with a high percentage high-spin, suggesting minimal movement in the 
binding site. The biotransformation produced one hydroxylated product for the mono 
chlorinated diphenylmethane (this product could not be identified) and none for the 
dichiorinated molecule. 
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Table 4.8: Biochemical data of compounds 3840. 
Compound Structure % KD GC peaks Retention time 
and percentage 
high- (.tM) in 111111, 
(% total) 
spin 
38 81 - starting material 18.35 (IJ>i1II .] 
hydroxy product 19.63 
39 Cl a - starting material 17.98 
37 HOOCJjJ 
a a a - 
HN 
ci 
40 ci 93 - starting material 15.49 
product 16.92(1%) 
a-Compound was too insoluble for accurate readings. 
Unfortunately diclofenac could not be studied directly because it was insoluble 
in any solvent at usable concentrations. A synthetic precursor to diclofenac, [40], was 
synthesized in-house. This bound to the enzyme with a high value for the percentage 
high-spin. A binding constant could not be determined accurately due to compound 
insolubility. The biotransformation produced one product which could not be readily 
identified. The fragmentation pattern showed the characteristic peaks for dichlorinated 
molecules, but the absence of the mass ion make identification difficult. 
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4.3.2.6 	Aliphatic Substituted Aromatics. 
It had been known from previous data that phenyl substituted aliphatic ring are 
potential substrates for the P-45Ocam Y96A mutant. 13-15,21,22,25  A range of derivatives 
were tested with different linkages to the aromatic 'handle', including keto, ester, and 
ether linkages. One of these compounds, 1-benzoyl-cyclohex-2,3-ene [41], was 
known to have a good binding affinity but the identification of the product had not 
been determined, table 4.9. 
From the GC/MS data, 41 is oxidized to the epoxide, figure 4.11. 
Cytochrome P450 
2e, 2H,02 
Figure 4. 1 1:Hydroxylation of 41 by the P-450cam Y96A mutant. 
This is consistent with the previous results, where hydroxylation on the 3 or 4 
position was observed. Despite a binding constant better than camphor and high 
percentage high-spin, the yield for this substrate was very low with < 5 % of the 
reaction mixture being product, compared to camphor and adamantane which give 
100 % product under the same conditions. An obvious reason for this can not be 
found since peroxide production would not be expected due to the high percentage 
high-spin. It might be possible that the product is acting as an inhibitor by binding too 
strongly to the heme thus reducing the efficiency of turn over. 
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Table 4.9: Biochemical data of compounds 4143. 
Compound Structure % KD GC peaks Retention time 
and percentage 
high- (tiM) in mm, 
(% total) 
spin 
41 52 1 starting material 10.05(84%) 
eo'c epoxide product 11.73 (16%) 
42 95 3 starting material 9.14 (86 %) 
o hydroxy product 11.69(14%) 
43 95 25 starting material 8.85(99%) 
hydroxy product 11.51 (<1 %) 
Two other substrates were tested to examine whether a more flexible ether 
linkage would improve the substrate binding and product formation. Benzyl-oxy-
cyclohexane [42] and benzyl-oxy-cyclopentane [43] were examined as potential 
substrates, table 4.9. As can be seen from the data both substrates bound to the 
enzyme, ailbeit with poor binding constants. What could not be understood from the 
data was why neither substrate appeared to produce product. An explanation could be 
that similar to 41 or the product yield is low and this might not be detected by our 
GUMS assay. 
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4.3.2.7 	Aromatically Substituted Pip eridines. 
Hydroxylated pip eridines are of potential interest as synthetic intermediates for 
the production of a range of pharmaceuticals. Previously, a range of aromatically 
substituted piperidines were found to be substrates for the P-450cam Y96A mutant. 2 
All these piperidines are attached to the phenyl group through the piperidine nitrogen 
to avoid nitrogen ligation to the heme. Here we further explore their use as substrates 
for the mutant enzyme, in the hope of providing a greater insight into the effect of 
substitution on the piperidine ring and the nature of the linkage between the piperidine 
and phenyl rings. 
Three substrates contained the benzoyl group bound to an unsubstituted, 
dimethylated and ethylated piperidine ring (N-benzoylpiperidine [44], N-benzoyl-2,6-
dimethylpiperidine [45] and N-benzoyl-2-ethylpiperidine [45], respectively). These 
substrates all bound to the enzyme, with the substituted piperidine rings showing 
greater affinity and displacement of the water, table 4.10. 
All three substrates produced hydroxylated products with only 46 giving two 
products. However, for reasons discussed previously, this method only detects 
multiple products that are distinguishable by our GC/MS method. The yields of 
products were better here than for the similar aliphatic substrate (41), with 13 % for 
44, 33 % for 45. For 46, the major peak was 37 % and the minor peak was 6 % of the 
total compounds present. It is clear therefore that with these substrates increased 
steric bulk on the piperidine ring enhances all aspects of the binding and turn over to 
the mutant enzyme. 
Initial modelling studies indicated that a longer linkage between the aromatic 
and piperidine rings might enhance substrate binding. Since the aromatic 'handle' was 
designed for the enzyme and not because of any pharmaceutical interest, it was 
decided to use the benzoylcarbonyl group (Cbz) linked to the piperidine nitrogen, 
which could easily be cleaved from any hydroxylated product. 
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Table 4.10: Biochemical data of compounds 44-51. 
Compound Structure % K0 GC peaks Retention time 






44 76 >20 starting material 10.77(87%) No 
el&o~ 1 
hydroxy product 13.52(13%) 
45 0 95 10 starting material 11.71(63%) 
cIIIIr1IIIIIIIIIIJ 
hydroxy product 14.65 (33 %) 
hydroxy product 14.89 (4 %) 
46 0 
6 




e-I 1 _;: hydroxy product 15.07 (5%) hydroxy product 15.16 (37 %) 
47 45 starting material 11.45 (88 %) 
hydroxy product 14.64 (12 %) 
48 90 >20a starting material 12.06 (64 %) 
V111" N hydroxy product 14.58(36%) 
15.30 (<1 %) 
keto product 
49 ° 40 starting material 12.65 (52 %) 
hydroxy product 15.51 (48 %) 
50 Oxygen 
ligation 
- starting material 11.48 
51 a a a - 
a-Compound was too insoluble for accurate readings 
As before, three substrates with Cbz substituted piperidines were studied, with 
an unsubstituted, methyl and dimethyl piperidine ring (N-Cbz-piperidine, [47], N-Cbz- 
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4-methylpiperidine, [48], and 	N-Cbz-2, 6-dimethylpiperidine [49]). The three 
substrates all bound to the enzyme, table 4. 10, but with lower binding affinities than 
the benzoyl substituted piperidines. Only 48 generated a good percentage high-spin, 
with 47 and 49 being comparable to camphor, indicating a degree of motion. All three 
substrates produced products with a yields of 15 %, 33 % and 50 % for 47, 48, and 
49 respectively. 
Comparisons of the data for 44-49 gives us a further insight into the P-450cam 
mutant enzyme. For the linker, the longer Cbz group reduces the binding affinity for 
the enzyme but slightly enhances product yields, (possibly due to faster substrate 
release). Substitution of the piperidine ring enhances all aspects of the substrate 
towards the enzyme, the greater the degree of substitution the better the binding/turn 
over. 
Two other phenyl substituted nitrogen heterocycles were studied here. N-
benzoyl azabicyclo[2,2,1] pentan-2-one [50] was provided by colleagues at the 
University of Exeter and was of interest because the substrate was a phenyl 
substituted camphor analogue. Data, table 4. 10, indicates that the substrate binds with 
oxygen ligation to the heme, with no product upon hydroxylation. 
The other substrate studied was a substituted adamantane, adamantyl 
pyridinium (bromide salt) [51]. However, 51 proved difficult to handle due to high 
insolubility. 
4.3.2.8 	Oxygen Heterocycles with Aromatic Sidechains. 
The final category of substrates studied was a series of oxygen heterocycles. It 
was of interest to use cyclic acetals as an aromatic handle, as hydroxylation and 
subsequent cleavage of the acetal would yield diols. Two substrates tested were 2-
benzyloxy-2, 3,5, 6-tetrahydropyran, [52] and 2-benzyloxy-2, 3,4, 5-tetrahydrofuran, 
[53]. Both substrates exhibited 0 ligation to the heme with relatively poor binding 
constants, table 4.11. 
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Table 4.11: Biochemical data of compounds 52-57. 
Compound Structure % K, GC peaks Retention time 
high- and 
spin (jiM) percentage 
in mm, 
(% total) 




Oxygen 30 starting material 9.01 
((10 	o ligation 






40 starting material 8.34 




:::: 57 ______________ 0 __ 
a-Compound was too insoluble for accurate readings 
b-Compound could not be analyzed due to excessive evaporation 
The isomer of 53, 3-benzyloxy-2,3,4,5-tetrahydrofuran, [54], gave a similar 
effect, with a slightly higher binding constant. When the linker was changed to a 
benzoyl group as in 3-benzoyl-2,3,4,5-tetrahydrofuran, [55], again oxygen ligation 
was observed with an improvement binding. It would appear therefore that with an 
available free oxygen, ligation to the heme is observed, with the orientation of the 
oxygen and nature of the linker only affecting the binding affinity. 
It was of interest to examine if an alkyl substitution next to the heterocyclic 
oxygen would prevent heme ligation. A substrate of this type was commercially 
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available, 5-methyl-2-furylmethylbenzoate [57]. This substrate did indeed prevent 
oxygen ligation to the heme with a percentage high-spin better than many of the 
previously studied substrates. However no product was detected in the 
biotransformation. The reason for this could not be determined but may be due to 
positioning of the methyl group near the heme, which would provide the active 
species with an unfavourabe primary carbon to hydroxylate. 
Another approach to preventing heme ligation was to use a substrate with 
rigid linkage to the 'handle'. One substrate was commercially available that could fall 
into this category, 6,6-bi-3,4-dihydro-2H-pyran, [56]. This compound was confirmed 
to be a substrate, table 4.11, although due to evaporation binding constants and 
products could not be determined. 
4.4 Conclusions. 
These studies on the cytochrome P-450cam Y96A mutant have revealed some 
patterns in the properties of its substrates. 
All wild-type substrates would appear to be substrates for the mutant enzyme 
indicating no loss in binding site volume. All these substrates undergo 
biotransformations with poor stereoselectivity. 
The use of an aromatic ring in the substrate enhances the binding. If the other 
part of the substrate is an aliphatic ring, the degree of substitution and the linkage 
between the aromatic handle and the aliphatic ring are important. Increasing amounts 
of substitution on the aliphatic ring increases binding. However, if an oxygen group is 
present in the aliphatic ring the binding of the oxygen to the heme centre prevents turn 
over. Flexible linkers (e.g. ethers) and long linkers (e.g. cbz) reduce the binding 
affinity of the mutant enzyme. For the greatest binding, the benzoyl group should be 
used preferentially attached to an aliphatic ring with aliphatic side-chains. 
In order to understand the binding properties of these substrates it is necessary 
to examine the substrate/enzyme interactions in more detail. Molecular modelling and 
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structural analysis was performed to better understand the cytochrome P-450cam 
Y96A mutant binding site and how substrates interact with it (chapters 5-9). 
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5 Crystallization of the P-450cam Y96A Mutant. 
5.1 Introduction. 
Crystals are highly ordered three dimensional arrays of molecules made up 
from a basic unit cell. Each unit cell is related to another by a well defined symmetry 
operation, known as the space group. The unit cell is repeated many thousands of 
times in a crystal, thus forming a regular lattice. Due to this regular arrangement of 
atoms, when X-ray radiation is focused through a crystal, the X-rays diffract to 
produce an ordered diffiaction pattern. Using a number of mathematical processes, 
the diffraction pattern can be extrapolated to give the positions of the atoms in the 
unit cell and thus a structure can be determined. 
For any protein larger than 30 kDa, X-ray crystallography has become the 
fundamental method to determine the structures at atomic resolution. Consequently, a 
great deal of time has been spent trying to develop new and faster techniques. Despite 
standard crystallization methodologies and advances in computer technology, the 
crystallization and subsequent X-ray structural determination of proteins can be a long 
cumbersome process. 
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The production of an X-ray structure can be broken up into six stages: 
• Expression and purification of the protein,, in sufficient amounts and of very high 
purity. 
• Screening for crystallization conditions. 
• Crystallization of protein. 
• Data measurements. 
• Phase determination. 
• Electron density map computation and interpretation. 
• Model refinement. 
Each of these stages has its own associated problems. With improvements in 
computational methodologies, however, the generation of suitable protein crystals has 
become the bottleneck to crystallographic studies. 
5.2 Protein Expression and Purification. 
Protein purification protocols for P-450cam have been established (chapter 2). 
A scale-up allowed for the production of sufficient protein from one set of purification 
runs for many crystal screening experiments, thus maintaining consistency in the 
protein batch used in different screens. The extra purification step for the P-450cam 
gave protein of greater purity than can be determined by SDS PAGE, which could 
yield a better quality crystal. 
5.3 Crystallization Screens. 
P-450cam was first crystallized in 1974, ' for purification studies and not for 
use in X-ray structural determination. Cytochrome P-450cam crystals for structural 
studies were first made in 1982. 2 Three types of crystals were produced, of differing 





have better diffraction than the other two, diffracting to 3.0 A. This crystal form 
was used in the determination of the wild-type structure 3  which later was refined to 
2.6 A. 
Crystallization conditions for the P-450cam protein have now been 
standardized, 4 which has led to 11 different substrate bound structures and two 
mutant structures. 3-15 Crystals were grown by the free interface diffusion technique 
with the protein solution layered over a high concentration ammonium sulfate solution 
in a narrow bore glass tube. Crystals of cytochrome P-450cam appear at the interface 
between the two phases. DTT is added to the protein solution to prevent dimerization 
caused by disulfide bond formation through free cysteine C334. After crystallization, 
DTT can be removed by washing the crystals. Ligands are then soaked, over a 
number of weeks, into the crystal. Although this technique has been used for over ten 
years there are problems of reproducibility. 4 P-450cam crystallization has been shown 
to be sensitive to protein concentration, ammonium sulfate concentration and 
temperature. 4 
As discussed previously, the Y96A protein studied here is, in fact, a double 
mutant, where cysteine 334 has been mutated to an alanine (C334A). The removal of 
the free cysteine facilitates handling of the protein in solution, negating the need for 
reducing agents such as DTT or mercaptoethanol to prevent dimerization. This is 
beneficial for the crystallization studies as there is no need to co-crystallize the protein 
with the reducing agents and then consequently remove them. This means that the 
conditions for crystallizing wild-type protein will possibly not apply to this double 
mutant, hence the need to screen for crystallization conditions. 
5.3.1 	Using Wild-Type Conditions. 
Initial crystallization conditions for the wild-type protein were followed. 2 This 
consisted of a screen of ammonium sulfate concentration vs. pH. Ammonium sulfate 
was screened in 6 x 7 % increments from 35 % to 70 % ammonium sulfate at a pH of 
7.4 and 7.0, with a protein concentration of 20 mg/ml and temperature of 4 °C. All 
screens were conducted using vapor diffusion by the hanging drop method. For all the 
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wells of ammonium sulfate concentration greater than 42 %, protein piecipitated 
almost immediately (10 - 20 minutes). In the other wells no crystallization occurred. 
This was repeated with higher protein concentration (30 mg/ml) with the same result. 
Rapid crystallization does not lead to the formation of crystals suitable for 
crystallography, therefore no further attempts to use ammonium sulfate as a 
crystallizing agent were performed. 
5.3.2 	Development of New Conditions. 
Polyethylene glycol (PEG) was then screened as a potential precipitant to 
examine conditions which produced crystals slower than the conditions using 
ammonium sulfate. 
5.3.2.1 	pH Dependence. 
The pH was not varied because literature on the P-450cam wild-type enzyme 
suggests that protein crystallizes within the range of pH that the protein is stable (-pH 
7.4).4 Small changes (i.e. 7.2-7.4) to pH do not affect the crystallization, however 
larger changes in pH degrade the protein. 16 
5.3.2.2 	Substrate Co-crystallization Effects. 
Crystallization studies were initially performed, in parallel, using wells both with 
and without substrate. At camphor concentrations of 4 mM no appreciable difference 
was noticed in the crystallization pattern. At high substrate concentrations, 
precipitation of the substrate resulted in premature precipitation of the protein. It is 
known that camphor confers stability upon P-450cam, especially at higher 
temperatures, therefore it was thought better to perform all initial screens in the 
presence of substrate. Camphor was chosen because it has reasonable aqueous 
solubility and was readily available. 
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5.3.2.3 	PEG and Protein Concentration. 
Crystallization screens were performed with varying PEG size (weight 2000-
20000) and concentration (10-30 %) and with different protein concentrations (5-80 
mg/ml). The initial results of these screens are summarized in table 5.1. 
Table 5.1: Crystallization screens of PEG. 
Protein concentration! 10 mg/ml 20 mg/ml 30 mg/ml 
Precipitant  
PEG (MWt 2000) no crystals no crystals no crystals 
PEG (MWt 4000) crystals formed not done crystals formed 
(26-28% PEG)  (22-26% PEG) 
PEG (MWt 6000) crystals formed crystals formed crystals formed 
(22-28% PEG) (14-30% PEG) (14-22% PEG) 
PEG (MWt 8000) crystals formed crystals formed crystals formed 
(22-28% PEG) (14-30% PEG) (14-22% PEG) 
PEG (MWt 10000) crystals formed crystals formed precipitation 
(22-28% PEG) (14-26% PEG)  
PEG (MWt 12000) crystals formed crystals formed precipitation 
(22-28% PEG) (14-26% PEG)  
PEG (MWt 20000) crystals formed crystals formed precipitation 
(20-24% PEG) (14-30% PEG)  
N.B. Screens performed at lower protein concentration yielded no crystals. 
It was clear from preliminary results that a relationship between the PEG size 
and concentration exists with the protein concentration. Crystals only grew when, 
either the protein concentration, or the PEG concentration was sufficiently high, but 
low enough not to cause precipitation. A variety of crystal forms were observed for 
P-450cam (figure 5. 1), the predominant crystal form present in the crystallization 
trials was a medium sized crystal of a wedge like nature figures 5. 1-u, 5.2-d, e. These 
were found to produce diffraction of sufficient size to yield basic structural 




tetragonal I 	orthorhombic I 	 orthorhombic II 
(wild-type crystal forms) 
iii) 	 iv) 	v) 	 vi) 
Vii) 	 viii) 	 ix) 
 
Figure 5.1: Structure of the crystals previously observed 2  for wild-type P-450cam compared to the 
new Y96A mutant crystal forms (i-ix). 
After conditions were established for the production of crystals it was 
necessary to optimize these conditions, to produce crystals of sufficient size and 
quality for good diffraction. It was found that crystals that grew in the larger PEG 
solutions were small and of poor diffraction quality. The best crystals grew in PEG 
(MWt 6000) at a concentration between 14 % and 20 % (figure 5.2-d, e), with a 
protein concentration of 20 mg/mi. These conditions produced 3-10 medium sized 









Figure 5.2: Photographs of the different crystal types of P-450cam Y96A C334A mutant. 
At 14 % PEG (MWt 6000) larger crystals grew (figure 5.2-a), but the 
diffraction was poor due to the splitting of the diffraction signal by fractures in the 
crystal. At higher than 20 % PEG (MWt 6000) smaller crystals grew in about 48 
hours (figure 5.2-b, f). For most other PEG conditions needles formed or the crystals 
were small and not uniform. In one case for 24 % PEG (MWt 10000) rose coloured 
plates formed (figure 5.2-c), possibly similar to orthorhombic I crystals previously 
described. 2 Crystals from the 14 and 18 % PEG (MWt 6000) wells with protein 
concentration of 20 mg/ml were used in further X-ray crystallography studies, figure 
5.2-d, e. 
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Unfortunately crystals grown at the 'optimal' conditions for growth, produced 
poor diffraction with considerable amounts of twinning. This was possibly due to the 
length of time it took to produce these crystals, (about 6 weeks). It was decided to 
find a way to speed up the crystal formation whilst maintaining good quality crystals. 
At higher PEG concentrations, small crystals formed suggesting that it was better to 
increase the protein concentration and not the PEG concentration. 
With further screening, it was found that 45 mg/ml protein induces faster 
crystallization without loss of crystal quality. Higher concentrations of protein than 
this resulted in precipitation and denaturing of the protein. Once it was established 
that 45 mg/ml protein could give the desired speed of crystal growth, the well 
conditions were reoptimized based on this protein concentration. 
	
5.3.2.4 	Temperature. 
Initially the temperature was kept constant at 4 °C throughout the screening, 
as P-450cam is unstable at room temperature in an oxygen atmosphere. However, 
stable crystals can form at higher temperatures, therefore screening was performed at 
a variety of different temperatures. It was found that crystals formed more slowly at 4 
°C than 14 °C. However at 18 °C the quality of the crystals formed was not sufficient 
for data collection, probably due to protein degradation. The difference between plate 
incubation temperature and crystal quality at 4 and 14 °C was found to be variable so 
both temperatures were used in crystal generation. 
5.3.2.5 	Substrate Concentration. 
After suitable conditions were found to induce crystallization, the effects of 
the substrate were explored. At 45 mg/mi (1 mM) to maintain a substrate to enzyme 
ratio of 1:1, at least 2 mvI substrate is required. This caused problems with some of 
the substrates because of their poor aqueous solubility. However, so long as the 
substrate did not precipitate, crystal formation was essentially unaffected. 
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5.4 Final Crystallization Conditions. 
PEG 6000 and PEG 4000 gave good quality crystals between 14-26 % PEG 
concentration (figure 5.2-g). PEG 4000 was the preferred choice since its lower 
viscosity meant it was easier to handle in solution. Final conditions used six wells with 
PEG concentrations from 14-26 %, at both 4 °C and 14 °C. 
5.5 Data Collection. 
With the selection of good crystals only a number of small problems exist with 
the data collection of the mutant crystals. Even with ciyo-freezing P-450cam crystals 
degrade over time, usually —50-75 hours, on the in-house rotating anode generator. 
These time limits are such that collection of sufficient frames for complete processing 
was not always possible. The only other problem with the data collection of the 
crystals is the crystal shape. As mentioned previously (chapter 2) the crystals that give 
the best diffraction are long needles, this means that with the long axis of the crystal 
lying in the plane of the loop, the X-ray beam passes through the small axes. Thus, to 
get sufficient diffraction for structural determination large forms of these needles are 
required. 
5.6 Phase Determination. 
The phase for the first structure, 4-hydroxydiphenylmethane, was solved by 
molecular replacement, by Paul Taylor, University of Edinburgh. 
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5.7 The New Unit Cell. 
With the new crystallization conditions and the use of the C334A mutant, the 
P-450cam crystallized with new unit cell parameters. This new crystal form has cell 
angles close to orthorhombic, however, refinement in the orthorhombic space group 
gave significantly higher R,, values than the corresponding monoclinic refinement. 
Comparison of the unit cell dimensions of other forms of wild-type P-450cam (table 
5.2) show that the double mutant protein has a different number of molecules per unit 
cell and significantly different unit cell dimensions. 
Table 5.2: Summary of the unit cells of known P-450cam crystals. 
Cell dimensions 
Crystal type 
a (A) b(A) c(A) Space 
group 
No. molecules 
per unit cell 
Wild-type orthorhombic J2 174 64 39 P2 1 2 1 2 4 
Wild-type orthorhombic 1129 108.73 104.46 36.44 P2 1 2 1 2 1 1 
Wild-type tetragonal 12 64.2 64.2 255 P4 122/P 
4322 
8 
Y96A C334A mutant 
orthorhombic III 
—62 —61 —96 P2 1 4 
The unit cell is approximately orthorhombic with angles of 90.00, 91.24, 90.00 
O  The cell dimensions are, for example: a = 62.252 A, b = 6 1.508 A and c = 95.657 A 
for the 4-hydroxydiphenylmethane structure and the protein belongs to the space 
group P2 1 . There is only a slight difference between the unit cell dimensions for the 
other Y96A structures solved here, table 5.3, 5.4, 5.5. 
The crystal properties of the orthorhombic II species were recalculated in 1985 to higher resolution 
3 
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5.7.1.1 	Differences in the Asymmetric Units. 
The two molecules in the asymmetric unit were compared and found to have a 
root mean squared difference (rmsd) of 0.27 A for the backbone and 0.45 A for the 
side chain atoms (based upon comparison of the units of the camphor bound 
structure). Residues with rmsd over 1 A were all surface residues with long, 
disordered side chains. Average temperature factors between the units differed by 
rmsd of 1.7 A2 . The active site showed no other significant changes in topology, the 
largest difference being less than 0.1 A. As in previous P-450cam structures, the 
assignment of residues 1-9 was not possible due to poor electron density in this 
region. The summary of the data diffraction statistics are presented in tables 5.3-5.5. 
To check the validity of the data, the files were examined by Procheck. Of the 
information examined the most important is the Ramachandran plot, which shows the 
4 and  N'  angles for every residue in relation to idealized values shown in the plot 
(based on a large selection of previously solved crystal structures), figure 5.3. 
5.8 Conclusions. 
Reproducible crystallization conditions have been produced using PEG as the 
precipitant, with the protein at a concentration of 1 mM. These conditions gave co-
crystallized mutant crystals that diffiact to a resolution of better than 2.4 A and in 
some cases to 2.0 A. The crystals diffracted in a new crystal form with the monoclinic 
space group P 21 . Although the crystallization conditions are efficient at producing 
good quality crystals, a problem does exist. At this protein concentration substrates 
have to be soluble at concentrations of significantly greater than 1 mM. For some of 
the crystals the presence of possibly poorly soluble substrates clearly reduced the 
quality of the crystals (e.g. diphenylmethane and N-cbz-2,4-dimethypiperidine). The 
other problem with poor aqueous solubility is that the binding site might not be fully 
occupied. This is observed for some of the substrates studied here (see chapter 6). For 
insoluble substrates it might be worth considering substrate soaks as a means of 
obtaining the substrate bound structure. 
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Table 5.2: Data statistics for 4-hydroxydiphenylmethane and camphor bound structures. 
4-hydroxydiphenylmethane camphor 
resolution 2.00 2.00 
unit cell 94.51, 61.70, 66.74 
90.00, 90.28, 90.00 
96.45, 62.78, 66.95 
90.00, 90.28, 90.00 
no. molecules per 
asymmetric unit 
2 2 
total observations 81735 227193 
unique reflections 50447 53664 
Rsym(overalll last shell) 6.0/26.1 7.3/23.7 
% completeness (total) 96.7 96.5 
% completeness (last shell) 91.1 (2.03-2.00) 81.7 (2.03-2.00) 
reflections used for 
refinement 
45089 50587 
Rfactor 17.39 16.02 
R&ee 24.78 20.74 
overall average B 21.6 17.7 
no. water molecules 955 1197 
Rsym =1 I-<I> / I. 
Ractor = I I F0,I _I Fcaicl I / I F0bI 
5 % randomly omitted reflections were used for Rfree. 
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Table 5.2: Data statistics for diphenylmethane and phenylcyclohexane bound structures. 
diphenylmethane phenylcyclohexane 
resolution 2.34 2.54 
unit cell 95.32, 62.51, 67.09 
90.00, 90.42, 90.00 
96.24, 63.04, 66.57 
90.00, 90,41, 90.00 
no. molecules per 
asymmetric unit 
2 2 
total observations 121600 171575 
unique reflections 41342 32398 
Rsym(overall/ last shell) 9.3/21.3 10.7/48 
% completeness (total) 92.2 98.1 
% completeness (last shell) 88.2 90.2 
reflections used for 
refinement 
39137 39137 
Rfactor 21.16 17.82 
Rfree 29.79 27.65 
overall average B 21.2 32.2 
no. water molecules 1871 1906 
=1 i-<i>I / I. 
Rfactor = II F0 ,I -I Fcaic / I F0 I 
5 % randomly omitted reflections were used for Rñ-ee. 
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Table 5.2: Data statistics for diphenylmethane and phenylcyclohexane bound structures. 
bicyclohexyl N-cbz-2,4-dimethypiperidine 
resolution 2.30 2.30 
unit cell 95.26, 62.30, 67,06 
90.00, 90.40, 90.00 
95.84, 62.66, 66,78 
90.00, 90.41, 90.00 
no. Molecules per 
asymmetric unit 
2 2 
total observations 338642 214266 
unique reflections 35358 34751 
Rsym(overalll last shell) 13/36 8.4/37.8 
% completeness (total) 99.9 98.5 
% completeness (last shell) 99.9 97.0 
reflections used for 
refinement 
33286 34322 
Rfactor 18.71 17.0 
Rfree 27.85 25.95 
overall average B 24.3 24.3 
no. water molecules 925 1001 
RsymI i-<i>I /1. 
Rfactor = I I FoijsI _I Fcaicl IA F0bI 
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6 Crystal Structure of the Cytochrome P-450 Y96A- 
C334A Mutant. 
6.1 Introduction. 
The analysis of the crystal structure of the cytochrome P-450cam double 
mutant is subdivided into a number of categories. Firstly, the effects of the two 
mutations are discussed; the C334A mutation does not effect the Y96A site so the 
effect of each mutation is discussed separately. The orientation of each substrate is 
then discussed and comparisons are made to previous structures or the other substrate 
structures studied here. Finally a more in-depth discussion of the most important 
features of the structures is presented. 
6.2 Effects of the C334A Mutation. 
Cysteine 334 is located on a long loop between the L helix and the 34 sheet of 
P-450cam with the free cysteine on the surface, figure 6.1 (nomenclature based on 
original crystal structure 1). 
148 
II 
Figure 6 1 i) location of csteine 357 on the L. helix (cysteine is in yellow) ii) cysteine 357 in relation 
to the whole protein (cysteine is in green, heme in blue and camphor in yellow). 
This surface cysteine leads to dimenzation of the enzyme in solution. 2 
Mutagenesis of the cysteine to alanine shows no effect on the turnover rates of 
camphor. However, until now the structural effect of this mutation remained 
unknown. 2 ' 3 
Analysis of the region surrounding the C334A mutation indicates no visible 
change in the secondary or tertiary structure. Sigma weighted difference maps, 
contoured at a 3c level, showed no density in this region. When compared to the 
wild-type cryo-structure (5cp4 4),  the rmsd for the side-chains of the surrounding 
residues (Ala 333, Pro 335, His 337) is 0.40 A compared to the total protein rmsd of 
0.61 A. The mutant alanine at 334 adopts the same backbone configuration as the 
wild-type cysteine with a rmsd of 0.26 A compared to total protein backbone 
differences of 0.29 A. The overall temperature factors of side-chains in this region 
differ by rmsd of 3.0 A 2 , compared to the average protein value of 6.1 A2 . These 




6.3 Effects on the Binding Site by the Y96A Mutation. 
To aid the description of the binding site a number of cartoons have been 
provided, figures 6.2 and 6.3. 
Phe 193 
(I) 	'Upper' ring 






Figure 6.2: Schematic of the P-450cam-Y96A binding site showing important residues mentioned in 
the following chapter. Picture shows the method of defining the different substrate rings with the 
term 'upper' and 'lower'. 
Thr 101 	substrate 
/\\ 'lower' ring 
Asp 297 ( : 







Phe 87 	Phe 98 	substrate 
0 'upper' ring 
Val 395 V.. 	Val 247 
heme 
lie 396 
Figure 6.3: Orientation of the P-450cam Y96A binding site showing the orientation of the i) 'lower' 
and ii) 'upper' rings of the substrate. 
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6.3.1 	Effects on the Y96A Binding Site Based on the Camphor Bound 
Structure. 
For the camphor structure, compared to the wild-type camphor bound cryo-
structure (5cp4), the total rmsd of the binding site side-chains is less than 0.67 A, 
compared to total protein side-chain rmsd of 0.61 A (residues 87, 98, 101, 185, 244, 
247, 252, 297, 395, 396 and heme). This would indicate that there has been no 
'significant' alteration of the binding site, other than by the mutation itself. The sigma 
weighted difference map of the Y96A protein compared to the wild-type confirms 
the absence of the tyrosine residue caused by the mutation, figure 6.4. 
Figure 6.4: cs-weighted difference map showing the result of modelling the wild-type structure (with 
the tyrosine 96 to alamne change). i) shows, clockwise, camphor, Phe 87, Phe 198 and Phe 98. ii) 
shows more clearly the Phe 193 (top) and Phe 98 density. The colour code is positive density in blue 
and negative density in red. 
The difference map also shows that the space left by the tyrosine has some 
positive density in it (blue) and the Phe 87 residue has some corresponding negative 
density (red) on the phenyl ring. This implies that the Phe 87 residue is incorrectly 
positioned in its current (wild-type) position and should, in fact, be moved into the 
space previously occupied by Tyr 96. This map additionally shows that, to a lesser 
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degree, residues Phe 98 and Phe 193 are also incorrectly positioned in their wild-type 
positions. Comparison of the fmal refined structure shows these differences more 
clearly, figure 6.5. 
Figure 6.5. Comparison of the wild-type (red) to the Y96A (green) camphor bound structures. 
Residues are clockwise: Camphor, Phe 87, Phe 193, Phe/Ala 96, Phe 98. 
The Phe 87 residue has undergone a 57 1 rotation and 1.8 A movement 
towards the space left by the removal of the tyrosine residue; in addition to this Phe 
98 has also shifted 0.98 A, into this gap. Two residues have moved as a consequence 
of the Phe 87 movement, Phe 193 has shifted 1.3 A and rotated 30 towards the 
wild-type Phe 87 site and the isoleucine 395 CG carbon rotates 109 towards the 
wild-type Phe 87 site. These changes to this region of the protein will be discussed in 
more detail later (section 7.2.1). 
The only other binding site change is Thr 101 which, in the wild-type 
structure, is hydrogen bonded to the tyrosine 96 hydroxyl. With the removal of the 
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tyrosine and thus the hydrogen bond the Thr 101 has adopted a new configuration, by 
moving 0.9 A away from the heme centre and rotating 104°, figure 6.6. 
Figure 66. Comparison of Thr 101 for the wild-type (red) with the Y96A mutant (green). The Tyr 96 
Thr 101 hydrogen bond for the wild-type protein and the new water molecule (cyan) are also shown. 
This movement has allowed an extra water molecule to enter the binding site 
which H-bonds to the newly positioned Thr 101 hydroxyl (OGI), the heme oxygen 
(02D) and a water molecule. This new water is sufficiently removed from the heme 
active centre (7.2 A) that it is unlikely to interfere with the catalytic mechanism of 
the heme centre, although its presence may alter the relative hydrophobicity of the 
binding site. 
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6.3.1.1 	Modelling the Iron-Sulfur Bond. 
The iron-sulfur distance is potentially important in the increasing debate over 
the cause of the Soret shift (see section 7.4.2) therefore careful analysis of it was 
made. Variations in the starting distance did not affect the final refined iron-sulfur 
bond length of 2.34 A when no bond restraint was used. When using an iron-sulfur 
distance restraint, (using the 'DFIX command), the final value for the refined distance 
was 2.34 A (without deviating more than 0.2 A from the restraint), therefore for 
future refinements no iron-sulfur distance restraints were used. Anisotropic 
parameters indicate that the shape of the iron and sulfur atoms does not significantly 
deviate from spherical. This data, combined with the low temperature factors of the 
atoms, would indicate that there is only one orientation of the iron-sulfur bond and 
that its distance is 2.34 A. 
6.3.2 	Effects on the Y96A Binding Site by Phenyl Substituted Substrates. 
6.3.2.1 	Differences in the 4-Hydroxydiphenymethane Bound Structure Compared 
to Camphor Bound Structure. 
The Y96A 4-hydroxydiphenylmethane bound structure is essentially the same 
as the Y96A-camphor bound structure (rmsd of the binding site side-chains of 0.46 A 
compared to total protein of 0.49 A). There are however two residues that have 
alternate orientations. Phe 98 rotates 35 ° to minimize a potential 2.8 A interaction 
distance with the unhydroxylated 4-hydroxydiphenylmethane ring, improving it to a 
minimum interaction of 3.5 A (discussed in more detail later, section 7.2.1). 
The more significant change in this structure is to the key catalytic residue 
Thr 252, which has rotated 78 ° so that the threonine hydroxyl group forms a 
hydrogen bond with the substrate hydroxyl (3.0 A); the Thr 22 CG2 carbon moving 
into the hydrophobic pocket around Val 294, Val 295 and Val 396. This rotation of 
the Thr 252 has an additional effect on the Glu 251 backbone, rotating the backbone 
carbonyl 85 0  This rotation alters an extensive H-bond network behind the binding 
154 
CH;\PJ:ER 6: CRYS:AU STRti(.[1JRE 
site, including residues Mn 255, Gln 186, Glu 251 and a number of water molecules 
(discussed in more detail later, section 7.1.2). 
The new water molecule bound to the Thr 101 is in a slightly different 
orientation here; instead of being between the heme and the Thr 101 hydroxyl, the 
water is nearer the substrate, further into the binding site. This change in water 
orientation is probably caused by the alteration in the binding site hydrophobicity 
caused by the combination of the rotation of the Thr 252 and the presence of a 
hydroxyl group on the substrate. 
6.3.2.2 	Differences in the Diphenylmethane, Phenylcyclohexane and N-cbz-2,6- 
dimethylpiperidine Bound Structures. 
These three structures have essentially the same binding site structure as the 
Y96A-camphor and 4-hydroxydiphenylmethane bound structures. The Thr 252 has 
the orientation observed in the camphor structure, (i.e. the same as in the wild-type 
structure). The residues around Phe 87 and Phe 98 adopt the same configuration as 
the 4-hydroxydiphenylmethane bound structure so that they minimize the contact 
between the Phe 98 and the phenyl ring of the substrates. The Thr 101 bound water 
has the same location as in the camphor bound, Y96A-structure. The only significant 
differences in these structures is in the location of the binding site water molecules 
(see section 6.4.4.2). 
6.3.3 	Effects on the Y96A Binding Site with a Non-Aromatic Substrate. 
6.3.3.1 	Differences in the Bicyclohexyl Bound Structure. 
The binding site of the bicyclohexyl structure is the same as the three above 
structures. Despite the absence of an aromatic group in the substrate, the presence of 
the aliphatic ring near Phe 87 and Phe 98 has the same effect on the Phe 87, Phe 98 
and Phe 193 orientation as the phenyl substituted substrates. 
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6.4 Substrate Orientations in the Y96A Mutant Binding Site. 
6.4.1 	Orientation of Camphor in the Y96A Mutant. 
6.4.1.1 	Main Orientation of Camphor. 
The camphor molecule was modelled into the orientation originally taken by 
camphor in the wild-type structure, then adjusted to fit the density of the Fo-Fc 
difference man and aflov.ed to refine freeh. figure 6.7 
1) 
Figure 6.T i) Fo-Fc map of the camphor bound binding site, with the final orientation of camphor 
added, contoured at a level of 3. ii) a-weighted difference map of the camphor bound binding site 
After refinement, the camphor molecule occupied an orientation essentially 
the same as that initially modelled into the Fo-Fc difference map. A temperature 
factor of 26.5 A, for the camphor molecule, indicates that the thermal motion of the 
camphor is more similar to that of previously co-crystallized wild-type camphor 
analogues (e.g. camphane (30.1 A), adamantane (24.7 A) and norcamphor (33.5 
A 2)), 5 than to camphor (16.2 A2).6 
6.4.1.2 	Alternative Orientations of Camphor. 
Since it is known that the Y96A mutant catalyses the formation of products 
other than 5-exo-hydroxycamphor (section 4.3.2.1), the substrate was modelled in 
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different orientations in order to account for potential hydroxylations of other carbon 
atoms. This was achieved by placing the hydroxylated carbon closest to the heme and 
fitting the camphor into the remaining density. These orientations were then allowed 
to refine with free occupancy, for 5 cycles. All refinements gave the previously 
optimized position in all but one case, in which the 3-exo-hydroxycamphor was the 
predicted product. In this case, the rotation of the camphor molecule back to the 
'normal' orientation is prevented by unfavorable hydrophobic contacts with the 
methyl groups on the camphor, however, the occupancy was too low and the 
temperature factor was too high to definitely assign this as an orientation. Although 
other orientations of the camphor molecule must exist, it is not possible, at this 
resolution, to definitely assign any of them. These alternative orientations probably 
account for the higher temperature factor of the camphor with the Y96A mutant 
compared to the wild-type structure. 
6.4.1.3 	Addition of a Water Molecule to Camphor Bound Binding Site. 
Since it was known that there is a water molecule in the presence of camphor 
within the Y96A mutant binding site (section 4.3.2.1), the area between the heme and 
the camphor molecule was examined. The a-weighted difference map, contoured at 
3a, clearly shows density corresponding to a molecule above the heme with the centre 
of this density being 1.5 A from the iron, figure 6.8. 
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Figure 6.8. cs-weighted difference map showing the positive density (red) for a molecule above the 
heme. 
This molecule was modelled as water and was initially placed at a distance of 
1.5 A from the iron which was consistent with previously reported water-iron 
distances in the presence of substrates. 5 This water was allowed to refine with a Fe-U 
bond set with no distance restraint and a freely refining occupancy. The final refined 
value of the occupancy was 58 % which is consistent with the binding data, which 
indicates a water molecule present at 52 % occupancy. The Fe-U starting distance 
was altered and the structure refined to investigate the effect on the final orientation, 
but the distance repeatedly refined to 1.45 A. The starting occupancy was also varied 
and again refined to 58 %. When the occupancy of the water was forced to be 100 % 
the temperature factor increased form 24.5 A2 to 34.5 A2 . 
6.4.1.4 	Comparison of Camphor in Wild-Type and Y96A Mutant P-450cam 
The final orientation of the camphor molecule is almost identical to the 
wild-type structure with a rmsd of only 0.28 A, compared to the average nnsd 
between the two structures of 0.45 A, figure 6.9. 
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1) 
Figure 6.9: i) the wild-type camphor bound and ii) the Y96A camphor bound binding sites. 
These similarities can be seen more clearly when the two structures were 
overlapped, figure 6.10. 
The temperature factor of the camphor is lower in the wild-type structure 
(16.2 A2 vs. 26.5 A 2  ) as would be expected from the binding data, which indicates 
increased movement of the camphor molecule in the Y96A mutant, resulting in the 
entry of a water molecule and loss of stereoselectivity. 
The largest difference in the orientation of the camphor molecule in the 
Y96A mutant vs. the wild-type enzyme is 0.69 A for the carbonyl oxygen, the other 
differences ranging from 0.65 A-0.35 A. 
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Figure &M Overlap of the wild-type (blue) and Y96A (coloured by atom type) camphor bound 
binding sites 
This indicates that the camphor carbonyl to tyrosine 96 hydrogen bond does not fully 
control the orientation of the camphor molecule within the binding site. The 
camphor molecule, with the loss of the hydrogen bond, has rotated slightly towards 
Thr 101 (22.5 0)  however, the additional restraints on the substrate maintain the CS 
carbon (hydroxylation site) within 0.34 A of the wild-type position. 
6.4.2 	Orientation of 4-Hydroxydiphenylmethane in the Y96A Mutant. 
4-Hydroxydiphenylmethane is the sole product of the biotransformation of 
diphenylmethane with the cytochrome P450cam Y96A mutant. 7 This product was 
chosen for initial crystallization studies because, as an alcohol, it has higher aqueous 
solubility, facilitating co-crystallization; additionally the hydroxy group of the 4- 
hydroxydi phenyl methane ligates to the heme as indicated by a Soret band maximum 
at 417 nm. It was hoped that this additional constraint on the substrate orientation 
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would make the molecule less mobile and therefore facilitate interpretation of the 
substrate electron density maps. The density of the Fo-Fc difference map, at a level 
of 2a, shows clearly the orientation of the 4-hydroxydiphenylmethane in the binding 
site, figure 6.11. 
Figure 6.11: The positi e I u-Ic diiIei Cilce inap of the bmdiiig Site ot the 4-Iiydroxdiphenylmethane 
structure, with the final refined 4-hydroxydiphenylmethane orientation added for clarity. 
The final refined position of the 4-hydroxydiphenylmethane molecule can be 
seen below, figure 6.12. 
This orientation of the 4-hydroxydiphenylmethane 'upper' (unhydroxylated) 
ring is significantly different from the formal location of the wild-type tyrosine ring 
where it was initially envisaged that the phenyl ring might be positioned. The 'upper' 
ring has, rather than fit between the Phe 87 and Phe 98 residues, orientated between 
Phe 87 and Val 247, stabilized by a series of hydrophobic contacts from Phe 87, Phe 
98, Phe 193 and Val 395, to the upper 4-hydroxydiphenylmethane phenyl ring, figure 
6.13. 
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Figure o. I 	Binding site of the 4-hydrox) dzphenylniethane bound ' ')oA sO uetui e hum t u dmtlerent 
perspectives. 
I 
Figure 6.13: Comparison of the phenyl ring orientations of Phe 87, Phe 193, Phe 98 and Tyr 
96 
 for the 
wild-type camphor bound structure (i), with the 4-hydroxydiphenylmethane structure (ii). Val 247 is 
also shown. Rings are shown in CPK format. 
The 'lower' (hydroxylated) ring has no close (<3.5 A) interactions with any 
protein residues except for the hydroxyl group which ligates to the iron and Thr 252, 
figure 6.14. 
Figure 6.14: The hyurogcn bonus De  ten 4-11 dro\ uipnen\ MICHILille and 1 h 
The 4-hydroxydiphenylmethane hydroxyl oxygen is 2.39 A from the heme 
iron with a 154 ° angle between the oxygen, heme iron and the Cys 357 sulfur (SG). 
A 180 ° angle for an octahedrally co-ordinated system would be expected, however, 
the deviation from linear is likely to be caused by a hydrogen bond to Thr 252 (3.0 
A), which is indicated in the CT-weighted map at a level of 2o, figure 6.15. 
The temperature factor for the hydroxyl group is higher (40 A2) than the rest 
of the ligand (35 A2 ) probably due to improper optimization of the oxygen electron 
density by SI-IELX (because of the electron displacement of the oxygen over the Fe-
0 bond and the hydrogen bond to Thr 252). 
Previous structures of P-450cam have ligand temperature factors ranging 
from 16.2 A2 (camphor)6 to 33.5 A2 (norcamphor). 5 This would indicate that, by 
comparison, the 4-hydroxydiphenylmethane is relatively mobile in the active site. 
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Figure 6.15: a-weighted density map of the 4-hydroxydiphenylmethane structure showing the density 
between the hydroxy group and the threonine side-chain oxygen. 
The density of the 'upper' ring indicates that the hydroxydiphenylmethane is able to 
move in the plane of the phenyl ring only. Motion perpendicular to the ring is 
prevented by interactions with Phe 87 and Val 395 and motion 'upwards', away from 
the heme, is prevented by residue Phe 193 and restrained by the hydroxy ligation to 
the heme. This rocking motion of the 'upper' ring is effectively a 0.5 A movement to 
either side of the optimized structure (figure 6.16), this motion bringing the phenyl 
ring either closer to residues Val 385 or Phe 98. The nearest the phenyl ring gets to 
either residue is 3.3 A, the optimized location being 4.0 A from Val 385 and 3.5 A 
from Phe 98. 
Some small positive density was noted in the weighted 2Fo-Fc map by the 
upper phenyl ring, so the 4-hydroxydiphenylmethane was modelled with the phenyl 
rings reversed such that the hydroxy group was on the 'upper' ring; the occupancy of 
the ligand was then modified. 
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Figure 6.16; -weighted density map showing the area of motion covered by the upper phenyl ring. 
The newly refined structure indicated that if an oxygen exists in this location it must 
have an occupancy of less than 10 %. This clearly is inconsistent with the occupancy 
of the other atoms of the ligand and is therefore unlikely to be a major ligand 
orientation. However, a potential hydrogen bond to the backbone carbonyl of Met 
184, to the substrate hydroxyl group, could stabilize this orientation of the substrate 
so it cannot be ruled out as a minor substrate orientation. If this orientation did exist 
in any significant amount we would expect to find the dihydroxylated product, which 
is not detected in the biotransformation. 
There also exists the possibility that the 4-hydroxydiphenylmethane is not 
fully occupied in the binding site. This is plausible due to the low solubility of the 
substrate, although the relatively good binding constant makes this less likely. The 
combination of these factors could explain why the temperature factor of this ligand 
is higher than for the previous structures. 
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6.4.3 	Orientation of Diphenylmethane in the Y96A Mutant. 
6.4.3.1 	Diphenylmethane Orientation. 
The electron density in the Fo-Fc difference map, for the di phenyl methane, 
was not as clear to that of the hydroxydipheriylmethane, however, the difference map 
suggested it has a similar orientation as the 4-hydroxydiphenylmethane. This can be 
seen more clearly with the cs-weighted map, figure 6.17. 
Figure 6.17. a-weighted diierenee map 01 Liiphcnylmethanc in inc binding site. 
The optimized orientation of the diphenylmethane does appear to be similar 
to the 4-hydroxydiphenylmethane, with one phenyl ring between the Phe 87 and Val 
244 and the other ring orientated above the heme, figure 6.18. 
The diphenylmethane is in an orientation that holds the C4 carbon on the 
'lower' ring above the heme (2.86 A), the next nearest carbon is the C3 carbon at 3.39 
A. This supports the experimental result, in which the P-450cam Y96A mutant 
produces only 4-hydroxydiphenylmethane. 
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Figure 6 18: Diphenylmethane (purple) binding to the Y96A mutant. 
6.4.3.2 	Binding Site Water in the Diphenylmethane Bound Structure. 
The density around the diphenylmethane was not as clear as in other 
structures. It was thought that this was due to partial occupancy of the binding site by 
the diphenylmethane ligand. For the wild-type structure, with no substrate present, 
six water molecules occupy the binding site. 8 Therefore, if the diphenylmethane is 
only partially occupied, these water molecules could occupy the binding site and 
distort the density map. When the ligand was refined based on this premise, the 
diphenylmethane occupancy was refined in addition to four water molecules 
occupying the unassigned density of the substrate bound cs-weighted 2Fo-Fc map. 
When this was done the water and substrate refined to 50 % each. The orientations 
of these bound waters are shown in figure 6.19. 
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Figure 6.19: Binding site ot We upiienyiiiethaoe '01 uC1U!e flo\Uig Ifle iu,.ation of the partially bound 
waters (red) in relation to the substrate (purple). 
To improve the electron density maps another co-crystallized structure for 
diphenylmethane was solved. This structure was of lower resolution (2.4 A) than the 
previous diphenylmethane structure, however, it showed the same 50 % occupancy 
of the diphenylmethane. The diphenylmethane has a 1.7 p.M binding constant, 
therefore, the partial occupancy is probably due to the low aqueous solubility. This is 
a problem due to the use of co-crystallization as a method of substrate addition. The 
solubility of the diphenylmethane is probably not sufficient to give the maximum 
occupancy of the ligand. This aside, it was still possible to assign the density to a 
fixed orientation, although we cannot be confident of the temperature factors. 
6.4.4 	Orientation of Phenylcyclohexane in the Y96A Mutant. 
6.4.4.1 	Orientation of Phenylcyclohexane. 
From the density of the Fo-Fc difference map of the phenylcyclohexane 
structure, figure 6.20, it was clear that the phenylcyclohexane was in a similar 
orientation to 4-hydroxydiphenylmethane and diphenylmethane. 
168 
Figure 6.20: The Fo-Fc difference map ol the phenleyJohexane structure contoured at a a4evel of 2. 
The phenyl ring was easily modelled in the space between Phe 87 and Val 
244 with clear density. It became obvious that the cyclohexane ring could not be 
orientated to give one refined position that covered the density shown in the 
difference map. It was found that two phenylcyclohexane orientations could fit into 
the density, figure 6.21. 
The phenyl rings were essentially in the same position, -0.5 A difference. 
The main difference between the two orientations is in the configuration of the 
cyclohexane rings. The two cyclohexane rings are in opposite chair configurations. 
One is orientated towards Val 295, the other towards Val 244. In both cases the 
cyclohexane ring is oriented away from the heme centre towards the Thr 101/ Asp 
297 edge of the heme. The nearest hydrogens for potential hydroxylation, for the 
molecule near Val 295, are the equatorial C3 (2.2 A) and both the C4 axial (3.3 A) 
and equatorial (3.5 A) hydrogens; for the other orientation, near Val 244, the 
equatorial C2 (4.6 A) and C3 (4.4 A) and the axial C4 (4.5 A) hydrogens are nearest 
to the iron. For hydroxylation to take place, the cyclohexane molecule would have to 
move closer to the centre of the heme. 
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Figure 6.21 Orientations of the phenvicyclohexane structures from two perspectives 
If we assume that the phenyl ring maintains its position then the cyclohexane 
ring must move, thus changing the positions of the nearest hydrogens. When this is 
taken into account, the movement of the cyclohexane ring would move the C4 and 
C3 hydrogens nearer but move the C2 hydrogen further away from the iron centre. 
This is consistent with the experimental evidence which shows 4-axial, 4-equatorial 
and 3-equatorial hydroxylation, see chapter 1. 
The density between the two orientations of the phenylcyclohexane would 
suggest there is a degree of mobility between the two orientations, rather than two 
distinct cyclohexane orientations. This explains the higher temperature factor of 
phenylcyclohexane (60 A2 ) than previous structures. 
6.4.4.2 	Phenylcyclohexane Active Site Bound Water. 
As for the Y96A camphor bound structure the difference map for the binding 
site has unexplained density above the heme iron that could not be accounted for by 
the ligand. A water molecule was modelled into this position and refined with 
varying occupancy. The final refined value was 64 % occupancy and a temperature 
factor of 28 A2 . There is a large difference in this high occupancy for the water 
molecule compared to the low occupancy suggested by the percentage high-spin of 
85%. 
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The water molecule is in close contact (< 3A) with some of the hydrogens on 
the substrates, which would suggest that the water cannot be present in this position 
when the substrate is in its crystal (average) orientation. This implies that the 
occupancy of the water molecule here is too high (if the phenylcyclohexane is fully 
occupied) and that the water molecule can bind to the heme only when the 
cyclohexane ring moves way from the iron center. If, however, the phenylcyclohexane 
is not fully occupied, that could explain why the water occupancy is higher than 
expected; although there is no unexplained density as in the case of the 
diphenylmethane structure. 
Examination of wild-type P-450cam structures with bound water indicates that 
the water ligand is always <3 A from the substrate. 5 ' 9 It is possible that the water 
molecule can exist in tandem with a close substrate. For this to happen the water must 
have a smaller Van der Waals radii than normal, due to delocalization of the electrons 
towards the heme, thus allowing interactions of <3A. 
6.4.5 	Orientation of Bicyclohexyl in the Y96A Mutant. 
As with the previous structures the Fo-Fc difference map showed clear density 
for the bicyclohexyl rings, figure 6.23. 
One of the cyclohexane rings lies in the chair conformation between Val 247 
and Phe 87, in approximately the similar orientation as the 'upper' phenyl ring in 4-
hydroxydiphenylmethane, diphenylmethane and phenylcyclohexane, figure 6.23. 
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Figure 6.22: The Fo-Fc difference map of the bicyclohexyl structure contoured at a -level of 2. 
Figure 6.23. Bicyclohexyl in the Y96A binding site. 
This ring is slightly flattened compared to the optimized chair conformation 
with angles of 110 ° - 111 ° (vs. 111 ° - 115 ° for the energy minimized structure). 
The other cyclohexane ring lies in a chair conformation with the C4 carbon on the 
ring pointing towards Val 295. The C3 axial hydrogen on the lower' ring is nearest to 
the iron centre, with the next nearest hydrogen being the C4 axial, although neither 




the cyclohexane ring would have to move towards the iron centre. This would place 
the C3 equatorial and axial and the C4 axial hydrogens within hydroxylation 
distance. There is no evidence in the cr-weighted difference map of an iron bound 
water. 
6.4.6 	Binding of N-cbz-2,6-dimethylpiperidine. 
From the Fo-Fc difference map for the N-cbz-2,6-dimethylpiperidine [49] it 
was not obvious what the exact orientation was, although the density of the 'upper' 
ring suggested it was occupied by a phenyl ring. After some manipulation the final 
refined structure did fit the density, figure 6.24. 
Figure 624: a-weighted difference map of N-cbz-2,6-dimethylpiperidine contoured at 2. 
The reason for the problem in fitting 49 to the density was that none of the 
energy minimized structures seemed to be consistent with the electron density map. 
It was not until the structure was refined separately, (i.e. with the phenyl ring, linker 
and piperidine ring all placed into the density then joined together), that a 
satisfactory orientation could be found, figure 6.25. 
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Figure 6.25: Separate parts of 49 modelled into the electron density. 
The orientation of the final refined 49 was not close to any of the energy 
minimized forms. A Monte Carlo search of various low energy forms of the molecule 
did not reveal this orientation either. However, when the final refined value for the 
orientation was subjected to an energy minimization routine in Insightil, it maintained 
its orientation. This shows that crystal orientation of 49 is indeed in a local energy 
minimum and not thermodynamically impossible. 
The final binding orientation of 49 has the 'upper' phenyl ring in the same 
position as for the other aromatically substituted substrates, with the lower ring sitting 
above the heme, slightly towards Asp 297, figure 6.26. 
The methyl groups of the piperidine ring could not be satisfactorily placed in 
the density in any one orientation, therefore, they were left out of the final refinement, 
although they are in a cis position with regards to the cbz group. This lack of clear 
density for the methyl groups suggests a high degree of movement of the piperidine 
ring. The only other feature of note in the binding of 49 is a hydrogen bond from the 
carbonyl to the Asp 297 (0G2), at a distance of 2.6 A, figure 6.27. 
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Figure 6.26: Substrate 49 in the Y96A binding site 
Figure 6.27: a-weighted difference map of N-cbz-2,6-.dimethylpiperidine showing the hydrogen bond to 
Asp 297contored at 2. 
The temperature factors of this substrate are higher than for the other 
substrates. The reasons for this are probably a combination of the movement of the 
substrate and a lower occupancy. The binding constant for 49 is poorer than for any 
of the other crystal bound substrates and it has poor aqueous solubility. This would 
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imply that the substrate may not be fully bound. The substrate was finally modelled 
with an occupancy of 70 % which gave the piperidine ring and the ether linkage a 
similar temperature factor to the other substrates (-40 A). It was found however that 
the temperature factor of the phenyl ring was significantly higher (50 A) and had to 
be refined at an occupancy of 50 % to maintain consistant temperature factors over 
the molecule. The reason for this cannot be immediately determined, however, it may 
be that the poor binding of this substrate is due to the strain placed upon the molecule 
by this binding orinetation. Thus due to this, the phenyl ring is not in a low energy 
conformation and is more mobile in an attempt to reduce the intramolecular energy. 
6.5 Comparison of the Binding Orientations. 
6.5.1 	Orientation of the 'Upper' Phenyl Rings. 
The phenyl rings of 4-hydroxydiphenylmethane, diphenylmethane 
phenylcyclohexane and all sit in similar orientations. The phenyl rings all sit in the 
same plane (<20 ° difference) between Phe 87 and Val 247. The differences between 
the structures lie in the distance of the centre of the phenyl ring to the iron centre. The 
'upper' phenyl rings of diphenylmethane and hydroxydiphenylmethane are almost 
identical, the diphenylmethane ring being -0.5 A further from the heme than the 
hydroxydiphenylmethane ring. 
When comparing the bicyclohexyl 'upper' ring orientation, it is orientated 
slightly further away from the heme (1.0 A) and nearer Val 247 (3.8 A vs. 4.3 A) than 
the 4-hydroxydiphenylmethane phenyl ring. 
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6.5.2 	Comparison of the 'Lower' Rings of the 4-Hydroxydiphenylmethane, 
Diphenyimethane, Phenylcyclohexane and Bicyclohexyi Bound 
Orientations. 
6.5.2.1 	4-Hydroxydi phenyl methane vs. Diphenylmethane. 
In the case of 4-hydroxydi phenyl methane the hydroxylated phenyl ring was 
orientated so that the C4 carbon was 'pulled' towards Thr 252 by the hydrogen bond 
to the 4-hydroxydi phenyl methane hydroxyl group, to give an angle between the Cys 
357, sulfur heme iron and the C4 carbon of 157 0  figure 628. 
Figure 6.28: Comparison of diphenylmethane (green) and hydroxydiphenylmethane (red) from two 
perspectives. 
However, for the diphenylmethane there is no Thr 252 hydrogen bond and the 
diphenylmethane lies slightly closer to the heme (2.71 A vs. 3.17 A for 4-
hydroxydiphenylmethane) to give a Cys (SG) to iron to 4-hydroxydiphenylmethane 
(01) angle of close to linear, 171.84 O•  Other than this, the hydroxydiphenylmethane 
and diphenylmethane molecules are in essentially the same orientation. 
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6.5.2.2 	Phenylcyclohexane 	Compared 	to 	4-Hydroxydiphenylmethane/ 
Diphenylmethane. 
The fundamental difference in structure between the phenylcyclohexane and 
4-hydroxydiphenylmethane/ diphenylmethane bound structures is the fact the 4-
hydroxydiphenylmethane/ diphenylmethane had a bridging' functional group 
between its two rings. As stated previously, the 'upper' phenyl rings are essentially in 
the same orientation, thus the absence of the bridging carbon for phenylcyclohexane 
orientates the cyclohexane ring in a different orientation to the 'lower' phenyl rings of 
4-hydroxydiphenylmethane and diphenylmethane. This orientation of the 
phenylcyclohexane is away from the centre of the heme towards Val 295, figure 
6.29. 
Figure 6.29: Showing one orientation of phenylcyclohexane (i) compared to hydroxydiphenylmethane 
(ii), showing the similar orientation of the 'upper' phenyl rings but different orientations of the 'lower' 
rings. 
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6.5.2.3 	Comparison 	of Bicyclohexyl 	to 	4-Hydroxydiphenylmethane/ 
Diphenylmethane and Phenylcyclohexane Structures. 
The 'lower' cyclohexane ring of bicyclohexyl is in a significantly different 
orientation to the hydroxylated 4-hydroxydiphenylmethane ring which lies above the 
heme ring. The lower bicyclohexyl ring lies away from the heme center towards Val 
295, figure 6.30. 
Figure 6.30: Comparison of bicyclohexyl (yellow) with 4-hydroxydiphenylmethane (green) in the 
binding site, form two different perspectives. 
The bicyclohexyl, like the phenylcyclohexane molecule, has no 'bridging' 
methylene group to orientate the molecule towards the heme centre. There is a strong 
correlation between one of the phenylcyclohexane cyclohexane orientations and the 
bicyclohexyl 'lower' cyclohexane ring. Both cyclohexane rings lie away from the 
heme centre towards Val 295 (3.7 A for bicyclohexyl and 4.0 A for 
phenylcyclohexane). 
Despite the similarities the two cyclohexane rings are in opposite chair 
configurations with the Cl, C2 and C6 carbons overlapping but the C3, C4 and C5 
carbons of the phenylcyclohexane ring are nearer the heme centre. The orientation of 
these two substrates close to Val 295 implies that there is a strong hydrophobic 
binding affinity in this region that these substrate preferentially bind to, rather than 
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occupy the large space above the heme. In fact for camphor binding, both Y96A 
mutant and wild-type, the two bridging methyl groups (C8, C9) are orientated into 
this region. Thus substrates that have some degree of motion in the binding site seem 
to position hydrophobic centers close to the Val 295 side-chain. 
6.6 Conclusions. 
Here we have determined the structures of the cytochrome P-450cam Y96A 
mutant co-crystallized with the natural substrate, camphor, 4-
hydroxydiphenylmethane, diphenylmethane, phenylcyclohexane, bicyclohexyl and N-
cbz-2,6-dimethylpiperidine. 
The orientation of the 4-hydroxydiphenylmethane and diphenylmethane 
structures was similar to that expected, with the one phenyl ring in the upper aliphatic 
pocket and the other ring pointing towards the iron at the centre of the heme. The 
phenylcyclohexane and bicyclohexyl structures however bound with the lower ring 
towards Val 295 and not above the iron centre. This must be due to a strong aliphatic 
attraction to the region of the binding site around Val 295. Binding in this region is 
also seen in the camphor bound structure (both Y96A and wild-type) which has both 
the geminal methyl groups in this pocket. The N-cbz-2,6-dimethylpiperidine bound 
orientation was not predicted, although the poor binding was indicated by the 
experimental data (chapter 4). The important properties of these structures are 
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7 Features of the Cytochrome P-450 Y96A Mutant. 
7.1 Implications of the Substrate Bound Data. 
7.1.1 	Enzyme Complementarity Towards Camphor. 
The results presented here reflect the role of a number of parameters 
controlling the efficiency of substrate binding. Comparison of data from the 
biotransformation of camphane and norcamphor and the data from the Y96F and 
Y96A biotransformations of camphor indicate the importance of the various 
controlling factors. The increase in space in the binding site, by making a mutation, 
increases the production of the 3-exo product (the thermodynamically favoured 
hydroxylated product)' which can only result from significant rotation of the camphor 
molecule. The same result is gained by removal of the geminal carbons on the 
substrate (i.e. norcamphor). 2 
Camphane has no carbonyl oxygen available for hydrogen bond formation 
with the Tyr 96 hydroxyl, however the substrate/enzyme complementarity remains 
essentially the same as for camphor, i.e. no significant rotation of the camphane 
molecule was possible and thus little 3-exo product is produced. 3 Quantum 
mechanical calculations on the camphor have indicated that hydroxylation of the 5- 
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and 6- positions are energetically similar, therefore in cases where the motion of 
camphor is only slightly increased (e.g the Y96A mutant) a significant amount of the 
6-exo product is produced. This shows that there is not enough selectivity in the wild-
type enzyme to confer specificity without the hydrogen bond and additionally some 
hydrophobic interaction with the substrate. 
7.1.2 	Implications of the 4-Hydroxydiphenylmethane Structure for 
Cytochrome P-450 Mechanisms: an Unusual 251/252 Configuration in 
the 4-Hydroxydiphenylmethane Structure. 
One of the remaining areas of uncertainty in cytochrome P-450 research is the 
mechanism for proton transfer to the active oxygen species. Unlike peroxidases, 
which have an acid-base catalyzed reaction supported by a binding site histidine, 4 P-
450 monooxygenases have no obvious proton delivery mechanism. 
Thr 252 is a conserved residue in all known P-450 monooxygenases (except 
P-450eryF 5 where its function is replaced by a binding site water). The role of this 
conserved residue is thought to be in stabilizing the iron bound oxygen and as part of 
a possible proton delivery channel to the heme. 6-8 Thr 252 is present in an unusual 
kink in the I helix in both the wild-type and Y96A mutant structures, figure 7.1. It has 
been proposed that this kink between Thr 252 and Glu 248 could provide space for an 
oxygen binding pocket. 6 ' 9 This would thus allow molecular oxygen to access the iron 
during the catalytic cycle. 
Glutamate 251 (next to threonine 252) has also been shown to have a role in 
the catalytic cycle. Mutagenesis of Glu 251 results in reduction of the turnover rate by 
an order of magnitude, the effect occurring after the second electron transfer.'° 
Additionally the effect of the mutation of Glu 251 can be linked to the solvent pH." 
Kinetic isotope effects indicate that two protons are involved in the catalytic 
cycle, probably double protonating one of the bound dioxygen molecules so that it can 
be lost as water. The exact mechanism of this proton transfer is still unclear but the 
most likely mechanism, proposed recently by Sligar, has proton transfer via a catalytic 
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triad near a solvent rich cleft of residues Arg 186, Asp 182 and Lys 178 ; the proton 
then entering the binding site via this triad followed by an interaction with Glu 
251 . 4.12 
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Figure 7.1: i) The I helix of wild-type (red) and Y96A (green) showing the kink due to Thr 252 in the 
middle (heme, Thr252 and Glu 248 have been shown). ii) The I helix (red) viewed by looking 'through' 
it, the ribbon from Glu 248- Thr 252 has been shown in green. Camphor and the heme group have been 




Figure 7.2: i) The protein Connely surface showing the solvent cleft with residues Arg 186, Asp 182, 
Lys 178 (coloured by atom) and a number of water molecules (brown). ii) The side view of the cleft 
containing water molecules (yellow). The protein surface is coloured by charge (red-positive, blue 
negative). 
184 
Examination of the protein surface shows the cleft and the accessible charged 
residues with the bound water molecules, figure 7.2. 
The pathway from the binding site to this solvent rich cleft is quite clear, as 





Figure 7.3: Showing Inc pioposed residues of the p101011 delivery pathway (green) in relation to the 
heme (yellow) and substrate (blue). The arrows indicate the proposed proton pathway. 
It is postulated that once protons reach the end of the pathway, i.e. glutamate 
251, the Glu side-chain acts as a carboxylate switch, transferring protons via two 
water molecules and Thr 252, to the bound dioxygen. This transfer of protons is only 
made possible because of an intricate hydrogen bonding network leading from the 
water rich surface cleft to the binding site, figure 7.4. 
Mutagenesis of any of the residues in this pathway has been shown to lead to 
serious disruption in P-450cam turnover. 4 • 13 It has additionally been previously 
postulated that the Thr 252 could rotate in the binding site and stabilize the bound di-






Figure 7.4: The hydrogen bonding network around Glu 251 (centre) with, clockwise, Thr 185, Arg 
186, Asp 182, Lys 178, Asn 255 and Glu 251. 
Figure 7.5: Section of the 1 helix huiiig he h'rugen bend bteCIi jlU 248 and Thr 252, camphor 
and heme have been included for clarity. The 'kink' is indicated in green. 
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In addition to this, Thr 252 has a hydrogen bond to water 687 and rotation 
would disrupt a hydrogen bonding network that extends to highly conserved Glu 366, 
figure 7.6. 
Figure 7.6 Hydrogen bonding network behind' the Thr 252 residue. Water 687 is enlarged and Thr 
252 is highlighted. Residues include, clockwise, Thr 252, Glu 248, Gly 249, Glu 366. 
For these reasons it was thought that the rotation of Thr 252 was energetically 
unfeasible. The exact role of the Thr 252 therefore still remains in some question. In 
the P-450cam Y96A 4-hydroxydiphenylmethane bound structure we have discovered 
the first evidence that the threonine can indeed rotate into a hydrogen bonding 
position towards a heme bound oxygen (figure 7.7), and this has lead us to a new 
model of proton transfer, which slightly differs from that recently proposed. 
In this case, the rotation was initiated by ligand binding, however it can be 
postulated that a similar effect could occur upon the binding of dioxygen to the iron 
(H) species (after conversion of the molecular oxygen to superoxide). The Thr 252 
could then stabilize the dioxygen in one orientation so that only one of the oxygen 
atoms is in a position to be double protonated via the proton channel, thus preventing 
the peroxide shunt (chapter 1). 
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Figure 77: Comparison of wild-type (red) and Y96A, 4-hydroxydiphenylmethane (green) Thr 252 
orientations. Glu 248 (yellow) - Thr 252 (wild-type) and Thr 252 - 4-hydroxydiphenylmethane 
hydroxyl group (cyan) hydrogen bonds are indicated. 
This orientation of the threonine, thus the orientation of the bound di-oxygen, is ideal 











Figure 78: Schematic of the proposed proton delivery mechanism. 
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An additional consequences to the movement of the threonine, beyond that of 
rotating into a hydrogen bonding position towards the heme, is the disruption to the 
residues surrounding the Thr 252 main chain. The most significant change is the 
rotation of the backbone carbonyl of Glu 251, figure 7.9. 
Figure 7.9: Comparison or '.iId-t'pe (green) virh \ 9bA 4-hydroxdiphenyImethane (red) orientation 
of the Glu 251 backbone carbonyl. 
This movement of Glu 251 backbone has previously been observed for the 
T252A mutant structure and three other ligand bound structures, that of adamantane, 
an unnamed inhibitor and one of the 2-phenylimidazole orientations. 6"4-16 Each of 
these structures has a different cause for this movement (table 7. 1), but in every case 
the intricate H-bonding network around water 687 was disrupted. 
The data from the T252A mutant suggests that this orientation of the 
backbone is the low energy position and the strained configuration observed in the 
wild-type enzyme is only stabilized via the Thr 252-Glu 248 and Thr 252-Water 687 
hydrogen bonds. 
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Table 7.1: Comparison of structures showing a On 251 backbone rotation. 
structure possible reason for rotation of the Glu 251 carbonyl 
T252A mutant 6 Thr 252 has lost H-bonding potential to water 687 
adamantane 14 Water 687 has moved into binding site 
Pfizer unnamed (-) inhibitor 15 Inhibitor carbon C20 comes into contact with Thr 252 
CG2 (2.8A) and it moves to compensate (3.2A) 
disrupting H-bond to water 687 
one of the 2-phenylimidazole New binding site water (802) H-bonds to Glu 251 and 
orientations 16 disrupts the H-bonding pattern to water 687 
4-hydroxydiphenylmethañe Thr252 moves to H-bonds to substrate and therefore 
removes bond to water 687 
Disruption to this hydrogen bonding network via mutagenesis, interference with water 
687 binding pattern or rotation of the threonine side-chain allows the more 
thermodynamically favourable orientation. 
One major consequence of the rotation of the Glu 251 backbone, in this 
structure, is the effect on the hydrogen bond between it and the proposed carboxylate 
switch (Glu 251). Upon movement of the Glu 251 backbone carbonyl the hydrogen 
bond between it and the Glu 251 oxygen (OD I) is broken and a new one is formed, to 
the other Glu 251 carbonyl oxygen (0132), figure 7.10. 
The hydrogen bond from the backbone carbonyl to the Asn 255 (ND2) 
nitrogen is also lost, which is of importance mechanistically as Asn 255 is one of the 
residues stabilizing the proposed Glu 251 carboxylate switch. The movement of the 
Thr 252 backbone carbonyl induces a movement in Asn 255, thus affecting the 
strength of its hydrogen bond to Glu 251. It is thought that these changes to the 
environment of the carboxylate switch, especially the change in direct hydrogen 
bonding from the backbone oxygen, could be sufficient to change the pKa and initiate 
the proton transfer. 
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Figure 7.10: Movement ot uiu ...' 	 VuIk 	 i-ype orientation (red) to 4- 
hydroxydiphenyhnethane orientation (green), showing the change in H-bonding to the glutamate side-
chain. 
Another important factor in stabilizing threonine 252, in the 
thermodynamically unfavored position, is an intricate hydrogen bonding network 
'behind' the threomne (i.e. away from the binding site). As well as a hydrogen bond 
to the backbone of glutamate 248, threonine 252 hydrogen bonds to a water 
molecule, previously assigned as 687. This water molecule has a rigid conformation 
with hydrogen bonds to Gly 249, Val 253 and to Glu 366 via another water molecule, 
figure 7.11. 
Figure 7.11: comparison of hydrogen bonding network behind Thr 252 for wild-type (red) and the 
Y96A 4-hydroxydiphenylmethane structure (green). 
Glu 366 is another highly conserved residue in P-450 monooxygenases and it 
had been previously thought that the intricate hydrogen bonding around water 687 
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might have a role in the proton delivery mechanism; however mutagenesis 
experiments and no accessibility to the bulk solvent ( figure 7.12) have tended to 
discount this. 6 
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Figure 7.12: Showing the Glu 366 (red) in relation to the protein. The arrow indicates how the protons 
would have to pass through the protein from Glu 366, a pathway not supported by a proton channel. 
Another possible role for the region between the Glu 251 backbone and Glu 
366 is in providing water to the binding site. In either model for the proton transfer, a 
water molecule is needed to transfer the proton from the Glu 251 carboxylate to the 
heme bound oxygen. No water molecules are readily observed in this region of the 
binding site in most of the crystal structures, which implies that water enters during 
the catalytic cycle. Indeed there is a putative binding site discovered by electrostatic 
modelling that is in the region of our proposed water molecule, figure 7.13.1 7 
A water bound in this site should be capable of hydrogen bonding to Glu 251. 
It was additionally proposed that this water can only bind to Thr 252 if it underwent 
rotation. 6 The movement of the Glu 251 backbone carbonyl in fact enhances the 
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propensity for a water to bind in this site, by providing additional space for the water 
molecule and an additional hydrogen bond to Glu 251 side-chain carbonyl. 
Figure 7.13. Showing the position ot the proposed watel molecules for the Sugar model (1) and our 
model (ii). 
This results in slight differences in the location of the proposed water molecules, 
figure 7.14. 
The only case when a water is observed in this proposed site is the 2-phenyl 
imidazole inhibitor structure. 6 It is important to note that not only does this water 
bind to Glu 251 (the carboxylate switch), but the backbone carbonyl of Glu 251 has 
rotated to the orientation observed in our structure. There are few instances where no 
water 687 is present in the binding site of previous crystal structure (e.g. camphane 
and adamantane and substrate free), however in these cases a binding site water is 
present, perhaps as a consequence of water 687 moving into the binding site. 
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Figure 714; The differences in the proposed piuuii deliveiy mechanisms, showing Thr 252, Glu 251 
the proposed water molecules and the dioxygen (red) bound to the heme (green/blue). The Sligar 
model is in yellow, 4  our alternate model is in red. 
Thus we can propose a possible mechanism of proton transfer based on these 
disruptions to the binding site: 
. After substrate binding and electron transfer, molecular oxygen binds to the 
reduced heme. 
. After the second electron transfer Thr 252 rotates to H-bond to the bound 
dioxygenl Glu 251 backbone rotates and Wat 687 enters the binding site (in 
unknown sequence). 
• The carboxylate switch can then transfer a proton to this water which, in turn, 
transfers it to the bound dioxygen. 
• A further proton transfer to the dioxygen. 
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• The double protonated oxygen is expelled as water leaving the reactive iron (V) 
species. 
Thus the 4-hydroxydiphenylmethane structure might have given us an 
important insight into the cytochrome P-450 binding site and a possible explanation 
for the role of the Thr 252 residue in the catalytic cycle. The only questions 
unanswered would therefore be whether there is one or two water molecules in the 
pathway and how water 687 enters the binding site. 
7.2 Common Features of the Y96A Mutant Structures. 
7.2.1 	The Hydrophobic Binding Region (the 'Phenyl Pocket'). 
In the wild-type structure a close aromatic interaction exists between Phe 87, 
Phe 98 and Phe 193 to the Tyr 96, figure 7.15. 
It was hoped that the Y96A mutation would maintain this interaction by 
replacing the tyrosine phenyl ring with one from the substrate. This assumption was 
the basis for some of the initial modelling (chapter 8), however it is clear from the 
camphor bound structure that when no substrate phenyl ring is present, phenylalanines 
87, 98 and 193 rearrange to a new aromatic stacking arrangement (to minimize the 
residues around the hole left by the removal of the tyrosine). When the substrate 
contains a phenyl ring this aromatic stacking arrangement is maintained, with the 
substrate aromatic ring supporting this new configuration, figure 7.16. 
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Figure 7.15: A CPK representation of the phenyl rings surrounding tyrosine 9b, showing, clockwise: 
Phe 87; Phe 193 and Phe 98 with Tyr 96 in the centre. 
I, 
Figure 7.16: Comparison of the arrangement in the Y96A mutant of the phenylalanines around residue 
96 for the proposed model (i) and the actual crystal structure (ii). 
Comparison of the temperature factors for the aromatic residues (table 7.2) 
indicates that the Y96A camphor bound mutant orientation is the more stable, with 
the wild-type and Y96A- 4-hydroxydiphenylmethane structure being of similar 
stability. 
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Table 7.2: Comparison of the temperature factors of wild-type and Y96A camphor and 4-
hydroxydiphenylinethane in the region around Tyr 96. 
Temperature factor (A2) 
residue! Phe 87 Phe 98 Phe 193 Tyr 96 protein 
structure average 
wild-type 15.0 20.2 31.4 16.62 19 
(camphor bound) 
Y96A mutant 12.0 12.5 13.3 - 17 
(camphor bound) 
Y96A mutant 17.0 19.4 16.6 - 22 
(4-hydroxy diphenylmethane 
bound) 
The temperature factors indicate that the mutation has made this area of the 
structure less mobile than the wild-type enzyme. The reason for this reduction of 
mobility is probably the removal of the strain on the residue 96 backbone which 
causes the strained distortion at the end of the B' helix, figure 7.18. When phenyl 
substituted substrates are bound, the region has greater mobility (as mobile as the 
wild-type orientation). The Y96A camphor bound structure has greater potential 
mobility than the wild-type structure, therefore the lower temperature factor must be 
due to greater stability of this region caused by the Y96A mutation. 
7.2.2 	First Potassium Binding Site. 
Peterson discovered in the 1970's that there is a link between monovalent 
cation concentration and the efficiency of substrate binding. 18  The role of this cation 
has been explored both by biochemical studies and by crystallography. 19,20 This cation 
has been shown to be potassium, 19  although its role is unclear. There is a relationship 
between the cation and the state of the Tyr 96 residue; mutation from tyrosine to 
phenylalanine increases the level of potassium required to induce maximum 
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binding. 19,21 Recently Sugar and Polous have identified the previously hypothesized 
location of the cation binding site. 4 This binding site is formed between the 
backbone carbonyl groups of residues Gly 93, Glu 94, Ala 96 and Glu 84 and two 
water molecules, figure 7.17. 
Figure 7.17: The orientation of the potassium ion in the wild-type structure, showing from top. 
clockwise, Phe 96, Glu 94, Gly 93, Phe 87 
It is believed that this potassium ion stabilizes an unusual orientation of the 
Tyr 96 and the end of a helix starting at residue 89 (helix B'), figure 7.18. 
Figure 7.18: The H heII\ 	1) ing t1e p)tasIulu JOH P1tPe) and hov it ielates to the unusual 
termination of the B' helix. 
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In the Y96A mutant the potassium ion exists in this site, in an identical 
position to the wild-type enzyme. The density can be assigned as potassium from the 
a-weighted 2Fo-Fc map which indicates it is too big to be a water molecule (SHELX 
refines the atom to 0 occupancy as an oxygen, indicating an error in the assignment). 
The oxygen-cation distances are also consistent with potassium, rather than calcium 
or any other similarly sized cation. The temperature factor of the potassium is lower 
here (14 A) than the wild-type cryo structure, 5cp4, (22 A) and comparison of the 
average temperature factors for the side-chains involved in the potassium binding 
shows similar differences ( ii A2 for our structure compared to 23 A2 for the wild-
type cryo-structure, table 7.3). 
Table 7.3: Temperature factor of the potassium and its bound residues. 
WT-cryo 4 Y96A 
K 22 14 
84 22.0 12.8 
93 19.3 11.5 
94 23.7 12.2 
96 21.0 13.3 
total protein 19 17 
This decreased temperature factor, in this region, could indicate that without 
the camphor tyrosine hydrogen bond, the tyrosine (now alanine) backbone, adopts a 
more stable orientation. The overall temperature factors of the total protein backbone 
are comparable for both structures (-16 A2) therefore the 12 A2 difference in average 
backbone temperature factors is probably a real reflection of decreased mobility of the 
potassium bound residues and more particularly the B' helix. Thus the B' helix has 
adjusted its thermal motion due to the mutation which has resulted in a less mobile 
orientation of the both the cation and the B' helix. 
It has been shown previously that a dependence between potassium 
concentration and substrate binding affinity exists, even after removal of the tyrosine 
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H-bond to the camphor carbonyl (Y96F and camphor), indicating that the role of the 
potassium bound ligand to residue 96 goes far beyond that of stabilizing the camphor 
tyrosine hydrogen bond. 3"4"9'2 23  Since three octahedrally co-ordinated 0 donors are 
on the B' helix (89-96) it is possible that the role of the potassium is in controlling 
the movement of the B'helix. This small helix forms a significant portion of the 
proposed entrance channel and therefore potassium may play a role in controlling the 
size of the substrate entrance channel and consequently cause the observed effects on 
substrate binding. 
7.2.3 	A Second Potassium Binding Site. 
Another binding site for a potassium ion can be identified in the Y96A 
structure where potassium lies in a surface groove near the N-terminus, figure 7.18. 
This potassium binds the backbone carbonyl groups of residues Pro 15, Pro 16, Val 
18, side-chain oxygen OEI of Glu 20 and a surface water. This potassium exhibited 
similar electron density characteristics to the first potassium site. This potassium was 
identified as water 706 in the cryo structure (5cp4)4 but was not present in the other 
P-450cam structures. 
Figure 7.18: Second potassium binding site. the potassium is in purple, H-bondes residues are 
indicated in red, starting left and going anticlockwise: Glu 20, Val 18, Pro 16 and Pro 15. 
FM 
The structural significance of this potassium is not known, although it 
appears to stabilize the last -turn at the N terminus, figure 7.19. 
Figure 7.19: Showing the location of the second potassium binding site in relation to the 3-turn. 
This potassium has only been observed in the cryo-structures; at room 
temperature these residues may be too mobile to bind potassium. This potassium 
thus might be an artifact of the freezing process (although the room temperature 
structures have significantly fewer assigned water molecules). The overall 
temperature factors for our camphor structure (17.9 A2 ) is comparable to the wild-
type room temperature structure, 2ccp, (18.8 A2). However, the average temperature 
factor for the residues binding the potassium are 17.6 A2 for our structure compared 
to 29.0 A2 for the free residues in the wild-type structure. This shows that the 
potassium has the effect of stabilizing the orientation of the N-terminus and is not 
just an artifact of the crystallization. 
7.2.4 	Aqua Ligand. 
With no substrate bound, the heme iron exists as a hexacoordinate low spin 
species. Addition of substrate displaces the water and gives pseudo-pentacoordinate 
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geometry onto the heme, resulting in a high-spin species, as characterized by the shift 
in it.itc  bands in the UV spectrum ('Soret' shift). It is known that for non-natural 
substrates, e.g. camphane, norcamphor and adamantane, a state between high and low 
spin can appear. 3 It has been postulated from the crystallographic evidence that the 
water may be present 100 % of the time, but in two forms, as both hydroxyl and 
water. It is thus proposed that it is these two distinct forms that cause of the 
differences in the spectra. 14 Recent ab initlo studies have shown that the mixed spin 
state that occurs when substrates are bound is an effect caused by the shortening of 
the iron sulfur bond and not by the nature of ligated water. 24-26 This combines with 
recent analysis of the P-450 system, which suggests that the shift of water from the 
iron is not sufficient to induce the change in spin state and the substrate induced 
changes to the heme environment plays a significant role. 27'28 
During the recent ab initio analysis, a number of key conclusions were missed. 
The shift from high to low spin at iron sulfur bond lengths of over 2.2 A is governed 
solely by the presence or absence of the aqua ligand and is not related to the length of 
the bond. However when the iron sulfur bond is reduced towards 2.05 A a mixed 
state is induced between the high and low spin species. Theoretical calculations 
showed that this mixed state is independent of the presence of the aqua ligand 
(althought the aqua ligand may be inducing the shortening of the bond). All the 
camphor analogues that have these shorter iron sulfur distances exhibit mixed spin 
states. 14 
From previous data on camphor analogues it is clear that more 'mobile' 
substrates will allow water to enter the binding site and thus potentially change the 
iron-sulfur bond. Therefore the length of the iron-sulfur bond is dependent on the 
substrate and its effect on the heme environment and not on the nature of the aqua 
ligand itself. The factors that control the substrate/heme relationship are therefore 
more complicated than simple displacement of the water to induce a change in spin 
state. A combination of substrates hydrophobicity, steric bulk and mobility probably 
affect the heme environment and consequently the spin state of the iron. 
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7.2.4.1 	Camphor Bound Structural Water. 
Since camphor in the Y96A mutant has only 48 % high-spin, it was crucial to 
measure the correct iron-sulfur distance in the camphor bound structure and to 
establish if this mixed spin state is caused by shortening of the iron-sulfur bond or by 
some other mechanism. The result of a fully optimized iron-sulfur distances of 2.34 A 
is consistent with the camphor bound wild-type structure. This suggests that in the 
mixed spin states of the Y96A camphor bound structure is a direct result of the 
occupancy of the water ligand and not caused by shortening of the iron sulfur bond. 
This is confirmed by the refined occupancy of the water, at 58 %. This is the first of 
the P-450cam structures to have a partial water occupancy and would support the 
idea that mixed spin states can be caused by shortening of the iron-sulfur bond or 
partial occupancy of the aqua ligand. 
7.2.4.2 	Phenylcyclohexane Bound Structural Water. 
The iron sulfur distance for the phenylcyclohexane bound structure is 1.93 A 
which is longer than for the camphor bound structure but consistent with other 
previous bound water such as adamantane (1.95 A).14  The similarity of the distance 
between the iron and the bound water to the wild-type adamantane structure was of 
interest as the adamantane structure has the anomalous data of 100 % water 
occupancy combined with a high percentage high-spin. This is indeed the case for the 
phenylcyclohexane structure which has a percentage high-spin of 85 % and a water 
occupancy of 65 %. The adamantane structure additionally has a iron sulfur distance 
of 2.14 A, shorter than the camphor bound structure, but comparable to the 
phenylcyclohexane bound structure of 2.16 A. It can thus be concluded that unlike the 
camphor bound structure the phenylcyclohexane bound water does induce a change in 
the spin state due to the shortening of the iron sulfur bond. 
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7.2.4.3 	Water Occupancy of Other P-450cam Y96A Mutant Structures. 
For the obvious reason that the ligand ligates to the heme, the 4-
hydroxydipheny1methane structure has no bound water. The bicyclohexyl structure 
showed no sign of water in the binding site. As for the diphenylmethane and substrate 
49 the data suggests the poor substrate solubility has caused a partial occupancy of 
the ligands. Thus because of the partial occupancy of the water ligands it is difficult to 
determine if any bound water is present in the presence of the substrate. 
7.2.5 	Uncoupling. 
When unnatural substrates are used with P-450 monooxygenases, uncoupling 
can occur resulting in the production of peroxide rather than hydroxylated substrate. 
Accessibility of water to the active oxygen species during the catalytic cycle is 
believed to be the primary causal factor. Uncoupling is a problem for more 
commercial applications of P-450 monooxygenases as it utilizes NADH in the 
production of the peroxide. A number of substrates for the Y96A mutant have been 
studied over the years and they all indicate that there is a high degree of uncoupling 
for this mutant. 29-32  This may in part be due to greater water accessibility to the 
binding site due to poor substrate enzyme interactions, (especially when relying on the 
phenyl ring to provide substrate specificity). Another factor might be the effect of the 
Tyr 96 removal, as it has been postulated that the Y96 residue pushes camphor 
towards the iron centre maintaining a close iron C-5 distance. 33 A possible structural 
cause of uncoupling has been found in the Y96A mutant. 
With the removal of the Tyr96-Thrl0l hydrogen bond, Thr 101 has rotated 
105 creating a hydrophilic pocket with the Thr 101 OE1 and a heme proponate 
group. This pocket allows binding of an extra water molecule, not present in any 
published structures. Although this water molecule is 8 A from the iron, the presence 
of this water in the binding site may explain the increases in uncoupling with the 
Y96A mutant. Simple mutation of the threonine to valine could remove this problem 
without significantly altering the binding site volume. 
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7.3 Conclusions. 
The six substrate bound structures of the P-450cam Y96A mutant enzyme 
have yielded a number of important results. 
Firstly the camphor bound structure has indicated the elegant way in which the 
binding site has been designed for camphor and how one mutation cannot significantly 
disrupt the binding specificty of the enzyme towards its natural substrate. 
Analysis of the interaction of the other substrates with the binding site 
revealed the subtle relationship between the 'phenyl pocket' and the aromatic rings on 
the substrates. Bicyclohexyl showed that non-aromatic substrates can interact with the 
enzyme in a similar way. 
The 4-hydroxydiphenylmethane bound structure also provided an insight in to 
the relationship between the binding site and the possible mechanism of proton 
transfer. 
Overall, the six structures showed how the potassium binding site is stabilized 
by the mutation of tyrosine to alanine. In addition to this a new potassium binding site 
was discovered. 
These six structures also provided a possible explanation for the increased 
peroxide production witnessed in the P-450cam Y96A mutant turnover. 
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8 Molecular Modelling. 
8.1 Introduction. 
In recent years, molecular modelling has been used for a wide range of 
applications within cytochrome P-450 research. Unsolved structures have been 
hypothesized using X-ray crystal structures of known P-450s' -5 and available chemical 
databases are used to screen for potential substrates. 6- 10  Substrate entry into the 
binding site has been modelled, 11  as well as calculations of the maximum binding 
pocket space for potential substrates. 12 Interactions between P-450 monooxygenases 
and their electron transfer co-proteins can also be modelled. 13-15 Modelling studies 
have led to the creation of many mutant enzymes, 16  in an attempt to understand the 
importance of various binding site residues, for example mutants Y96F, 17 T252A, 182o 
D25 IN 21  Y96H, F87W and V3 96W. 22  
Without an available crystal structure for the Y96A mutant, a crude model 
was created by deletion of the tyrosine side chain to give alanine. It was hoped that 
substrates with an aromatic ring would interact with the mutant protein (due to, 
energetically favourable H-stacking within the aromatic pocket between phenylalanine 
residues Phe 87 and Phe 98). This gives a potential starting orientation for the 
substrate modelling, i.e. in the position previously occupied by the phenyl ring of the 
tyrosine side-chain. 
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If the aromatic ring fits into this aromatic pocket, the orientation of the 
substrate within the binding site will be limited by the phenylalanine residues on either 
side, (Phe 87 and Phe 98) and by the interactions with other residues of the binding 
site. This meant that a crude attempt at modelling the substrates could be made 
without the need for extensive computation. This was acomplished by placing the 
aromatic ring of the substrate in the aromatic pocket, in the position previously 
occupied by the tyrosine 96 aromatic ring. 
8.2 Confirmation of the Model by Modelling Known Substrates. 
Diphenylmethane and phenylcyclohexane are known substrates for the P-
450cam Y96A mutant and it was hoped that modelling them in the binding site could 
confirm the validity of the model system. Diphenylmethane was modelled with one 
phenyl ring in the location previously occupied by the tyrosine and the other 
positioned to avoid unfavourable interactions with the binding site residues, figure 
8.1. 
It was found that the orientation of the second phenyl ring placed the C4 
carbon in the closest hydroxylation position to the heme. This agrees with the 
experimental result which produces 4-hydroxydiphenylmethane as the sole product of 
the biotransformation with the Y96A mutant. 23  The same process was applied to 
phenylcyclohexane and it was found that both the C4 hydrogens and the trans (axial) 
C3 hydrogen were in close proximity to the heme. This is again in agreement with the 
experimental result which yields 4- and 3-hydroxy products. 24  It appeared from these 




Figure 8. 1. Diphenylmethane (i) and phenylcyclohexane (ii) in the binding site model. 
8.3 Modelling of Novel Substrates. 
8.3.1 	Diclofenac. 
Diclofenac [37] is an important anti-inflammatory agent and it has been 
suggested that hydroxylation of either of the aromatic rings could enhance biological 
activity. Selective hydroxylation of diclofenac is chemically difficult and it was 
hoped that hydroxylation of diclofenac or a synthetic intermediate might be achieved 
using the P-450cam mutant enzyme system. To this end, diclofenac and some of its 
synthetic precursors (58, 40, 59, 60, 61) were modelled in the binding site of the 
Y96A mutant, figure 8.2. 
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Figure 8.2: Diclofenac [37] and some of its synthetic precursors. 
Compound 58 is too small to fit into both the aromatic pocket and above the 
heme. It is thought that the free amine would preferentially bind to the iron therefore 
making turnover impossible. For the other compounds, the chlorinated ring was found 
to have unfavourable Van der Waals interactions with the protein, so the non-
chlorinated ring of each compound was modelled in the aromatic pocket. 
Compounds 60, 37, 61 are all predicted to be too big to fit into the binding 
site. When the aromatic ring is orientated into the aromatic pocket there are 
unfavourable Van der Waal contacts with the substrate chlorines and the surrounding 
residues. These three molecules should only bind if there is a good degree of flexibility 
in the amide linkage between the two aromatic rings, which is unlikely. 
Compounds 59 and 40 appear to fit into the binding site but compound 59 has 
a different orientation of the two aromatic rings (perpendicular to each other) which 
does not lead to favourable Van der Waals interactions between the chlorine and 
some of the binding site residues. Compound 40 however binds well. The orientation 
of the rings is better due to the coplanarity of the aromatic rings with the amide. A 




figure 8.3i. There is also a potential hydrogen bond between the carbonyl on the 
diclofenac and the backbone carbonyl of phenylalanine 98, figure 8.3ii. 
1_\  0 
i) 
Figure 8.3: i) Model of compound 40 (in green) in the P-450cam Y96A binding pocket, ii) Model of 
compound 40 (yellow) showing possible hydrogen bond with phenylalanine 98. 
Binding studies have indicated that compound 40 does bind whereas the other 
compounds do not show any signs of binding. In this case, the modelling correctly 
predicted the binding of potential substrates to the P-450cam mutant enzyme. 
8.3.2 	Studies of 2,3-Epoxycyclohexyi-1 -benzoate. 
Another set of compounds, from previous work with substrates containing 
ben.zoyl attached to a non-aromatic six membered ring, 25 were modelled into the 
active site of the Y96A model. The substrates were four diastereomers of 2,3-
epoxycyclohexyl- I -benzoate(6 1-64), figure 8.4. 
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Figure 8.4: The four diastereomers of 2,3-epoxycyclohexyl-1-benzoate. 
All four diastereomers were modelled to discover if the enzyme could 
distinguish between them. In all cases the 4- position on the aliphatic ring was the 
favoured location for hydroxylation. There was very little difference in orientation of 
the substrate in each case, figure 8. 5i. 
For the RRR and SSS form (compounds 63 and 64), the epoxide was in close 
contact to the iron, figure 8.5ii. This might cause the epoxide to react with the iron 
centre, if it does not, it may still be possible to hydroxylate them. For the two 
enantiomers RSS (62) and SRR (65), the epoxide is not in close contact with the iron 
centre and therefore could be hydroxylated. Taking into account the movement of the 
substrate within the binding site, the major product in all cases should be the 4-
hydroxylated product but minor products might also be produced. This was later 




Figure 8.5: i) All four diastereomers (compounds 62-65) modelled in the active site of the P-450cam 
Y96A mutant. The heme distance from the 4-axial position on the substrates is marked. ii) All four 
diastereomers (compounds 62-65) modelled in the active site of the P-450carn Y96A mutant. The 
heme distance from the axial epoxides of compounds 63 and 64. Colour scheme: Purple for Y96A 
enzyme, compounds: 62 dark blue; 63 light blue; 64 green and 65 yellow. 
In this case it was not possible to distinguish significant differences in the 
binding capacity of the compounds (62-65). It is possible that a more refined model 
using Molecular Dynamics (MD) might find greater differences in the binding of 
these compounds. In these two distinct cases, both the potential benefits and 
limitation of molecular modelling have been demonstrated. 
8.4 Modelling of Previously Studied Substrates. 
A number of Cb:-substituted piperidines have been previously studied as 
substrates for the Y96A mutant, figure 8 . 6 . 26 
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Figure 8.6: Two Cbz-substituted piperidines used in the modelling study. 
From experimental results it was known that both substrates bind to the 
enzyme. However only substrate 47 produces a significant amount of hydroxylated 
product (5 %), compound 48 produced less than 1 % of product. On the other hand, 
binding studies indicated that compound 48 binds better than compound 47. In order 
to investigate this paradigm, modelling was performed with both substrates by 
placing the phenyl ring of the cb: group in the aromatic pocket, figure 8.7. 
Figure 8.7: Picture of compounds 48 (yellow) and 47 (blue) in the Y96A mutant model. 
The modelling studies gave almost identical orientations for both compounds, 
it was not therefore possible to establish why these two compounds had different 
binding and turnover properties. This demonstrates that the modelling studies are 
clearly not sufficient to fully predict the binding properties of compounds for the 
cytochrome P-450cam Y96A mutant. 
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Due to these areas of uncertainty about the Y96A model it was decided a 
more thorough investigation of the substrate binding was necessary. The modelling 
studies discussed so far were performed with a Y96A structure based on manipulation 
of the wild-type enzyme, not on the actual structure. In addition to this, even if the 
model of the Y96A structure is accurate, the orientation of the substrates in the 
binding site is unknown. For these reasons it was decided to investigate the structure 
of the P-450cam Y96A mutant and how substrates bind to it. To date X-ray 
crystallography is the only technique able to solve the structure of proteins of this size 
(-45 kDa). It was therefore decided that the only way in which we could satisfactorily 
explain the substrate binding to the Y96A mutant was to solve a number of substrate 
bound crystal structures. 
8.5 Remodelling the Substrates in the Y96A Crystal Structure 
When modelling substrates in the crystal structure similar assumptions were 
made to the previous modelling studies, i.e. using the location of the phenyl ring from 
known substrates to model the location of the aromatic handle of new substrates. 
8.5.1 	Camphor and Adamantane Analogues (2, 10, 23-28). 
All the camphor and adamantane molecules can be easily placed into the 
binding site, however, there is no way to assign the possible orientation without a 
frame of reference. Simple overlay of the molecule with the orientation of the 
camphor molecule in the crystal structure is not sufficient as the molecule can then 
freely rotate. Therefore without an aromatic handle or greater steric bulk these 
substrates can not be modelled accurately. 
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8.5.2 	Diphenylmethane Analogues (13, 18, 29, 30). 
There was no need to model some of these substrates as the crystal structure 
of diphenylmethane, phenylcyclohexane and bicyclohexyl bound to the P-450cam 
Y96A mutant has been solved, although instinctively the cyclohexane rings of 
phenylcyclohexane and bicyclohexyl would be modelled nearer the heme (i.e. like the 
diphenylmetyhane structure) and not towards Val 295 as in their crystal structures. 
The only substrate in this series without crystal data is amyl benzene, although 
attempt to co-crystalize it were made. Modelling cannot be easily made here as, after 
placing the phenyl ring in the aromatic pocket, the pentane chain has a high degree of 
potential mobility in the center of the binding site and no single orientation can be 
assigned. 
8.5.3 	Naphthalene Analogues (31-36). 
When placing the aromatic groups of these analogues in the phenyl pocket the 
distance between the other sections of the molecule and the heme is too great for 
hydroxylation to occur (>5 A). Since it is known that naphthalene is a wild-type P-
450cam substrate it is entirely possible that these substrates all bind in a similar way to 
the Y96A mutant. A possible mode of interaction could be partial it-stacking between 
the substrate and the heme, similar to the phenyl radical studied previously. 27 There is 
plenty of room for this to occur however the energetic feasibility is unknown and no 
obvious products would be produced. 
8.5.4 	Chlorinated Aromatics (38-40). 
It was extremely difficult to place these molecules in the binding site due to 
unfavourable Van der Waals interactions with the binding site residues. All substrates 
required extensive manipulation from the energy minimized structure to get them to 
fit inside the binding site. Even when a binding orientation could be found, no obvious 
hydroxylation sites could be elucidated. 
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8.5.5 	Other Aromatically Substituted Substrates (41-57). 
All the other substrates could be successfully modelled in to the binding site by 
placing the phenyl ring in the aromatic pocket however they all have slight differences 
depending on the linker between the aromatic and non-aromatic rings. 
The compounds that gave the best fit were those with a rigid single atom length 
linker (e.g. 44-46). The ones with the worst fit were those with the cbz group (e.g. 
47-49). All the other molecules fit inside the binding site with similar degrees of 
success. The oxygen substituted rings all fit in an orientation that places the oxygen 
near the heme, thus preventing turnover. 
8.6 Conclusions from the Substrate Modelling Studies. 
With this basic method of modelling, substrates can be successfully modelled 
into the binding site of the enzyme. What is clear is that without a aromatic handle it is 
impossible to predict any kind of information on the binding orientation of the 
substrates. With the aromatic handle the most that can be concluded is whether or not 
the substrate is too big for the binding site. Prediction of the site of hydroxylation is 
not valid as most substrates have a degree of potential movement in the binding site 
and this cannot be predicted with this methodology. However this technique can be 
used to access potential substrates before embarking on any practical experimentation. 
If modelling is to be used to predict substrates a more sophisticated method must be 
used (see chapter 9). 
8.7 Substrate Entry in P-450cam Binding Site. 
It became apparent from the first crystal structure ofP-4SOcam that there is no 
obvious entrance channel. 28  Upon closer examination a gap in the helical arrangement, 
above the heme was found, figure 8.7. 
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Figure 8.10: The ribbon structure 01 the protein coloured by temperature lactor (red-static, blue-
mobile) for substrate bound (i) and substrate free enzyme (ii). 
This chain appeared to stick into the entrance channel interfering with 
residues Phe 193, Phe 87 and Tyr 96 and in this 'open' configuration: the Phe 193 
ring points up towards the protein surface; the Phe 87 ring adopting the position 
formally occupied by the Phe 193 ring. When examining this binding channel it is 
apparent that entrance pocket is lined with hydrophobic residues, figure 8.11. 
A substrate binding must pass the Phe 87, Phe 98 and Tyr 96 residues on its 
way to the centre of the binding site; this must apply to our Y96A mutant as well. 
Thus with the mutation to the Tyr 96 residue the substrate entrance should be larger, 
thus facilitating easier binding of substrate. 
- 
L 
Figure 8.11: Surface of proposed entrance channel of P-450cam. coloured by charge (red-positive. 
blue-negative). Proposed entrance channel is indicated. 
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Due to the limited range of thermal motions possible in a protein crystal and the 
increased size (compared to typical wild type substrates) of our substrates it was 
decided to co-crystallize these substrates with the enzyme. Co-crystallization of 
course is only possible because mercaptans are not needed in the crystallization 
solution, through use of the C334A mutant. 
Thus substrate binding with P-450cam is only possible with significant 
movements of significant portions of the protein. With the availability of the 
substrate free structure the areas of the protein with increased thermal motions could 
be identified, figure 8.9. 
Ir 
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Figure 89. The Coniie)by surface of the protein coloured by temperature factor (red-static, blue-
mobile) for substrate bound (I) and substrate free enzyme (ii). Area of greatest change is boxed. 
As can be seen in the above figure there is a region of the protein that has 
significantly increased thermal motion upon removal of the substrate. Three main 
areas are affected by substrate binding, the B' helix between residues 87 and 96, the 
loop joining helixes F and G (185-192) and region around residue 251, figure 8.10. 
The first of these is the region around the Y96 residue, the area of the protein 
that was proposed as the binding entrance. This view was supported when Poulos 
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Figure 8.10: 'I he ribbon structure of the protein coloured by temperature factor (red-static, blue-
mobile) for substrate bound (i) and substrate free enzyme (ii). 
This chain appeared to stick into the entrance channel interfering with 
residues Phe 193, Phe 87 and Tyr 96 and in this 'open' configuration: the Phe 193 
ring points up towards the protein surface; the Phe 87 ring adopting the position 
formally occupied by the Phe 193 ring. When examining this binding channel it is 
apparent that entrance pocket is lined with hydrophobic residues, figure 8.11. 
A substrate binding must pass the Phe 87, Phe 98 and Tyr 96 residues on its 
way to the centre of the binding site; this must apply to our Y96A mutant as well. 
Thus with the mutation to the Tyr 96 residue the substrate entrance should be larger, 




Figure 8.11: Surface of proposed entrance channel of P-450cam, coloured by charge (red-positive, 
blue-negative). Proposed entrance channel is indicated. 
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Unfortunately this also applies to the dissociation of the substrate which 
should also be greater as recent studies with photoacoustic calorimetry have 
indicated that substrate can be expelled rapidly from the binding site by the 
photolysis of a bound carbon monoxide. 3 ' This could explain the good binding 
constants for P450cam Y96A mutants but why they give poor turnover. If the 
substrate enters and leaves the binding site quickly the catalytic cycle could be 
initiated but the substrate could leave the binding site before being hydroxylated. 
This would thus explain the increased peroxide production caused by the Y96A 
mutation. 32 
The other region to move, when substrate is removed, is the loop between the 
F and G helixes. These helixes form a 'lid' above the binding site with the residues of 
the loop between them lining the 'upper' region of the binding site (e.g. Phe 193), 
figure 8.12. 
It is clear from this picture that the substrate bound structure has less thermal 
motion than the substrate free structure, this area of instability being centered at the 
loop between the helixes. This region is more significant, not for the binding site 
residues it processes but for its role in the proton delivery pathway (see chapter 7). 
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Figure 8 12 The F and G helixes for substrate bound (i) (iii) and substrate free (n)/ (iv) enzyme from 
two perspectives. Colour scheme as before. Camphor and heme group are shown for clarity. 
A number of residues believed to be involved in this pathway lie in the region 
of this loop, (e.g. Met 184, Arg 186, Asp 182, Lys 178). Indeed the third region of 
movement is around Asp 251 which is the key catalytic residue in this model for the 
proton pathway. It would appear that these movements of the protein might be 
associated with salt bridges as it has been demonstrated that salt bridges must be 
broken upon substrate entry. 33 Thought these salt bridges have not been identified, 
Poulos 34  and Sugar 35  separately have proposed that a bridge between Asp 251 and 
Lys 178 might be responsible. Site directed mutagenesis of some of these residues 
would also seem to indicate that they have a role in regulation of substrate control. 
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This would lend credence to the theory proposed earlier (chapter 7), that the 
substrate entry to the binding site has an effect on the residues of the proton pathway. 
The link between these two regions can be seen more clearly when they are shown 
on the same picture, figure 8.13. 
F r4 -Adb~dllw 	 49 
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Figure 813. Showing the entrance channel (red) and the proton pathway (green) in relation to the 
substrate (blue) and heme (yellow). 
Thus it is clear from this that both the 'upper' region of the binding pocket 
and the proton delivery pathway are liked by their close proximity. This common 
region between them is also the more mobile area upon substrate disassociation. The 
P450cam system therefore has developed a method of associating the substrate entry 
with the proton pathway independent of the interactions with the heme. This 
relationship should be explored further, as mutagenesis to the binding site to expand 
the substrate range, may have an adverse effect on the proton pathway. Although this 
does not seem to have happened with the Y96A mutation. 
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9 Modelling with the Package DOCK. 
9.1 Introduction. 
DOCK is a suite of programs designed to find favourable orientations of a 
ligand in a receptor. First devised in 1982 by Irwin Kuntz,' at the University of 
California and later updated and revised. 2-14 DOCK has a unique method of 
modelling the receptor/ligand interactions, without extensive computational 
requirements. The DOCK suite consists of three basic programs, sphgen, grid and 
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Figure 9.1: Overview of the DOCK suite. 
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To complement these three programs other supplemental programs are 
available which enhance the DOCK suite or allow conversion of output files to more 
accessible fonnats. To reduce the computational time necessary to process the myriad 
of receptor/ligand interactions DOCK has two unique components. 
1) The first is the use of sphere centers to characterize the binding site. These 
centers are created with sphgen and consist of a series of partially overlapping 
spheres, which fit completely inside the binding site of a ligand, touching the 
surface but without intersecting the Van der Waals radii of the binding site atoms. 
To find a starting orientation for the ligand a number, usually three or four, of its 
atoms are overlapped with the sphere centers creating sphere-atom pairs. This 
gives the computer a starting orientation for the ligand. Alternate methodologies 
would use every possible orientation of the ligand, which can utilize considerable 
computer resources. DOCK then minimizes the ligand in this orientation and filters 
the ligand position for no 'bad contacts' (bumps) with any receptor atoms. These 
bumps are user defined minimum distances between the ligand and receptor atoms. 
An important point to note is the limitation put upon DOCK by this approach, 
since it does not allow for any movement of the ligand binding site. A good quote 
is 'what is good about DOCK is that it uses spheres; what is bad about DOCK is 
that it uses spheres... 12 It is not sufficient to rely on the spheres generated by 
sphgen to characterize the binding site. It is essential to view and manipulate the 
sphere centers to better characterize the binding site. This approach requires some 
level of intuition on the part of the user therefore mistakes can easily be made 
without careful analysis of the location of the sphere centers. 
2) The second aspect to the DOCK program suite is the scoring mechanism. Once a 
suitable ligand orientation has been found it must be characterized relative to other 
suitable orientations. The method by which DOCK does this is to use a predefined 
grid of points to describe the binding site, created with 'grid'. The suitable ligand 
orientations are then evaluated (scored) by their interaction with points on the grid. 
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grid created can be based on the distance between the receptor atoms, (contact 
scoring), or a more complicated grid based on the electrostatic parameters of the 
atoms (energy scoring). Contact scoring is based upon a predetermined value for 
the atom-atom minimum allowed distance, usually about 3 A. The energy scored 






Figure 9.2 Lennard-Jones function, used to calculate the energy scored grid. Where: Eintermolecular 
interaction energy; r,=distance between atoms i and j; Aij and Bij= van der Waals repulsion and 
attraction parameters; a and b=van der Waals repulsion and attraction exponents; qi and cij=point 
charges on atoms i and j; D=dielectric function; 332=factor to convert electrostatic energy to 
kcallmol. 2 
The score of the ligand orientation is stored and a new orientation is 
considered, figure 9.3. 
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Figure 9.3: General schematic of scoring mechanism. 
Once this process is finished DOCK outputs the coordinates of the ligand 
orientation with the best score, its score and details of the number of orientations 
scored. 
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9.2 Previous studies with P-450cam and DOCK 
A number of previous studies of substrates with DOCK have been performed 
on P-450cam by deMontellano and coworkers. 15-18 The emphasis here was utilizing a 
search facility in DOCK to trawl through a database for possible ligands. This was 
attempted with both wild-type P-450cam and latterly with the L244A mutant. 15" 6 In 
each case deMontellano and coworkers selected a dozen of the best scored potential 
substrates and then physically tested them on the enzyme for binding and turnover. A 
number of compounds not chosen by DOCK to be substrates were additionally tested 
to validate the methodology. This technique proved to have some limited success 
however one major drawback occurred. It was apparent that the ability of DOCK to 
successfully predict real substrates was dependent on parameters for the polar and 
non-polar cut-off distances. If these distances were set too high, actual substrates 
would not be predicted as such and if it was set too low some non-substrates would 
be selected as candidates. Later, it was found that these distances also changed with 
the use of the L244A mutant. It is also important to note that camphor is not 
predicted to be a substrate with this method as its close contacts to the protein 
binding site give it a poor score. 
9.3 Differences in Our Studies with DOCK 
One difference to our approach is that here we do not use a database of 
randomly chosen potential substrates. Instead compounds are speculatively selected 
by eye from similarities to known substrates. This approach more rigorously examines 
individual compounds, however, it does not provide a means of exhaustively 
identifying all the P-450cam Y96A potential substrates. 
The key difference in our study is the due to the version of DOCK used. 
Previous studies with DOCK have used versions up to version 3.5 which all have 
similar drawbacks, namely the strong dependence on the non-polar and polar cut-off 
distances. In version 4.0 the contact scoring system was made more uniform with a 
contact distance and an allowed overlap (bump overlap) rather than different values 
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for non-polar or polar atoms. This reduction in control was due to the significant 
improvement in ligand orientation parameters. Up to DOCK version 3.5, ligands were 
placed in the binding site in a rigid form, which meant reduction of the allowed 
contact distances was necessary to allow for potential reorientation of the substrate 
within the binding site environment. Additionally, this previous method could not 
compensate for multiple low energy conformations of ligands such as the two chair 
and boat forms of a cyclohexane ring. The significant improvement to DOCK is the 
ligand orientation and conformation parameters. With the 'orientation' parameters 
one can now search all the possible orientations of the compound in the binding site. 
Previously the ligand orientation was solely dependent on the location of the sphere 
centers and compounds without 4 atoms overlapping the sphere centers were missed 
out. Now the sphere centers are used as a guide, with only one sphere center 
necessary to orientate the molecule and greater deviation from the sphere centers 
allowed. This does however significantly increase the computational time used by 
DOCK. 
The other new DOCK algorithm is the 'conformational' search. This allows 
the all rotatable bonds to be adjusted in situ, in the binding site, until the best scored 
orientation is found (e.g. figure 9.4). 
NH 
Figure 9.4: Example of the parts of a molecule altered by the 'conformational' algorithm. 
This alters the limited method that DOCK searched for potential ligands. Now 
DOCK performs a sophisticated cycle of adjustments to find the best ligand 
orientation, figure 9.5. 
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Figure 9.5: Overall schematic of the ligand binding process. 
Thus the new version of DOCK reduces the previous two main drawbacks to 
its use, namely the strong reliance on sphere centres to orientate the ligand and the 
use of rigid ligands. These improvements are made at the expense of computational 
resources. 
9.3.1 	Best Binding Site Model. 
The two basic binding site models that were explored in our studies are the 
substrate free binding site of the cytochrome P-450cam Y96A mutant both with and 
without a bound single oxygen species. Since camphor is not predicted as a substrate 
with the previous DOCK methodologies it was decided to use camphor as a robust 
test of the new DOCK suite. 
When using camphor, the heme bound oxygen artificially pushed the camphor 
away from the heme towards Val 244 and rotates it so that the camphor carbonyl 
points towards the heme, figure 9.6. This is clearly a camphor orientation that is 
inconsistent with the crystal structure and binding data. 
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Figure 9.6. Orientation of camphor outputted by DOCK using a heme bound oxygen in the binding 
site. 
However, when the oxygen species is removed and new scoring grids were 
calculated it was found that camphor adopted a realistic orientation, alibeit slightly 
different from the orientation in our Y96A mutant structure, figure 9.7. 
Figure 9.7: Orientation of camphor outputted by DOCK using a no heme bound oxygen in the binding 
site. 
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The use of a oxygen species in the binding site would appear to be more 
appropriate as it should more closely resemble the binding site prior to hydroxylation 
(see chapter 1). The non-oxygen system, although a better model for the initial 
substrate binding of the catalytic cycle, is not a realistic representation of the later 
stages and is thus not a good model for the hydroxylation step. This would suggest 
that the system without oxygen would be a good model for substrate binding 
prediction but that the active site with bound oxygen should be used in calculation of 
the potential hydroxylation sites. This however proves not to be entirely accurate as 
demonstrated above by the camphor system. The reason for this is probably not that 
the oxygen bound model is not a good representation of the hydroxylating species, 
but due to a number of inaccuracies in this model. Firstly it is not know if the binding 
site undergoes minor rearrangement during the catalytic cycle which could reorientate 
the substrate back towards the repulsive Van der Waals interactions with the oxygen. 
Secondly, and more importantly, the oxygen species modelled by DOCK is based on 
Van der Waals radii of 'normal' oxygen atoms. The species here is of unknown 
charge and it is likely that some of the electron density assigned to the oxygen by 
DOCK is distributed towards the iron and possibly the heme ring. This would thus 
make the radii of the oxygen atom less than that used by DOCK and therefore less 
repulsive to the substrate. Additionally to this DOCK cannot account for the 
interaction between a radial (if the oxygen species is indeed a radical) and the 
substrate. For these reasons it was decided that the oxygen free system is a better 
model for both the substrate binding and for calculating the potential hydroxylation 
site. For purposes of calculation of oxygen-substrate distances, a bound oxygen was 
added to the post calculation model but it was not present during the calculations 
performed in the DOCK run. 
9.3.2 	Selection of the Best Forcefield. 
Although it increases the computational time used by DOCK both energy and 
contact scoring were used. To examine the reliability of the scoring mechanism it was 
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decided to perform multiple DOCK runs with camphor. It was found that in all cases 
the lowest energy scored species was always in the same orientation irrespective of 
starting orientation. However when using the contact scoring system, different final 
orientations were produced (of equivalent score). All the orientations, upon 
examination, looked like plausible substrate binding orientation, however, they all 
significantly differed, both from each other and the low energy scored orientation. 
The reason behind the discrepancy between the contact and energy scoring is 
the reliance on fixed distance parameters for calculation of the atom-atom 
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Figure 9.8: Picture of the dependence on the distance for the ligand score. 
This effect was also examined for the other substrates and it was found that 
many of the contact scored orientations had binding orientations incompatible with 
known crystal data. However in some cases the contact scores had more feasible 
orientations therefore it was decided to score and model both methods. 
9.3.3 	Substrates Analysis. 
In order to understand the docking orientations of the molecules studied it is 
necessary to describe the important binding regions of the protein relative to some 
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fixed point of origin. For the purposes of clarity the binding site is always referred to 
similarly to the orientations used previously for the description of the crystal 
structure, figure 9.9. 
Phe 193 
0 	Phenyl pocket 
Phe87 c l- 1 > Val 247 
'Lower' ring 
Val 295 <- 
	
subzate 	
> Val 244 
heme 
Figure 9.9: Schematic of the P-450cam Y96A binding site showing important residues mentioned in 
the following chapter. Picture shows the method of defining the different substrate rings with the 
term 'upper' and 'lower'. 
A number of common substrate orientations exist in the binding site, identified by the 
DOCK simulations. The first is the hydrophobic binding pocket between Phe 87 and 
Val 247, called 'the phenyl pocket' the other binding regions are a pocket between Val 
295 and Asp 297 referred to as the 295/297 pocket and a region in front of Val 244 
referred to as the 244 pocket. 
9.3.4 	Understanding DOCK Output Files. 
In addition to providing the best ligand orientation for the contact scored and 
energy scored molecule, DOCK outputs a number of pieces of information which 
need to be explained if the result of the DOCK run is to be understood. The 'total 
conformations' reflects the number of unique substrate conformations that the DOCK 
routine could determine. Each one of these conformations was placed in the binding 
site to give between one and two million orientations per conformation ('orientations 
tried'). Of these orientation only a small number met the scoring criteria ('orientations 
scored'). The best scores are displayed for the contact and energy scores and the 
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difference between the orientation of the lowest energy scored molecule, for each 
scoring method, is displayed as an rmsd value. 
The orientation data gives an insight into the possible motion of the substrate 
in the binding site, as a low number of scored orientations would indicate low 
mobility. The scores for the substrates are only comparative but can be used to access 
the enzyme substrate recognition. The rmsq value for the two scoring methods 
assesses their complementarily. 
It should be noted that, with the exception of camphor, all other molecules 
were examined and are discussed without reference to their binding data. 
9.4 Results of DOCK Simulations. 
9.4.1 	Camphor and Adamantane Analogues. 
9.4.1.1 	Camphor. 
Camphor is a very inflexible molecule, indicated by only one conformation. 
The number of orientations scored for camphor was lower than for any of the other of 
the camphor/adamantane analogues, table 9. 1, indicating the strong enzyme substrate 
complementarily towards camphor. The contact score for camphor was higher here 
than for most other compounds, reflecting its smaller size, the energy score reflecting 
very favourable camphor interactions. 












2 1 789401 10000 -186.00 -22.18 1.25 
9.4.1.1.1 	DOCK Orientations of Camphor. 
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For the actual proposed position, the energy scored molecule occupies an 
orientation similar to that observed by the crystal structure except that the geniinal 
methyl groups are slightly 'lower' i.e. nearer the heme. This places their carbonyl 
pointing towards Ala 96, however the C5 and C6 positions are pulled slightly towards 
Leu 244, the geminal methyls pointing towards Val 295. The 5-exo or the 4 position 
are the likely hydroxylation sites. For the contact scored molecule the carbonyl points 
towards Thr 101 forming a potential H-bond with the side chain threonine oxygen. 
The rest of the molecule is slightly away form the heme centre and towards the 
295/297 pocket. In this case the C6 position could be the most likely to be 
hydroxylated. 
From this data it can be seen that DOCK successfully predicts camphor as a 
substrate for the enzyme. As stated previously the energy scored orientation is closer 
to the crystal data than the contact scored one, although the contact scored 
orientation does predict the second major product of the camphor hydroxylation (e. 
6-exo-hydroxycamphor). 
9.4.1.2 	Camphor Analogues. 
o
----  24 	 25 iII? 	
0 	 0 
26 
Compounds, 24, 25 and 26 are all smaller than camphor reflected in their low 
contact scores, table 9.2. 
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24 1 309673 20000 -179.00 -18.58 2.98 
25 1 99748 20000 -144.00 -12.11 3.63 
226EI:76 11214652 108141 -232.00 -24.03 1.23 
The energy scores are comparable for camphor, except for 25, which has a 
very poor score, probably due to its smaller size and lack of functionality. Compound 
26 is obviously more flexible than the others, since it is not a bicyclic system, and its 
large number of scored orientations could indicate that without a hydrogen bond it 
might exhibit poor stereoselectivity in its hydroxylation. 
9.4.1.2.1 	DOCK Orientations of 24, 25 and 26 
Compound 24 occupies a central position just above the heme. The energy 
scored molecule is positioned towards Val 297 and the contact scored molecule is 
towards Val 244, a theme seen in many more of the molecules studied. For the energy 
scored molecule C2, C3 and C4 are all equally near the heme but not in a particularly 
good orientation for hydroxylation. The energy scored molecule's carbonyl would 
seem to be able to hydrogen bond with Asp 297 however the contact scored 
molecule's carbonyl hydrogen bonds to Thr 252. All the hydrogens on the endo side 
of the ring are potential hydroxylation sites for both energy scored and contact scored 
models. 
Compound 25 is essentially the same as for 24, with the energy scored 
molecule towards the Val 295 and the contact scored molecule towards Val 244. For 
the contact scored molecule the orientation of the bicyclic ring is such that the 
bridgehead carbon is further most from the heme leaving all main ring carbons equally 
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positioned near the iron centre and thus none are in a sufficiently good hydroxylating 
position. 
For 26, both the scored options had the same basic orientation however with 
the alternate position of the side-chain carbonyl. The ring is towards the lower pocket 
between Val 295 and Asp 297. The molecule lies across the heme with the side chain 
near Leu 244. The nearest hydrogens are the single hydrogen on Cl or the hydrogen 
of the side chain methyl group. There are no discernable hydrogen bonds from the 
carbonyl groups to the enzyme. 
Thus from this data it can be concluded that, whilst all three compounds are 
probably substrates, the lack of complementarily of 26 and smaller size of 25 would 
make 24 the best of these compounds. 
9.4.1.3 	Adamantane and Adamantanols. 
OH 
OH 
10 	 27 	 28 
Although adamantane [10] is a rigid molecule, the lack of any functionality 
gives it multiple binding orientations, table 9.3. 












10 1 1772878 100000 -173.00 -17.39 3.16 
27 3 9188320 300000 -189.00 -22.18 3.30 
28 3 9281708 300000 -190.00 -22.09 3.27 
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This lack of functionality gives adamantane a poor contact score but a 
relatively worse energy score. Both adamantanols [27,28], have marginally improved 
scores compared to adamantane and both molecule share essentially the same DOCK 
profiles. 
9.4.1.3.1 	DOCK Orientations of 10, 27 and 28. 
For compound 10 the scored molecules are in slightly different orientations 
with the energy scored molecule slightly towards the 295/297 pocket and the contact 
scored molecule in the other direction towards Val 244. The three axial hydrogens on 
one 'hexane' ring are the most accessible to the heme. 
For 27 the orientations of the contact scored and energy scored molecules are 
virtually the same. The adamantane ring sits above the heme with minimal side chain 
interactions. The hydroxyl group is towards Glu 248 with the C2, C3, and C4 axial 
hydrogens all readily accessible to the heme for hydroxylation 
Compound 28 is in essentially the same orientation as 10, with the energy 
scored molecule slightly towards the 295/297 pocket and the contact scored molecule 
in the other direction towards Val 244. In both instances the hydroxyl group is 
pointing towards the heme ring at near Val 295 with the Cl-hydrogen and the axial 
C2 and C3 hydrogens are readily accessible by the heme. 
9.4.2 	General Orientations of Phenyl Substituted Substrates. 
Most of the following substrates have a aromatic ring, designed to fit into the 
pocket between Phe 87, Phe 98 and Val 247. For most of these substrates they do 
indeed have this orientation, figure 9.10. 
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Figure 9. 10 Compound 44, showing typical orientation of phenyl substituted substrates. 
This is a typical substrate orientation that can be used to visualize most of the 
orientations described below, with the aromatic ring in the 'upper' phenyl pocket and 
in this case the non-aromatic ring in the 295/297 pocket. 
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Diphenylmethane [13] binds with a relatively good score for both the contact 
and energy scored molecules, table 9.4. The scores for phenylcyclohexane [18] are 
essentially the same however the rmsd value would suggest the energy and contact 
scored molecules are in different orientations. Amyl benzene [29], again, has 
essentially the same scores as 13 and 18 although the higher number of 
conformations implies that the stereoselectivity could be poor. Bicyclohexyl [30] has 
a worse contact score than the others however the energy score is essentially the 
same. 
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13 20 20000000 13231 -230.00 -19.41 2.87 
18 6 6000000 11224 -222.00 -19.78 5.21 
29 40 40000000 543167 -233.00 -19.50 2.99 
30 3 3000000 2855 -196.00 -20.21 5.10 
9.4.3.1 	DOCK Orientations of 13, 18, 29 and 30. 
For diphenylmethane [13], for both the energy scored and contact scored 
molecules, one ring occupies the upper phenyl pocket. For the energy scored 
molecule the lower ring points down towards Thr 101, this leaves the C3 hydrogen 
the only one in any reasonable orientation towards the iron centre. The contact scored 
molecule is in a similar orientation to the crystal structure, with the lower ring 
pointing towards the heme so that the C3 and C4 positions could be hydroxylated. 
This is the first instance of the contact scored molecule having a more realistic 
orientation than the energy scored molecule. 
In the case of phenylcyclohexane [18], the energy scored molecule has the 
phenyl ring in the normal upper phenyl pocket and the aliphatic ring pointing down 
towards the heme, slightly towards Asp 297. This is an almost identical orientation to 
the crystal structure. However the contact scored orientation bizarrely has the two 
rings in the opposite positions with the aliphatic ring in the phenyl pocket. The reason 
for this orientation is unknown and this is the first time DOCK has preferentially 
placed an aliphatic ring in the phenyl pocket over a aromatic one. 
The orientations of amylbenzene [29], for both the energy scored and contact 
scored molecules are very different here. The energy scored molecule has the phenyl 
ring in the phenyl pocket with the aliphatic chain pointing down and towards Leu 244 
and Gly 248. The nearest hydrogen is on the C 1 carbon, i.e. second from the end of 
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the aliphatic chain. For the contact scored molecule the phenyl ring occupies the same 
position as the aliphatic chain of the energy scored molecule orientation. The aliphatic 
chain then coils round above the heme ring. Again the C 10 carbon is the nearest to the 
iron. 
For bicyclohexyl [30], one of the cyclohexane rings adopts the same 
configuration as a typical ring in the phenyl pocket, for both the contact scored and 
energy scored molecules. However the other ring is in a significantly different 
orientation in each case. The energy scored molecule lower ring sits towards Val 295 
with the axial-C4 carbon nearest the heme centre. The contact scored molecule lower 
ring however adopts an orientation on the other side of the pocket towards Leu 244. 
In this case both the axial-C4 and the equtorial-C3 are in a hydroxylating position. 
9.4.4 	Naphthalene Analogues. 
OH 
31003200 33 
35 	 36 
Both the tetrahydro [31] and dihydro [32] naphthalene have similar scores 
suggesting the extra hydrogens do not significantly alter the molecules, in this case, 
table 9.5. However, 33 has a better score for both the energy and contact scores 
suggesting the alcohol moiety actually enhances binding. 35 and 36 both have 
excellent contact scores suggesting a tight fit to the enzyme. 
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31 1 1477989 20000 -211.00 -18.54 4.18 
32 1 1256840 20000 -210.00 -18.19 0.91 
33 3 6000000 37784 -227.00 -20.90 0.64 
35 1 2000000 8219 -240.00 -20.20 3.04 
36 1 2000000 9324 -246.00 -20.00 3.11 
9.4.4.1 	DOCK orientations of 31, 32, 33, 35 and 36. 
Both energy scored and contact scored molecules are the same for 31. The 
orientation is not similar to any of the other previous substrates, i.e. instead of the 
aromatic ring orientating itself into the upper phenyl pocket, the substrate lies flat, in 
the same plane as the heme ring, figure 9.11. 
Figure 9.11: Orientation of 31 (green) iii the binding site, mth the heme group (yellow), Phe 87 and 
Phe 98 indicated (red). 
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The aliphatic ring is slightly towards Val 295. There are no obvious hydrogens 
for hydroxylation, although many of the aliphatic hydrogens could be in position with 
a small movement of the molecule away from Val 295. 
The orientation of 32 is similar to the 31 orientation, being planar and above 
the heme. The phenyl ring is towards Leu 244 in both cases. For the energy scored 
orientation the aliphatic ring is slightly towards Val 295, similar to the orientation of 
31, for the contact scored orientation, towards Thr 101. The orientation of the acyl 
bond is in both cases away from the binding site side chains. No hydrogens are in any 
obvious hydroxylation position, as for 31. 
Both the contact scored and energy scored molecules for 33 are the same as 
for the 31/32 with the phenyl ring towards Val 244 and the aliphatic towards Val 295. 
In this case the hydroxyl group points towards the heme on the Val 295 side of the 
binding site. 
Both energy scored and contact scored molecules are the same for 35, again 
the rings are in the same plane as the heme with the aliphatic ring towards Thr 252. 
This means both the aliphatic protons on one side are the only ones in hydroxylation 
range but the orientation is not particularly suitable for hydroxylation. 
The orientation of 36 is almost the same as for the unsaturated version, 35, 
except the aliphatic ring is further from the heme, more towards Val 396. In this case 
it is even more unlikely that hydroxylation would occur. 
The DOCK predictions for this range of substrates is that although they bind 
they do not fit into the aromatic pocket. This is consistent with the data that shows 
that these compounds are substrates for wild-type protein. 
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9.4.5 	Chlorinated Aromatics. 
CI 	 CI 	CI 
(rY 
38 	 39 
HO fl  "Y HN 	 HN 
CI 	 Ci 	 CI Ci 
37 	 61 60 
CI 
As discussed previously 38 and 39 are potentially of interest for crystallization 
studies although the tolerance of the enzyme for halogens is of interest. Both 
compounds fit inside the binding site, although with an extremely tight fit, shown from 
the low contact scores and the minimal number of orientations that bind, table 9.6. 












38 20 40000000 3444 -242.00 -20.17 5.21 
39 20 40000000 532 -249.00 -19.82 0.57 
37 50 50000000 0 * * * 
61 50 50000000 0 * * * 
60 1 1000000 0 * * * 
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9.4.5.1 	DOCK orientations of 38, 39, 37, 60 and 61. 
Both energy scored and contact scored orientations are the same for 38. One 
phenyl ring sits in the upper phenyl pocket, in the standard orientation. With the 
constraints placed on the molecule by the chlorine (needing a large space), the lower 
phenyl ring occupies the space in front of Leu 244, with a very close interaction 
between the ring and Leu 244 side chains. In both cases the C3 and C4 hydrogens are 
nearest but not in a particularly good orientation with the heme. 
Again for 39 both scored orientations are the same and are similar to 38 with a 
slight difference in angle of the lower ring, relative to the first, to allow for the extra 
chlorine. 
Molecules 37, 60 and 61 are all predicted by DOCK not to be substrates for 
the P-450cam Y96A mutant. These compounds are two large for the binding pocket 
and this is the first instance, in our study, of DOCK failing compounds as potential 
substrates. 
9.4.6 	Aliphatic Substituted Aromatics. 






DOCK suggests that these three molecules, 41, 42, and 43, are substrates for 
the Y96A mutant enzyme, table 9.7. The contact scores all have some of the best 
scores seen in any of the compounds studied, the energy scores being comparable. 
Despite a large number of potential orientations the number that could actually bind 
with the enzyme is comparatively low, indicating a good fit between the enzyme and 
these substrates 
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41 10 20000000 3175 -260.00 -21.38 2.43 
42 30 60000000 3098 -261.00 -19.08 4.96 
' 30 60000000 20863 -267.00 -18.92 	1 4.99 
9.4.6.1 	DOCK orientations of 41, 42 and 43. 
For 41, the contact scored and energy scored molecules are almost mirror 
images of each other. Both have the phenyl ring in the upper pocket, in the standard 
orientation. The energy scored molecule has the lower ring pointing towards Thr 101 
and the carbonyl group towards Val 396. The contact scored molecule has the 
aliphatic ring pointing towards Val 295 with the carbonyl towards Leu 244. Neither 
carbonyl would seem to have a preferred H-bond to the enzyme. The nearest 
hydrogen on the contact scored molecule is the axial-C4 however on the energy 
scored the equatorial-05 (0) hydrogen is nearest to the heme. 
In the case of 42 the energy scored molecule sits with the phenyl ring in the 
upper phenyl pocket which orientates the cyclohexane ring towards the iron centre, in 
a boat conformation. Both the C3 hydrogens are potential hydroxylation sites for the 
iron. The contact scored molecule has a different orientation with the cyclohexane 
ring towards the 295/297 pocket. This places all the C3 and C4 hydrogens within 
hydroxylation range of the iron. 
The contact scored orientation for 43 looks very strange at first glance with 
the molecule 'doubled up' in an implausible orientation so that the phenyl ring is next 
to Leu 244 and the cyclopentane ring in the 295/297 pocket, figure 9.12. 
The energy scored orientation however has the phenyl ring in the upper phenyl 
pocket with the cyclopentane ring slightly towards the 295/297 pocket. Both the C2 
hydrogens are potential hydroxylation sites. 
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Figure 912: The contact scored orientation ot 43 jeeii) in the binding site, with the heme group 
(yellow) Phe 87 and Phe 98 (red) indicated 
This is another example of the contact scored molecule scoring producing a 
unusual binding orientation. 
9.4.7 	Aromatically Substituted Nitrogen Heterocycles. 
0 	 0 	0 
44 LQ 
45 	 46 
0 
0 No 	 0 N 
47 	 48 
0 
 ~:b CO 
50c~~ 	51 
Compounds 44-49 all exhibit similar characteristics, with low contact scores 
and better than average energy scores, with a number of notable exceptions. Both 46 
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and 49 both have lower scores than the other compounds, indeed the energy score is 
considerably lower than most other compounds studied. A reason for this cannot 
immediately be ascertained. For 49, three orientations were modelled, two isomers 
and another structure from the crystal structure, all molecules showed a very tight fit 
to the enzyme with a very low number of orientations that bound. Although the 
contact scores for 49 are good the energy scores are some of the lowest seen for any 
substrate, suggesting that this would be a poor substrate for the enzyme. The only 
other molecule of note is 47 which has a slightly poorer energy score than the others 
but more importantly the rmsd between the two different scored molecules is 
significantly larger than the other molecules. Compounds 50 and 51 are structurally 
different from the other piperidine molecules studied however both bind extremely 
well with low scores for both the energy and contact scoring methods. For all these 
molecules, despite a large number of possible orientations, a low number of scored 
orientations were observed, indicating limited movement in the binding site and thus 
potentially high stereoselectivity. 












44 40 80000000 142 -217.00 -19.45 0.55 
45 4 8000000 292 -272.00 -23.85 0.51 
46 8 16000000 402 -173.00 -11.36 1.26 
47 40 80000000 2196 285.00 -17.77 5.72 






















50 4 8000000 1516 -254.00 -21.89 2.37 
51 3 6000000 2157 -264.00 -24.24 2.31 
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9.4.7.1 	DOCK orientations of 44, 45, 46, 47, 48, 49, 50 and 51. 
The energy scored and the contact scored orientations are essentially the same 
for 44. The phenyl ring occupies the upper phenyl pocket, the piperidine ring sits 
towards the 295/297 pocket, with the contact scored molecule being slightly nearer 
Asp 297 than the energy scored one. In both cases the C2, C3 and C4 hydrogens are 
near the heme, the C3 ones being the most likely candidate for hydroxylation. 
For 45 the energy scored and contact scored molecules are in identical 
orientations. The phenyl ring is in the upper phenyl pocket with the carbonyl pointing 
towards Leu 244, with no discernable hydrogen bond. The piperidine ring is 
orientated towards the 295/297 pocket so that the methyl groups sit above the heme 
ring. The nearest hydroxylation site for the iron is one of the methyl groups, none of 
the ring hydrogens are in range. 
Again for 46 both orientation are similar. The phenyl ring is in the upper 
pocket, the lower ring points towards the 297/295 pocket so that the ethyl group can 
orientate towards Thr 101 and Val 244. No apparent H-bond to the carbonyl exist. 
The nearest hydrogen bonds to the heme are the C3 hydrogens and the hydrogens on 
the first carbon of the ethyl group, the C3 hydrogens being in a slightly better 
orientation for hydroxylation. 
Both the contact scored and energy scored orientation are the same for 47. 
Again 47 is another instance of the aliphatic ring preferentially in the upper phenyl 
pocket over a aromatic ring. With the piperidine ring in the standard upper ring 
position. Neither of the oxygens in the ester linkage have potential hydrogen bonds. 
The phenyl ring orientates itself in the 295/297 pocket. The C2 on the phenyl ring is 
the closest hydrogen to the heme centre but is not in a good hydroxylating position. 
Both the 48 orientations look very strange at first glance, similar to that 
observed for 43. The energy scored molecule is doubled back on its self, with both the 
phenyl and piperidine rings pointing towards the heme. The intra molecular distances 
are too close for this to be an orientation. The contact scored molecule has the phenyl 
ring towards Asp 297 and the piperidine pointing up towards the upper phenyl 
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pocket. Again the molecule is bent back upon itself such that there are implausible 
intramolecular distances. 
There were three orientations modelled for 49, the pseudo stereoisomers 
about the amide bond (around the partial nitrogen-carbon double bond) and the 




~ N  =T 
Figure 9.13: Stereo isomers B and C of substrate 49. 
The conformation from the crystal structure, A, (same amide bond 
conformation as B 
) 
has the same orientation for contact scored and energy scored 
molecules, with the phenyl ring in the upper phenyl pocket. The piperidine ring sits 
towards the 297/295 pocket, so that the methyl groups point towards Val 396, figure 
9.14. 
Figure 9. 14:Orientations of isomer! and 2 for compound 49. 
The C2 and C2 methyl hydrogens are the nearest to the iron centre. The 
isomer with the same original stereochemistry as the crystal structure configuration, 
B, under went a rearrangement to adopt the same orientation as A. For the other 
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isomer, C, the phenyl ring in the phenyl pocket however the methyl groups pointed 
towards the heme, with the carbonyl group pointing towards Phe 87. This placed the 
methyl or trans-05 hydrogen nearest the heme. It is interesting to note that stereo 
isomer C actually under went a rotation around the pseudo double bond to change to 
isomer B (DOCK treats partial double bonds as single ones when performing 
orientation adjustments). The reason the molecule has not orientated itself to the same 
location as for B is because DOCK performs the rotation in situ and it is not possible 
to move the molecule into the orientation for isomer B. This would suggest that 
conformation B binds significantly better to the enzyme than conformation C. 
The phenyl ring of the energy scored molecule of 50 fits into the usual position 
in the upper pocket. This orientates the bicyclic ring towards the 295/297 pocket. The 
carbonyl groups are not hydrogen bonded to anything. The bicyclic ring carbonyl is 
the nearest group to the heme and no hydroxylation would seem possible. The contact 
scored molecule has the same upper ring conformation however the bicyclic ring is 
pointing over the heme and not towards the lower pocket. This orientation is the 
equivalent of the camphor position of the bicyclic ring and the nearest carbon-
hydrogen bond for hydroxylation is the equivalent of the 5-exo position on camphor. 
In both cases for 51 the phenyl ring is in the phenyl pocket in the normal 
orientation. There are slight differences in the adamantamine ring orientation with the 
energy scored molecule slightly towards the Asp 297 pocket the contact scored 
molecule is more centrally orientated. For the contact scored molecule the C6, C8 and 
C 10 axial hydrogens are all accessible however for the energy scored molecule both 
the hydrogens on the C6 carbon are the nearest to the heme. 
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9.4.8 	Oxygen-Heterocycles with Aromatic Sidechains. 
0"'00 	 0"'00- 	
oo 
52 53 	 54 
0 
0,101 	0 0 	 0 
C>— 0~ L,J 	56 57 
Compounds 52-55 essentially have the same scores, table 9.9. Both the energy 
and contact scores imply that these compounds would make good substrates, with 55 
having the one of the best energy scores of any compound. However there is a high 
number of scored orientations suggesting a potential lack of stereoselectivity. For 56 
the scores are slightly lower than for the other oxygen heterocycles however it would 
still appear to be a good substrate. 57, however, has a lower number of scored 
orientations despite a high number of conformations. This must mean a good 
substrate/enzyme recognition, which is supported by a good contact score. The 
energy score for 57 is extremely poor due to intramolecular clashes in this orientation. 
This would suggest that despite the close similarity to other substrates 57 could have 
very poor binding potential. 
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52 30 60000000 16871 -250.00 -24.23 2.35 
53 30 60000000 44199 -269.00 -30.43 4.60 
54 30 60000000 23071 -275.00 -25.45 4.98 
55 12 24000000 5673 -265.00 -28.47 2.89 
56 2 4000000 10799 -205.00 -18.85 4.90 
57 40 80000000 1606 -206.00 38.98 5.51 
9.4.8.1 	DOCK orientation of 52, 53, 54, 55, 56 and 57. 
Both the contact scored and the energy scored molecules for 52 have the 
phenyl ring in the upper pocket, however the pyran rings differ in orientation 
significantly. The energy scored molecule is orientated towards the 295/297 pocket 
so that the pyran oxygen and the trans-C3 hydrogen are nearest the heme. The contact 
scored molecule locates the pyran ring towards the Leu 244 pocket with the pyran 
oxygen and the trans-C6 hydrogen near the heme. With the closer orientation of the 
oxygen this should not produce a product. 
The energy scored molecule for 53 has its phenyl ring in the upper phenyl 
pocket. This orientates the furan ring towards the heme, and slightly towards Leu 
244. This places the trans-05 hydrogen and to a lesser extent the trans C3 and C4 
hydrogens in hydroxylation distance from the iron. This visually has a very good 
substrate binding for hydroxylation. The contact scored molecule has a strange 
orientation, seen for 43 and 48 with the phenyl ring doubled back on the furan ring, 
both above the heme, with the phenyl group towards Leu 244 and the fliran towards 
the 295/297 pocket. The contact scored molecule does not seem to be a realistic 
orientation as the intramolecular distances are too short. 
Again the orientations of 54 are similar to 43, 48 and 53. The contact scored 
molecule is in the 'doubled up' position with the phenyl towards Leu 244 and the 
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furan towards 295/297. The energy scored molecule orientates the furan ring towards 
Val 295 but not Asp 297 so that the cis-C4 hydrogen lies above the heme. However 
the energy scored molecule also orientates the furan oxygen to a position very close 
to the iron centre suggesting strong oxygen binding might be possible. 
The contact scored and the energy scored molecules of 55 look here like 
mirror images of each other with both molecules having the phenyl ring in the upper 
phenyl pocket. The energy scored molecule has the carbonyl pointing towards Val 
396 with the furan ring in the 295/297 pocket. This places the trans-C4 hydrogen near 
the iron centre. The furan oxygen is slightly further from the iron than the previous 
case but still might interfere with turnover. The contact scored molecule is orientated 
to place the carbonyl towards Leu 244 so that the furan ring sits in the 244 pocket. 
This places the trans-C4 hydrogen nearest the heme, again with the furan oxygen 
close to the iron. 
The energy scored molecule for 56 lies with one ring in the upper pocket and 
the other ring near Thr 101. The oxygen on the upper ring is nearest to lie 395 and in 
the lower ring to Leu 244. There are no easily discernable hydrogen bonds to either 
oxygen. The nearest carbon to the iron center is on CS on the lower ring, i.e. in the 
para position. If the lower ring was to move into a hydroxylating distance to the heme 
centre it should hydroxylate the equatorial hydrogen in preference to the axial. No 
other hydroxylation sites would seem to be preferred. The contact scored molecule 
lies perpendicular to the energy scored molecule (one parallel to the heme) in the 
orientation seen for the naphthalene derivatives 
The energy scored orientation of 57 has the phenyl ring in a lower position 
than the more normal orientation in the upper pocket. The furan ring is then bent 
round almost back double on the phenyl ring so that the methyl group is pointing 
towards Asp 251. This is a bizarre orientation possibly due to the length of the 
inflexible region between the furyl methyl group and the ether linkage. The C4 
hydrogen is the only one in hydroxylation range of the iron. The contact scored 
orientation is equally strange with the furyl ring in the upper pocket and the phenyl 
ring above the heme, parallel to it. In this case the C2 and C3 positions on the phenyl 




The results here clearly show that DOCK can predict substrates and dismiss 
non-substrates for the cytochrome P-450cam Y96A mutant system. The main 
question that remains is whether or not these predictions are valid. With the 
availability of binding and turnover data we can verify the DOCK scores and the 
importance of the number of orientations that each molecule has. For the prediction of 
substrate orientations we have available six crystal structures that we can use to test 
the reliability of this aspect of the DOCK program. 
9.5.1 	Validation of the DOCK Output Data. 
The comparison of the data for the DOCK runs and the experimental data is 
presented in table 9.10. 
For the prediction of whether a compound was a substrate for the P-450cam 
mutant system or not would seem to be supported by the data from the DOCK runs. 
Substrates 37, 60, and 61 have been shown not to be substrates for the mutant. From 
this and previous studies it has been shown that these compounds are indeed not 
substrates for the P-450cam mutant enzyme. None of the other compounds predicted 
as substrates have been shown to be non-substrates for the enzyme, unlike camphor in 
previous studies. 15-18 Thus DOCK appears a suitable method for the prediction of 
substrates for this mutantenzyme. 
The compounds with the largest number of scored orientations are the 
camphor and adamantane derivatives (>20,000 orientations scored) which all show 
poor product stereoselectivity. The compounds with the lowest number of scored 
orientations are the aromatically substituted piperidines (44-49) (<1000 orientations 
scored); these molecules show good stereoselectivity. The compounds with 
orientations between these values have stereoselectivity that is appropriate to their 
scores. This would thus suggest that DOCK can successfully predict the 
stereo selectivity of substrates based on the number of scored orientations. 
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The energy scoring method produces very similar scores for most molecules 
(- -20) thus suggesting that the method is not able to distinguish the binding 
properties based on the electrostatic interactions with the binding site. However 
molecules with a low energy score (> 15) proved to have high binding constants. The 
contact scoring produced a range of values for the compounds showing that DOCK is 
able to distinguish them from each other. 
The contact score would seem to reflect the size of the molecules with scores 
of >-200 for small molecules, -200 to -250 for the medium sized molecules and scores 
of <-250 for the molecules that fit well into the binding site. Once molecules become 
too big their scores reflect this by increasing to values >_200. The contact score can 
thus be used to determine how tight the fit is between the molecule and the binding 
site; parameters such as binding constants rely on other factors such as the substrate 
hydrophobicity etc. therefore cannot be determined from this data. 
The more useful information produced by the scoring is the lowest energy 
orientation. The validity of this can be measured against the six available crystal 
structures and the known hydroxylation sites. DOCK was able to predict the crystal 
orientations of all the molecules studied, either with the energy scored or the contact 
scored molecules. In the cases where the substrate was found to sit away from the 
heme towards the Val 295 pocket, DOCK successfully predicted this 
(phenylcyclohexane and bicyclohexyl). When the substrate was found to lie over the 
heme center again, DOCK predicts this (diphenylmethane). When it came to the more 
difficult molecule, 49, DOCK again managed to predict the binding orientations of the 
molecule. 
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Table 9.10: Comparison of DOCK predictions with experimental data. 
Compound binding 
prediction 




DOCK of product 
experimental product 
data 
2 good good 5-exo-hydroxy mostly 5-exo--hydroxy 
24 good - many many 
25 poor - 1-epoxide - 
26 good good no product no product 
10 poor poor many many 
27 poor poor many many 
28 poor poor many many 
13 good good 3,4-epoxide 3,4-epoxide 
18 good good 3,4-hydroxy 3,4-hydroxy 
29 good good 10-hydroxy 10-hydroxy 
30 good good 3,4-hydroxy 1 product 
31 OK OK none 1 product 
32 OK OK none 3,4-epoxide 
33 good good no product no product 
35 good - no product - 
36 good - no product - 
37 poor poor none 1 product 
38 poor poor none no product 
39 no no no product no product 
60 no no no product no product 
61 no no no product no product 
41 good good 2,3-epoxide 1 epoxide 
42 good good 3,4-hydroxy no product 
43 good OK no product no product 
44 good good 3-hydroxy 1 product 
45 good good none 1 product 
46 OK good 3-hydroxy 2 products 
47 good OK none 1 product 
48 good OK none 1 product 
49 OK OK 5-hydroxy 1 product 
50 good good 5-exo-hydroxy no product 
51 good - many - 
52 good OK no product no product 
53 good OK no product no product 
54 good OK no product no product 
55 good OK no product no product 
56 OK OK 5-hydroxy no product 
57 poor - no product no product 
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a- for prediction of product: none is used when data is unclear if any product will be produced, no 
product is used when that is the predicted result. 
The data from known hydroxylation sites or oxygen ligation would also seem 
to be supported by the DOCK orientations. The two adamantanols (27, 28) show the 
oxygen away from the heme which is consistent with the production of the diols. The 
oxygen heterocycles (52-56), which show oxygen ligation to the heme, are supported 
from DOCK data which shows that the oxygen molecules in the ring come into close 
proximity to the iron. Most molecules bind in the DOCK simulation with the para 
position of the non-aromatic ring nearest the heme which is consistent with the known 
binding properties and product data for these molecules. 
Thus it would seem that DOCK can predict the binding of substrates, to some 
extent predict stereo- and regio selectivity of the oxidation and what the orientation of 
the molecule is in the binding site. This makes DOCK a far superior method for 
molecular modelling that the method used in the previous chapter (chapter 8). 
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10 Future Work. 
10.1 Expansion of Current Studies. 
10.1.1 	X-ray Crystallography. 
Since we have discovered a large number of substrates for the cytochrome P-
450cam Y96A mutant, it could be of interest to expand the number of crystal 
structures. The current substrates are of a similar type and shape and it would be of 
interest to expand the knowledge of the cytochrome P-450cam binding site with new 
substrates. This might give an insight into the binding of halogenated compounds or 
how the naphthalene analogues bind. 
For the substrates with low solubility, crystallization by soaking the substrate 
into the crystal, rather than co-crystallization might be a preferred method and 
conditions would need to be developed to perform this. 
If other mutants are made it would be essential to have a x-ray crystal 
structure of the protein; as this study has shown the difficulty in predicting the 
changes made to the binding site upon mutagenesis. 
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10.1.2 	Molecular Modelling. 
DOCK has been shown to be relatively accurate in predicting the binding 
properties of a variety of substrates. It should prove of interest to examine other 
potential cytochrome P-450cam substrates with this technique. DOCK has, 
additionally, a search function that can examine commercial databases for substrates. 
If this was employed, a complete range of the Y96A substrates could be determined 
and then further analysis could be made of any that have potentially interesting 
products. 
10.2 Scale-up of Cytochrome P-450cam Biotransformation. 
A potential problem in the large scale production of hydroxylated products by 
the P-450cam is the fact that its catalytic cycle relies on NADH and two co-proteins, 
thereby tripling protein expression and purification costs. There are three possible 
solutions to this problem, which have not been extensively studied to date. One is the 
use of electrochemistry, that is attachment of the cytochrome P-450cam directly to an 
electrode thus removing the need for NADH, Pd or PdR. This has been attempted by 
research groups in both Oxford and Japan 1-5  however turnover is low and the protein 
denatures after a short time, preventing large scale production of hydroxyated 
products. 
An alternative is to use different electron transfer agents. 6 NADH turnover in 
the absence of Pd and PdR has been attempted previously 7  and been reported here. In 
all cases however the product yields are significantly smaller than the reconstituted 
system. If a new chemical agent becomes available then this technique might become 
viable although currently it is not commercially viable. 
The third alternative to enhance product turnover is the use of whole cell 
systems. Whole cell systems have the advantage of no protein purification of NADH 
addition is necessary as the host organism provides all necessary electron transfer 
agents. Whole cell hydroxylation can be performed with simple addition of substrate 
to a growing/resting cell culture and leaving it to metabolize the substrate. Product 
267 
(iHA.PFER I F (.YIIIRE WORK. 
isolation can be performed by organic extraction and one step separation from starting 
materials. 
It would seem from this that whole cell systems are better than purified 
systems however there are disadvantages to there use. In order to generate mutants of 
the required protein the gene must first be transferred to E.coli to perform the 
mutagenesis before being placed back into the host organism. This would therefore 
require shuttle vectors that are compatible with both the host and E.coli, which is 
severely limiting. The most efficient method would be to find a well characterized host 
system that has generic electron transfer proteins that will be compatible with all 
added cytochrome P-450s. The a suitable shuttle vector should be designed that is 
compatible with both E.coii and the host organism. This should be the most 
commercially viable method, although will require much exploratory experimentation. 
Even if this system was devised whole cell systems have one other disadvantage over 
the use of recombinant systems in that the required products might be degraded by 
other enzymes in the host organism, especially problematic are esterases. 
A alternative to transferring the gene for P-450cam back and forward between 
expression systems would be to use E.coii as the whole cell system. Our experiments 
with the E. coil reductases indicate that suitable co-proteins are not available in E. coil. 
One solution to this would be to express the P-450cam gene as a triple fusion protein 
(mimicking cytochrome P450BM-3). This was attempted by Montellano and co-
workers, although product yields were 10w. 8 Further experimentation with this system 
might allow successful product formation with E.coii as a biotransformant. 
10.3 Further Mutagenesis of Cytochrome P-450cam. 
Further mutagenesis of P-450cam should expand the substrate range, could 
prevent peroxide production or enhance stereoselectivity. For further expansion of the 
substrate range Phe 87 is a good residue to pick since it has an effect on both the 
binding site and substrate entry. Phe 193 is also a potential target as it would allow 
longer substrates that stick out of the binding site similar to the Pfizer inhibitors. 9 As 
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discussed earlier Thr 101 could be responsible for the increased peroxide production 
in the Y96A mutant and thus mutagenesis could remove this problem. Other 
mutations to the binding site around Thr 252 could also be made to prevent peroxide 
production however change to the delicate proton transfer pathway is potentially 
disruptive to turnover rates. If a particular stereoselective product is desired, small 
subtle changes to the binding site, especially the lower portion nearer the heme, could 
be made. Amino acids Val 244, and Val 295 are especially good targets for this as 
both control the hydrophobic pockets either side of the heme. 
If a particular target substrate is desired one technique that can be applied is 
directed evolution. One experiment that has recently been applied to cytochrome P-
450cam is random mutagenesis. Arnold and coworkers enhanced the ability of P-
450cam to hydroxylate naphthalene by use of directed evolution. 10 The main 
disadvantage of this methodology is the screening protocols. In order to find an 
effective mutant a quick simple screening protocol must be developed preferably using 
a colormetric assay. This currently limits the substrate range to compounds that 
change colour upon hydroxylation and ones that can be easily converted to coloured 
compounds. 
10.4 NMR Studies. 
Although, due to its size, the NTvIR structure of the P-450cam Y96A mutant 
cannot be determined, other N]'fR experiments are possible which will provide useful 
data on the substrate in the binding site. Structural information on the P-450cam 
binding site by NIVIR has been attempted as long ago as 1975, when water was 
detected in the vicinity of the heme. 1 ' Since then experiments have been performed on 
P-450's to detect the binding of substrate 12,13 and to observe changes to the binding 
site after mutagenesis. 14  It is also possible to detect the movement of residues in the 
binding site upon substrate binding. 15-17 Using information form the crystal structure 
of the mutant enzyme with bound substrates and from N1\'fR protein-substrate 
experiments, it should be possible to obtain dynamic information not accessible by X- 
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ray crystallography. Although preliminary experiments would suggest that this 
approach is not as quick and simple as literature experiments might imply (data not 
shown). 
10.5 Molecular Dynamics. 
Another area of potential research is extensive computational studies of the P-
450cam mutant protein. Molecular dynamics (MID) has been extensively used over the 
last five years to model aspects of the protein that cannot be determined by the crystal 
structure alone. These have included MID, explaining difference between predicted 
results (from X-ray structure) and experimental results of the thiocamphor 
hydroxylation by P450cam. 18  Extensive attempts have been made to predict products 
and product distribution from MD alone 19,20 and with the benefit of experimental 
verification. 2 1-25 It is this potential prediction of products that is of major interest to 
us. The modelling studies to date have only given crude details of the fit of a substrate 
within the binding site. MD can be used to give more realistic data on the enzyme 
substrate interaction, by allowing for bond flexibility of both the enzyme binding site 
residues and the substrate. Thus MID, in time, could accurately predict the products of 
mutant P-450cam hydroxylation without the need for any experimentation. 
Initial studies have indicated that this approach is successful at predicting the 
interaction between the substrate and the P-450cam Y96A mutant enzyme (data not 
shown). Although further analysis in this area is needed. 
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11 Appendix 1: Example datasets for the calculation 













0 	 2 
Total concentration of substrate in solution 
Figure 11.1: An example of the percentage binding curve generated by the method outlined in 
Chapter 4. In this case the substrate was compound 46. 
0.5000 
(1.5000) - 	 - 
log [S]free 	___-..--___ 
Figure 11.2: Example graph for calculation of KD, in this case for compound 43. 
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12 Appendix 2: The DOCK instruction file. 
flexible _ligand yes 
orient_ligand yes 
score_ligand yes 
minimize _ligand yes 
multiple_ligands no 
random—seed 0 
anchor search no 
torsion _drive yes 
clash—overlap 0.5 




receptor _sites yes 
random_ search yes 
ligand_centers no 
automated—matching yes 
maximum orientations 20000 




write configuration total 	10 
intramolecular_score yes 
intermolecular _score yes 
gridded_score yes 




contact _cutoff _distance 4.5 
contact—clash—overlap 0.75 
contact—clash—penalty 50 
chemical score no 
energy_score yes 
energy cutoff distance 10 
distance—dielectric yes 




vdw scale 1 














receptor _ site _file 
score_grid_prefix 













/hosts/gordon/usr6/adams/o4.0. 1  /parameter/vdw. defi 
/hosts/gordon/usr6/adams/oc4 0.1/parameter/flex. defn 
flex drive file 
/hosts/gordon/usr6/adams/o4 0.1 /parameter/flexdrive.tbl 
ligand_contact file 	hg_contact. mol2 
ligand_energy file hg_energy. mol2 
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13 Appendix 3: Example of DOCK output file. 
University of California at San Francisco, DOCK 4.0.1 




time 	Fri Dec 24 11:43:00 1999 
host—name gaffer 
memory limit 	 156712960 
working_directory 	/hosts!gordonJusr6Iadarn5/'04 0.1 /new/camphor 














—Flexible Liganci Parameters 
anchor _search 	no 
torsion drive yes 
clash—overlap 	o.s 




random _search yes 
ligand_centers no 
t automaed_matching yes 
maximum orientations 10000 
write _configurations yes 







grid _version 4 
bump_filter yes 
bump _maximum 0 
contact—score yes 
contact _cutoff _distance 4.5 
contact _clash _overlap 0.75 
contact clash_penalty 50 
chemical score no 
energy_score yes 
energy_cutoff_distance 10 
distance _dielectric yes 









initial translation 	1 
initial rotation 0.1 
initial torsion 	10 





ligand_ atom _file 	lig.mol2 
receptor _ site _file near. sph 
score_grid_prefix 	grid 
vdw_definition file /hosts/gordon/usr6/adams/dock_4 .0. 1/parameter/vdw. defn 
flex _definition_file 	/hosts/gordon/usr6/adams/dock_4. 0.1/parameter/flex. defn 
flex—drive—file 
/hosts/gordon/usr6/adams/dock4. 0. 1/parameter/flex_drive.tbl 
ligand_contact_file 
ligand_energy_file 





Reading general grid info from grid.bmp 
Reading bump grid from grid.bmp 
Reading contact grid from grid.cnt 
Reading energy grids from grid. nrg 
VDW grids use a 6-12 Lennard-Jones potential with a united atom model. 
Reading attractive VDW energy grid. 
Reading repulsive VDW energy grid. 
Reading electrostatic energy grid. 
Pocking—Results 
Name 	: CYHIX_BO 
Description 
Total conformations 	 : 	1 
Orientations tried 788786 
Orientations scored 	 : 	10000 
Best contact score 	 -182.00 
Intramolecular contact score 	 : 	0.00 
Intermolecular contact score : -182.00 
RMSD of best contact scorer (A) 	 : 	64.88 
Best energy score 	 : -22.17 
Intramolecular energy score 	 0.00 
Intermolecular energy score : -22.17 
RMSD of best energy scorer (A) 	 : 64.46 
Elapsed cpu time (sec) 	 : 206.51 
Finished processing molecule in 206.545 seconds. 
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